INDEX PROGRAM WELCOME LETTER TIME TABLES COMMITTEES. WEDNESDAY, OCTOBER 5th. THURSDAY, OCTOBER 6th. FRIDAY, OCTOBER 7th. SATURDAY, OCTOBER 8th

Transcription

1 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL INDEX WELCOME LETTER TIME TABLES COMMITTEES PROGRAM WEDNESDAY, OCTOBER 5th THURSDAY, OCTOBER 6th FRIDAY, OCTOBER 7th SATURDAY, OCTOBER 8th LOCATION MAP SPONSOR POSTERS CLINICAL CASES INDEX AUTHORS see pag 150 in the spanish version program see pag 184 in the spanish version program see pag 200 in the spanish version program

2

3

4 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL WELCOME LETTER Dear Colleague, It s a great honor for the Organizing Committee to welcome you to the II International Congress of Dual Pathology: Addictive Behaviors and Other Mental Disorders, to be held in the city of Barcelona. Dual Disorder, or what is the same, the concurrence of Substance Use Disorders and other mental disorders is a complex clinical reality that affects an increasingly important number of our patients. Following the success of the First International Congress held in Madrid in 2008, the Spanish Society of Dual Pathology (SSDP) calls again all professionals involved in Psychiatry, Addictions and Mental Health to perform an update in knowledge on this area and open a discussion focusing on the current challenge posed by the dual pathology in our everyday clinical practice. The aim of this Congress is to provide a platform where professionals of Psychiatry, Mental Health and Addictions, along with key opinion leaders in this field, update and share knowledge and experiences. The topics to be discussed are the etiopathogenesis, assessment, diagnosis, treatment and outcome of Dual Pathology. From advances in molecular biology, to the daily clinical practice and from prevention strategies, to social rehabilitation programs. In this Congress you will be able to find the most of the extensive and multiple disciplines related to Dual Disorders, which will be addressed through plenary sessions, symposia, workshops, meetings with the expert, oral communications and posters, in 32 routes grouped by subject areas, both in Spanish and English. Also, special symposia have been scheduled, in English, with the titles of Parallel Symposia on Self Medication and Self-Regulation in Dual Disorders and Rethinking Dual Disorders, in order 06

5 BARCELONA 5th-8th OCTOBER 2011 to prepare Task Forces aiming to study in depth both issues with the aim of presenting findings in the coming National Conference and the Second International Congress of Dual Pathology. The Organizing Committee are very proud of the sponsorship received from the most prestigious national and international Mental Health, Psychiatry, and Addiction institutions, which is reflected in its active participation in the Congress. We are confident that Barcelona will be a magnificent setting, with its two thousand years of history reflected in monuments, streets and museums and with its modern, cosmopolitan and Mediterranean ambient, which will help to enhance and promote the work of this Congress. We wish you a very active participation in the Conference and a pleasant stay in Barcelona. Yours sincerely Miguel Casas Congress Chairman Professor and Head Servei de Psiquiatria Hospital Universitari Vall d Hebron Universitat Autonoma de Barcelona Néstor Szerman President Spanish Society of Dual Pathology Sociedad Española de Patología Dual (SEPD) 07

6 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 18:00 18:30 19:00 19:30 20:00 Room 1 (Translation) S1-01 Bipolar Disorders W1-03 Child and Adolescent Psychiatry Room 2 (Translation) ME1-07 Meeting with the Expert S1-07 Legal Aspects Room 3 (Translation) W 1-01 Useful Psychotropic Drugs W1-04 Useful Psychotropic Drugs WEDNESDAY OCTOBER 5th 2011 Room 4 (Translation) Room 5 (Translation) Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Dialogue: Let s Talk About Drugs. Dra. Nora Volkow. Sponsored by Fundació La Caixa. Special Venue: CaixaForum Barcelona. (Av. Marquès de Comillas - Plaza España) Registration and Documentation Delivery S1-03 Behavioral Addictions and Gambling W1-05 Behavioral Addictions and Gambling S1-04 Sexual Dysfunction S1-09 Eating Disorders S1-05 Eating Disorders W1-02 Cannabis S1-80 Tobacco S1-10 Tobacco W1-06 Tobacco S1-11 Alcohol SS1-07 Alcohol PLI - 01 Book Presentation S1-12 Alcohol Assembly of the Sociedad Española de P. Dual Oral Communications CO1 Oral Communications CO2 08

7 BARCELONA 5th-8th OCTOBER 2011 THURSDAY OCTOBER 6th 2011 Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Room 5 (Translation) Room 4 (Translation) Colloquium with Dra. Nora Volkow (Invitation-only access) Room 1 (Translation) Room 2 (Translation) Room 3 (Translation) Breakfast with the Expert in DD and ADHD Breakfast with the Expert in DD and Opioid System Meeting with the expert in Dual D. and Anxiety S2-16 Multidisciplinary Approaches S2-85 Opioid System 08:30 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 Oral Comunications CO3 Rethinking Dual Diagnosis SS2-12 S2-18 Psychoestimulants and Dual Diagnosis S2-17 Impaired Doctors Oral Comunications CO5 S3-48 Evaluation S2-14 Opioid System W2-07 Tobacco S2-33 Tobacco Presentation SEPD ME2-01 SS2-04 Oral Anxiety Comunications ME2-02 CO4 SW2-01 Tobacco ME2-03 Lunch with Prof. Pedro Ruiz (Invitation-only access) S2-24 School Failure CC2-04 Clinical Case Contest in DD Working lunch: Tobacco S2-23 Psychoestimulants and Dual Diagnosis S2-22 Impaired Doctors S3-34 Spirituality and Dual Diagnosis S2-19 ADHD Oral Comunications CO6 Oral Comunications CO7 Self - Medication Hypothesis 17:30 18:00 18:30 19:00 S2-26 ADHD SS2-20 Opioid System SS2-01 Bipolar Disorder CCC2-01 Clinical Case Contest in ADHD I have a question for Dr. Nora Volkow CCC2-02 Clinical Case Contest in Opioid System S2-27 Opioid System S2-83 S2-25 Bipolar Disorder W2-09 Impaired Doctors S2-28 Bipolar Disorder S2-90 Spirituality and Dual Diagnosis S2-32 Resources Mangement S2-29 Tobacco S3-40 Epidemiology Oral Comunications CO8 Oral Comunications CO9 W2-10 Evaluation SS2-08 Depression S2-31 ADHD SS2-03 Bipolar Disorder S2-30 Psychoestimulants and Dual Diagnosis 09

8 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL 08:00 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 18:00 18:30 19:00 Room 1 (Translation) S3-87 Multidisciplinary Approaches S3-50 Multidisciplinary Approaches S3-51 Cannabis S3-57 Cannabis Room 2 (Translation) S1-08 Sexual Dysfunction S3-39 Transcultural Psychiatry S3-52 Epidemiology S3-58 Psychotherapeutic Treatment Room 3 (Translation) S3-78 Basic Research S3-86 Psychopharmac. Treatment SS3-05 Psychopharmac. Treatment Room 4 (Translation) S3-35 PTSD S3-42 PTSD W3-11 Psychopharmac. Treatment S3-81 Psychopharmac. Treatment S3-59 Impulsivity FRIDAY OCTOBER 7th 2011 Room 5 (traducción) Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Institutional Activity Breakfast The Brain and Dual Diagnosis. DRA. NORA VOLKOW S3-76 Sleep Disorders Lunch with S3-56 Cannabis S3-43 Evaluation ME3-05 S3-37 Basic Research ME3-06 the Expert S3-44 Psychosis W3-29 Psychopharmac. Treatment S3-53 Suicide S3-60 Suicide Rethinking the Dual Diagnosis S3-61 Multidisciplinary Approaches S2-13 Personality Disorders W3-30 Psychopharmac. Treatment S3-82 Multidisciplinary Approaches Self-Medication Hypothesis S3-38 Child and Adolescent Psychiatry S13-01 Oral CCC3-03 Best Poster in DD Contest S3-84 Psychosis S3-45 Basic Research W3-12 Psychopharmac. Treatment S3-77 Legal Aspects W3-13 Legal Aspects S3-46 Child and Adolescent Psychiatry Communications CO10 SS3-06 Oral Communications CO11 S3-63 Useful Psychotropic Drugs S3-62 Basic Research Oral Communications CO12 10

9 BARCELONA 5th-8th OCTOBER :30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 Room 1 (Translation) S4-64 Gender S4-66 Gender Room 2 (Translation) W4-14 Personality Disorders S4-67 Personality Disorders S4-72 Personality Disorders Room 3 (Translation) W4-15 Multidisciplinary Approaches S4-68 Resource Management S4-73 Resource Management Room 4 (Translation) W4-16 Psychotherapeutic Treatment S4-69 Resource Management W4-24 Psychotherapeutic Treatment SATURDAY OCTOBER 8th 2011 Room 5 (Translation) Room 6-7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 15 W4-23 Gender W4-27 Child & Adolescent Psychiatry S4-65 Multidisciplinary Approaches W4-17 Multidisciplinary Approaches W4-18 Child & Adolescent Psychiatry W4-19 Multidisciplinary Approaches W4-20 Psychotherapeutic Treatment S2-55 Depression S4-70 Multidisciplinary Approaches W4-21 Multidisciplinary Approaches S4-71 Child & Adolescent Psychiatry W4-22 Multidisciplinary Approaches W4-25 Psychotherapeutic Treatment S4-74 Multidisciplinary Approaches W4-26 ADHD S4-88 Child & Adolescent Psychiatry W4-28 Multidisciplinary Approaches 11

10 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL PRESIDENT OF HONOUR S.M. La Reina Dª Sofía COMMITTEES ORGANIZING COMMITTEE Coordinator: Dr. Carlos Roncero Dr. Joan Alvarós Costa Dr. José M. Argüello Alonso Sra. Diana Bachiller Valdenebro Sra. Thais Ballabriga Córdoba Dra. Mª Carmen Barral Picado Dr. Miquel Bel Aguado Sra. Rosa Bosch Munsó Dr. Eugeni Bruguera Cortada Dra. Natalia Calvo Piñero Prof. Miguel Casas Brugué Dr. Xavier Castells Cervelló Sr. Eduardo Castrillo Alonso Dr. Francisco Collazos Sánchez Sra. Marina Comín Zafón Dra. Margarita Corominas Roso Sra. Montserrat Corrales de la Cruz Dr. Joan Creixell Sureda Sra. Constanza Daigre Blanco Dr. Andrea Di Genova Dr. Ángel Egido Polo Sr. Francisco Eiroa-Orosa Sra. Sònia Fuentes Trillas Sr. Oriol Esteve Mejías Dr. Marc Ferrer Vinardell Sra. Sara Guila Fidel Kinori Dra. Gideoni Fusté Coetzee Sra. Susana Gómez-Baeza Dra. Nuria Gómez Barros Dra. Begoña Gonzalvo Cirac Dra. Lara Grau-López Sra. Lidia Huguet Bové Dr. Carlos Jacas Escarcelles Sra. Mª Victoria López-Craver Dra. Cristina López-Ortiz Sra. Carolina López Pérez Dr. Carlos Martínez Aparicio Dra. Nieves Martínez-Luna Dra. Laia Miquel de Montagut Dr. José Eduardo Montejo Celis Sra. Elisabeth Monterde Ochoa Dra. María Cecilia Navarro Marfisis Dr. José Antonio Navarro-Sanchis Sra. Gemma Nieva Rifa Sra. Mariana Nogueiras Morais Sra. Begoña Olivares Mariscal Sra. Yasmina Pallares Dra. Gloria Palomar Martínez Dra. Gemma Parramón Puig Dra. Marta Quesada Franco Dr. Adil Qureshi Dra. María del Mar Ramos Gascón Dr. Josep A. Ramos Quiroga Dr. Alberto Real Dasi Dra. Marta Ribasés Haro Dra. Vanesa Richarte Fernández Sra. Cristina Rivas Pérez Sra. Laia Rodríguez-Cintas Sra. Lola Rodríguez-Martos Dra. Amanda Rodríguez Urrutia Dra. Ana María Romaguera Piñol Dra. Naia Sáez Francás Sra. Cristina Sánchez Mora Sra. Vanessa Sentís Benito Dr. Sergi Valero Ventura Sra. Nuria Voltes Manils 12

11 BARCELONA 5th-8th OCTOBER 2011 ACADEMIC COMMITTEE Coordinator: Prof. Adolf Tobeña Prof. Joseba Achotegui (Universidad de Barcelona) Prof. Enric Álvarez (Universidad Autónoma de Barcelona) Prof. Javier Álvarez (Universidad de Valladolid) Prof. Celso Arango (Universidad Complutense de Madrid) Prof. José Luis Ayuso (Universidad Autónoma de Madrid) Prof. Enrique Baca (Universidad Autónoma de Madrid) Prof. Elisardo Becoña (Universidad de Santiago de Compostela) Prof. Miguel Bernardo (Universidad de Barcelona) Prof. Alfonso Blanco Picabia (Universidad de Sevilla) Prof. Julio Bobes (Universidad de Oviedo) Prof. Antoni Bulbena (Universidad Autónoma de Barcelona) Prof. Alfredo Calcedo Barba (Universidad Complutense de Madrid) Prof. José Luis Carrasco (Universidad Complutense de Madrid) Prof. Miguel Casas (Universidad Autónoma de Barcelona) Prof. Leonardo Casais (Universidad de Cádiz) Prof. Jorge Cervilla (Universidad de Granada) Prof. Benedicto Crespo (Universidad de Santander) Prof. Juan Gibert Crespo (Universidad de Cantabria) Prof. Enrique Echeburua (Universidad del País Vasco) Prof. M. Dolores Franco (Universidad de Sevilla) Prof. José Giner (Universidad de Sevilla) Prof. Ana González Pinto (Universidad del País Vasco) Prof. José Guimón (Universidad del País Vasco) Prof. Cristobal Gastó (Universidad de Barcelona) Prof. Diego Gracia (Universidad Complutense de Madrid) Prof. Manuel Gurpegui (Universidad de Granada) Prof. Miguel Gutiérrez (Universidad del País Vasco) Prof. Antonio Labad (Universidad Rovira i Virgili) 13

12 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL Prof. Carmen Leal (Universidad de Valencia) Prof. Giner Llorca (Universidad de Salamana) Prof. Antonio Lobo (Universidad de Zaragoza) Prof. Juan José López-Ibor (Universidad Complutense) Prof. María Inés López-Ibor (Universidad Complutense) Prof. Raimundo Mateos (Universidad de Santiago de Compostela) Prof. José Manuel Menchón (Universidad de Barcelona) Prof. Leopoldo Ortega-Monasterio (Univ.Inter. Catalunya) Prof. Tomás Ortiz (Universidad Complutense de Madrid) Prof. Tomás Palomo Ortiz (Universidad Complutense de Madrid) Prof. Antonio Pérez-Urdaniz (Universidad de Salamanca) Prof. Miguel Roca (Universitat Illes Balears) Prof. Luis Rojo (Universidad de Valencia) Prof. Gabriel Rubio (Universidad Autónoma de Madrid) Prof. Jerónimo Sáiz (Universidad de Alcalá de Henares) Prof. Lluís Sánchez-Planell (Universidad Autónoma de Barcelona) Prof. Pilar A. Sáiz (Universidad de Oviedo) Prof. Marta Torrens (Universidad Autónoma de Barcelona) Prof. Rafael Torres (Universidad de Granada) Prof. Rafael Torrubia (Universidad Autonoma de Barcelona) Prof. Manuel Valdés (Universidad de Barcelona) Prof. Julio Vallejo (Universidad de Barcelona) Prof. Francisco José Vaz (Universidad de Extremadura) Prof. José Luis Vazquez-Barquero (Universidad de Cantabria) Prof. Eduard Vieta (Universidad de Barcelona) 14

13 BARCELONA 5th-8th OCTOBER 2011 LOCAL SCIENTIFIC COMMITTEE Coordinator: Prof. Miguel Casas Dr. José Oñorbe Dr. Joan Colom Prof. Jerónimo Sáiz Prof. Julio Bobes Dr. Néstor Szerman Dra. Teresa Brugal Dr. Manuel Alfonso Dr. Carlos Álvarez-Vara Prof. Javier Álvarez Prof. Emilio Ambrosio Dr. Francisco Arias Dr. Francisco Babín Dr. Ignacio Basurte Dra. M. Dolores Braquehais Dr. Eugeni Bruguera Dr. Luis Caballero Dr. Gaspar Cervera Dr. Miguel Del Río Dr. Xavier Ferrer Dra. Rosa Fernández-Marcote Prof. M. Dolores Franco Dr. Francesc Freixa Dr. Antoni Gual Dr. Josep Guardia Prof. Miguel Gutiérrez Dr. Gonzalo Haro Dr. Ioseba Iraurgi Dr. Miguel Ángel Jiménez-Arriero Dr. Miguel Landabaso Dra. Pilar Lusilla Prof. Rafael Maldonado Dr. José Martínez-Raga Dra. Beatriz Mesías Dra. Enriqueta Ochoa Dr. Cesar Pascual Dr. José Pérez de los Cobos Dra. Cristina Pinet Dr. Carlos Pino Dr. Guillermo Ponce Dr. Juan Ramírez Prof. J. Antoni Ramos-Atance Dr. Carlos Roncero Prof. Gabriel Rubio Prof. Pilar A. Sáiz Dr. Luis San Dra. Amparo Sánchez Dra. Mar Sánchez Dr. Manuel Sanchis Fortea Prof. Joaquin Santo-Domingo Dr. Pere Antoni Soler Insa Dr. Antonio Terán Prof. Marta Torrens Dr. Joan Trujols Dr. Rafael Valenciano Dr. Xavier Valls Dr. José María Vázquez Dr. Pablo Vega 15

14 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL INTERNATIONAL SCIENTIFIC COMMITTEE Coordinator: Prof. Miguel Casas Prof. Pedro Ruíz Prof. Enrique Camarena Prof. Antonio Abad (USA) Dr. Luis Alfonzo (USA) Prof. Philip Asherson (United Kingdom) Prof. Tarek A. Asaad (Egypt) Prof. Marc Auriacombe (France) Prof. Edgard Belfort (Venezuela) Dr. Amine Benyamina (France) Prof. Enrique Camarena (México) Dr. Alfredo Cia (Argentina) Dr. Jean Pierre Daulouede (France) Dr. Javier Didia (Argentina) Prof. Nady El-Guebaly (Canada) Prof. Gabriele Fischer (Austria) Dra. Celia Franco (Portugal) Prof. Marc Galanter (USA) Prof. Alan Green (USA) Prof. Christian Haasen (Germany) Dra. Debora Hasin (USA) Prof. Thomas Kosten (USA) Prof. Mary Jeanne Kreek (USA) Prof. Frances Levin (USA) Prof. Roberto Lewis (USA) Prof. Karl Mann (Germany) Prof. Icro Maremmani (Italy) Dr. Ivan Montoya (USA) Prof. Charles P. O Brien (USA) Dr. Luis Patricio (Portugal) Dra. Lola Peris (Switzerland) Dr. Michel Reynaud (France) Prof. Pedro Ruiz (USA) Prof. Leo Sher (USA) Prof. John Strang (United Kingdom) Prof. Manuel Trujillo (USA) Prof. Ambros Uchtenhagen (Switzerland) Prof. Win Van Den Brink (The Netherlands) Dra. Elvia Velásquez (Colombia) Prof. Roger Weiss (USA) Prof. Robert West (United Kingdom) 16

15 BARCELONA 5th-8th OCTOBER 2011 LOCAL ADVISORY COMMITTEE Coordinator: Dr. Eugeni Bruguera Sra. Nuria Espí Sra. Cristina Molina Prof. Jerónimo Sáiz Prof. Julio Bobes Dr. Néstor Szerman Dr. Conrad Casas Dra. Fanny Batlle Dr. Pere Bonet Dr. Garbiñe Caminos Dr. Indalecio Carrera Dr. Claudio Castillo Dra. M. Luisa Celorrio Dr. Javier Correas Dr. Bartolomé De La Fuente Dra. Begoña De Pablo Dr. Joan De Pablo Dr. Juan del Pozo Irribarria Dra. Celia Del Pino Dra. Rosario Demetrio Dra. Marina Díaz-Marsá Dr. Ángel Díaz-Ruano Dra. Nieves Domenech Dra. Mª Dolores Domínguez Dra. Marisa Dorado Dra. Pilar Duro Dr. Jesús Ezcurra Dr. Francisco Ferre-Navarrete Dra. Francina Fonseca Dr. Rafael Forcada Dr. Óscar Galera Dr. José María García-Basterrechea Dr. Fernando Gómez-Pamo Dr. Iñaki Madariaga Dr. Antonio Marcos Dr. Gregorio Martín Dra. Ángela Rita Martín Caballero Dr. Manuel Martín-Carrasco Dr. Manuel Martínez Dr. Manuel Mas-Baga Dr. Antonio Medina Dr. Carlos Mingote Dra. Marisol Mondragón Dr. José Manuel Montes Dr. José Manuel Morante Dra. Mª José Moreno Dr. Javier Ogando Dr. Ricardo Ortega Dr. Diego Palao Dr. César Pascual Fernández Dr. Víctor Pedreira Crespo Dr. César Pereiro Dr. Francesc Pérez-Arnau Dr. Bartolomé Pérez-Gálvez Dr. Víctor Pérez-Solà Dr. Carlos Pino Dr. Félix Poyo Dra. Carmen Puerta Dr. Javier Quintero Dr. José Luis Rabadán Dr. Emilio Rojo Dr. Salvador Ros Dr. Vicente Rubio Dra. Aimée Ruiz Dra. Amparo Sánchez Dra. Mar Sánchez Dr. Francisco Vidal Pardo Dr. Julio Zarco Dr. José Miguel Zoido 17

16 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL INTERNATIONAL ADVISORY COMMITTEE Coordinator: Dr. Nestor Szerman (España) Prof. Margarita Alegría (EEUU) Dr. José Arias (Paraguay) Dra. Flory Barrantes (Costa Rica) Prof. Carlos Blanco (EEUU) Dra. Usoa E. Busto (Canadá) Dr. Carlos Cabán (Puerto Rico) Dra. Susana Calero (Argentina) Dr. Rodrigo Chamorro Oschilewski (Chile) Dr. Humberto Guajardo (Chile) Dra. Cecilia Idiarte Borda (Uruguay) Dr. Eduardo Kalina (Argentina) Dr. Arturo Lerner (Israel) Prof. Carlos León (Ecuador) Dr. Daniel Martinez Aldunate (Chile) Dr. César Mella (República Dominicana) Dra. Maristela G Monteiro (Brasil) Prof. Rafael Navarro Cuevas (Perú) Dr. Nils Noya Tapia (Bolivia) Prof. Álvaro Olaya (Colombia) Prof. Maria Oquendo (EEUU) Dr. Saúl Pacururu (Ecuador) Prof. Flavio Pechansky (Brasil) Prof. Emma Saad de Janon (Ecuador) Prof. Ismael Salazar (Guatemala) Dr. Cesar Sánchez Bello (Venezuela) Dr. Daniel Seijas (Chile) Dr. Juan Triaca (Uruguay) Prof. Leopoldo Zarate (México) 18

17 BARCELONA 5th-8th OCTOBER II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL PROGRAM

18 WEDNESDAY OCTOBER 05th II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL

19 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 18:00 18:30 19:00 19:30 20:00 Room 1 (Translation) S1-01 Bipolar Disorders W1-03 Child and Adolescent Psychiatry Room 2 (Translation) ME1-07 Meeting with the Expert S1-07 Legal Aspects Room 3 (Translation) W 1-01 Useful Psychotropic Drugs W1-04 Useful Psychotropic Drugs WEDNESDAY OCTOBER 5th 2011 Room 4 (Translation) Room 5 (Translation) Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Dialogue: Let s Talk About Drugs. Dra. Nora Volkow. Sponsored by Fundació La Caixa. Special Venue: CaixaForum Barcelona. (Av. Marquès de Comillas - Plaza España) Registration and Documentation Delivery S1-03 Behavioral Addictions and Gambling W1-05 Behavioral Addictions and Gambling S1-04 Sexual Dysfunction S1-09 Eating Disorders S1-05 Eating Disorders W1-02 Cannabis S1-80 Tobacco S1-10 Tobacco W1-06 Tobacco S1-11 Alcohol SS1-07 Alcohol PLI - 01 Book Presentation S1-12 Alcohol Assembly of the Sociedad Española de P. Dual Oral Communications CO1 Oral Communications CO2

20 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER TRACK INDEX Track 03 BIPOLAR 16:00 17:30 TEMPERAMENTS, BIPOLAR SPECTRUM AND SUBSTANCE ABUSE. CLINICAL AND THERAPEUTICAL ASPECTS Room 1 Track 9 EATING 16:00 17:30 ADVANCES IN EATING AND DUAL DIAGNOSIS: FROM ADDICTIVE MODEL TO CLINICAL PRACTICE Room 6 17:30 19:00 ADDICTIVE AND FOOD : NEW BIOLOGICAL, CLINICAL AND PHARMACOLOGICAL PERSPECTIVES Room 6 Track 10 CHILD AND ADOLESCENT PSYCHIATRY 17:30 19:00 BEFORE THE NEEDLES. MULTIDISCIPLINARY DRUG COUNSELLING AND TREATMENT FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS Room 1 Track 16 ALCOHOL AND DUAL DIAGNOSIS 16:00 17:30 NEW PHARMACOLOGICAL TREATMENTS VERSUS TRADITIONAL TREATMENTS FOR DUAL DIAGNOSIS ALCOHOLICS Room 11 16:00 17:30 ALCOHOLISM AND DUAL DIAGNOSIS Room 12 17:30 19:00 TREATMENT OF ALCOHOLIC PATIENS PRESENTING DUAL DIAGNOSIS Room 12 Track 18 CANNABIS AND DUAL DIAGNOSIS 16:00 17:30 DIFFICULT CLINICAL CASES IN DUAL. CANNABIS Room 8 Track 19 TOBACCO AND DUAL DIAGNOSIS 16:00 17:30 SMOKING IN MENTAL HEALTH AND ADDICTION SETTINGS Room 9 17:30 19:00 HUMAN MODELS IN TOBACCO AND ITS RELATIONSHIP WITH DUAL DIAGNOSES Room 8 17:30 19:00 IMPLEMENTING A SMOKE-FREE PSYCHIATRIC UNIT Room 9 22

21 WEDNESDAY 05th OCTOBER 05 Track 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS 16:00 17:30 THE AMERICAN EXPERIENCE: MODEL OF INTEGRATION BETWEEN PSYCHOPHARMACOLOGY INTERVENTION AND CLINICAL GROUP PSYCHOTHERAPY PRACTICE Room 3 17:30 19:00 MANAGEMENT OF THE PATIENT WITH DUAL DIAGNOSIS IN HOSPITAL EMERGENCY DEPARTMENT Room 3 Track 26 SEXUAL DYSFUNCTION AND DUAL DIAGNOSIS 16:00 17:30 DRUGS AND SEXUALITY Room 5 Track 27 LEGAL ASPECTS IN DUAL DIAGNOSIS 17:30 19:00 THE FORENSIC PERSPECTIVE IN DUAL DIAGNOSIS Room 2 Track 29 BEHAVIORAL ADDICTIONS AND GAMBLING 16:00 17:30 PATHOLOGICAL GAMBLING AND DUAL DIAGNOSIS Room 4 17:30 19:00 CURRENT TENDENCIES IN THE INTEGRAL MANAGEMENT OF PATHOLOGICAL GAMBLING Room 4 23

22 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 10:00 13:00 DIALOGUE: LET S TALK ABOUT DRUGS Sponsored by Fundación La Caixa Dr. Nora Volkow. NIDA Director. USA. Venue: CaixaForum Barcelona (Av. Marquès de Comillas - Plaza España) Room 1 16:00 17:30 SYMPOSIUM S1-01 Track 03 BIPOLAR TEMPERAMENTS, BIPOLAR SPECTRUM AND SUBSTANCE ABUSE. CLINICAL AND THERAPEUTICAL ASPECTS Chair/Presenter: Prof. Icro Maremmani, University of Pisa. Italy TOWARDS A UNITARY PERSPECTIVE ON THE BIPOLAR SPECTRUM AND SUBSTANCE ABUSE: OPIATE ADDICTION AS A PARADIGM Prof. Icro Maremmani, University of Pisa, Italy THE EFFECTS OF PSYCHIATRIC SEVERITY ON THE OUTCOME OF OPIOID AGONIST MAINTENANCE TREATMENT Dr. Pier Paolo Pani, ASL8, Cagliari, Italy COCAINE ABUSE IN ALCOHOLICS: EVIDENCE FOR A BIPOLAR CONNECTION Dr. Matteo Pacini, G. de Lisio Institute of Behavioural Sciences, Pisa, Italy DUAL DIAGNOSIS AND CHRONOLOGY OF ILLNESS HEROIN DEPENDENT PATIENTS Dr. Angelo Giovanni Icro Maremmani, University of Pisa, Italy. Room 2 16:00 17:30 MEETING WITH THE EXPERT ME1-07 Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. 24

23 WEDNESDAY 05th OCTOBER 05 Room 3 16:00 17:30 WORKSHOP W1-01 Track 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS THE AMERICAN EXPERIENCE: MODEL OF INTEGRATION BETWEEN PSYCHOPHARMACOLOGY INTERVENTION AND CLINICAL GROUP PSYCHOTHERAPY PRACTICE Dr. Ricardo Restrepo Guzmán, M.D., M.P.H. Director, The Addiction Psychopharmacology Clinic at The Addiction Institute of New York. USA. FIRST STEP MODEL: INTEGRATED PSYCHOTHERAPY WITH CO-OCCURRING DISORDED CLIENTS Dr. Claudia Arlo, LCSW, CGP. Clinician/Coordinator, First Step Program at The Addiction Institute of New York. USA. INTEGRATED OFFICE-BASED TREATMENT: THE CONCEPT OF AN ADDICTION PSCHOPHARMACOLOGY CLINIC Dr. Ricardo Restrepo Guzmán, M.D., M.P.H. Director, The Addiction Psychopharmacology Clinic at The Addiction Institute of New York. USA. Room 4 16:00 17:30 SYMPOSIUM S1-03 Track 29 PATHOLOGICAL GAMBLING AND DUAL DIAGNOSIS BEHAVIORAL ADDICTIONS AND GAMBLING Chair/Presenter: Dr. César A. Sánchez Bello. Sección de Juego Patológico y Otras Adicciones Comportamentales APAL. Unidad de Atención Integral de Juego Patológico, Hospital I.V.S.S. Luis Ortega, Porlamar, Isla de Margarita, Venezuela. PERSONALITY AND PATHOLOGICAL GAMBLING Dr. Enrique Echeburúa. University of País Vasco, San Sebastián, País Vasco, Spain. ANXIETY AND PATHOLOGICAL GAMBLING Dr. Alfredo Cía. APSA, Buenos Aires, Argentina. AFFECTIVE AND PATHOLOGICAL GAMBLING Dr. César A. Sánchez Bello. APAL. I.V.S.S. Porlamar, Margarita, Venezuela. ADDICTIVE AND PATHOLOGICAL GAMBLING Dr. Elisardo Becoña. Universidad Santiago de Compostela. Galicia, Spain. 25

24 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 5 16:00 17:30 SYMPOSIUM S1-04 Track 26 DRUGS AND SEXUALITY SEXUAL DISFUNCTION AND DUAL DIAGNOSIS Dr. Ángel Luis Montejo. Psychiatry Service. Hospital Clínico Universitario de Salamanca. Spain. SUBSTANCE ABUSE, SEXUAL DYSFUNCTION AND PHARMACOLOGICAL PSYCHIATRIC TREATMENTS Dr. Ángel Luis Montejo. Psychiatry Service. Hospital Clínico Universitario de Salamanca. Spain. COCAINE, ALCOHOL AND SEXUAL ADDICTION Dr. José Antonio Navarro Sanchis. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Room 6 16:00 17:30 SYMPOSIUM S1-09 Track 09 EATING ADVANCES IN EATING AND DUAL DIAGNOSIS: FROM ADDICTIVE MODEL TO CLINICAL PRACTICE Dr. Ignacio Basurte Villamor. Psychiatry Service. Hospital Gregorio Marañón. Madrid. Spain. TCA ADDICTIVE MODEL Prof. Luis Rojo. Professor of Psychiatry, University of Valencia. Head of Section of Child and Adolescent Psychiatry and Eating Disorders, University Hospital La Fe, Valencia, Spain. IMPULSIVITY, EATING AND DUAL PATHOLOGY Dr. Marina Díaz Marsá. Hospital San Carlos. Associate Professor. Universidad Complutense. Madrid. Spain. DAILY CLINICAL PRACTICE OF EATING AND DUAL PATHOLOGY Prof. Francisco Ferre Navarrete. Head of Psychiatry. Eating Disorders Program. Hospital General Universitario Gregorio Marañón, Madrid, Spain. 26

25 WEDNESDAY 05th OCTOBER 05 Room 8 16:00 17:30 WORKSHOP W1-02 Track 18 DIFFICULT CLINICAL CASES IN DUAL. CANNABIS CANNABIS AND DUAL DIAGNOSIS Charis: Dr. Luis Caballero. Psychiatrist Hospital de Día. Hospital Universitario Puerta de Hierro de Majadahonda, Madrid. Spain. Dr. Lola Baño. Psychiatrist. CAID Majadahonda, Madrid. Spain. MOOD (FIRST PSYCHOTIC EPISODE) AND CANNABIS ABUSE Dr. Lidia Fernández Mayo. Clínica Doctor León. Madrid, Spain. CANNABIS PSYCHOSIS AND DISSOCIATIVE EPISODE FOR VARENICLINE Dr. Marisa Martín Calvo. Hospital Universitario Infanta Elena. Madrid, Spain. DIFFICULTY OF DIAGNOSIS AND TREATMENT OF FIRST EPISODE PSYCHOTIC ASSOCIATED TO CANNABIS DEPENDENCE Dr. Clara Pelaéz Fernandez. CSM Villalba. Universitario Puerta de Hierro. Madrid, Spain. Room 9 16:00 17:30 SYMPOSIUM S1-10 Track 19 SMOKING IN MENTAL HEALTH AND ADDICTION SETTINGS TOBACCO AND DUAL DIAGNOSIS Dr. Sílvia Mondon. Psychiatrist. Alcohol Unit, Department of Neurosciences, Hospital Clínic de Barcelona, Spain. SMOKING TREATMENT IN PSYCHIATRIC PATIENTS Dr. Antònia Raich. Psychologist. Mental Health Division. Xarxa Assistencial Althaia. Manresa. Spain. VARENICLINE TREATMENT FOR SMOKING CESSATION IN ADDICTION AND MENTAL HEALTH PATIENTS Dr. Mª Cristina Pinet. Unit of Addictive Behaviors. Psychiatry Service. Hospital Santa Creu i Sant Pau. Barcelona, Spain. SECOND-HAND SMOKE IN MENTAL HEALTH AND ADDICTION UNITS Dr. Montse Ballbè. Psychologist. Catalan Network of Smoke-free Hospitals, Institut Català d Oncologia. Hospital Clínic de Barcelona. Spain. 27

26 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 11 16:00 17:30 SYMPOSIUM S1-11 Track 16 ALCOHOL AND DUAL DIAGNOSIS NEW PHARMACOLOGICAL TREATMENTS VERSUS TRADITIONAL TREATMENTS FOR DUAL DIAGNOSIS ALCOHOLICS Dr. Eduardo Kalina. Director Psiquiatría Biológica Argentina. NEW PHARMACOLOGICAL TREATMENTS VERSUS TRADITIONAL TREATMENTS FOR DUAL DIAGNOSIS ALCOHOLICS Dr. Eduardo Kalina. Director Psiquiatría Biológica Argentina. THE CONSULTATION BECAUSE OF ALCOHOL AND DRUGS IN THE GENERAL HOSPITAL: CLINICAL PROBLEMS Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. NALTREXONE IN THE TREATMENT OF PATIENTS WITH SELF-AGRESSIVE BEHAVIORS AND DRUG ABUSE Dr. Ricardo Rojas. Buenos Aires. Argentina Room 12 16:00 17:30 SYMPOSIUM SS1-07 Track 16 ALCOHOLISM AND DUAL DIAGNOSIS ALCOHOL AND DUAL DIAGNOSIS Prof. Julio Bobes. Professor of Psychiatry. University of Oviedo. Spain THE ALICE RAP PROJECT Dr. Antonio Gual. Senior Consultant. Alcohol Unit. ICPP. ICN. IDIBAPS. Hospital Clínic. Barcelona, Spain. ALCOHOL DEPENDENCE AND DUAL DIAGNOSIS Dr. Antonio Terán. Coordinador del Centro Ambulatorio de Atención a Drogodependientes San Juan de Dios. Palencia, Spain. ALCOHOL AND DEPRESSION IN DUAL DIAGNOSIS Dr. Félix Poyo. Unidad de Desintoxicación Alcohólica. Hospital Rodríguez Lafora. Madrid, Spain. 28

27 WEDNESDAY 05th OCTOBER 05 Room 16 16:00 17:30 ORAL COMMUNICATIONS CO1 EATING, PSYCHOESTIMULANTS, SEXUAL DISFUNCTION, BEHAVIORAL ADDICTIONS AND GAMBLING Dr. Joan Alvarós. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain SUBSTANCE USE, MOOD AND COMORBID MOOD AND SUBSTANCE USE IN BINGE EATING DISORDER Carlos Grilo 1, Daniel Becker 2 1 Yale University School Of Medicine. USA. 2 University of California, San Francisco. USA COMMON PERSONALITY PSYCHOPATHOLOGY IN DAUGHTERS DIAGNOSED WITH EATING AND THEIR MOTHERS Mónica Moreno Aguilera, Carmen Valle Trabadelo Universidad CEU San Pablo. Spain COMPARISON OF THE EFFECTS OF ORAL OLANZAPINE AND SODIUM VALPROATE ON AGGRESSIVENESS IN METHADONE MAINTENANCE PATIENTS: A RANDOMIZED TRIPLE BLIND CLINICAL TRIAL Fatemeh Sheikhmoonesi 1, Mehran Zarghami, Jamshid Yazdani, Shahram Ala, Samaneh Farnia, Nasrin Bali Lashak Psychiatry And Behavioral Sciences Research Center, Mazandaran University Of Medical Sciences, Sari, Mazandaran,Iran 4.00 COMPLICATIONS FROM DRUG AND/OR ALCOHOL COSUME Humberto Guajardo Sáinz, Diana Kushner Lanis Facultad De Ciencias Médicas Universidad De Santiago De Chile 5.00 FORENSIC ASSESSMENT OF PATHOLOGICAL GAMBLING Ludvik Nábìlek, Ján Vongrej F.D.Roosevelt Hospital. Slovak Republic. 29

28 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 6.00 DUAL PSYCHIATRIC DIAGNOSIS AND SUBSTANCE ABUSE IN PATHOLOGICAL GAMBLERS Pinhas Dannon, Oded Rosenberg, Moshe Kotler Tel Aviv University & Beer Yaacov MHC. Israel INTERVIEWS WITH FORMER VIDEO GAME ADDICTS COMORBIDITIES AFTER TERMINATION OF PATHOLOGICAL GAMING Paula Bleckmann, Th. Mößle, F. Rehbein Criminological Research Institute of Lower Saxony, Hannover, Germany 8.00 RELATIONSHIP BETWEEN COPING STRATEGIES, SENSATION SEEKING, AND ATTACHMENT STYLES ON SUBSTANCE ABUSE TRENDS Majid Shafiei Amiri, Samira Ariaie far Azad University Young Researchers Club. Iran DOES STRESS COPING SKILLS TRAINING ENHANCE THE SOCIAL ADJUSTMENT IN ADDICTED WOMEN? Mehdi Dehestani, Mortezr tarkhan Payame Noor University. Iran. 30

29 WEDNESDAY 05th OCTOBER 05 Room 1 17:30 19:00 WORKSHOP W1-03 Track 10 BEFORE THE NEEDLES. CHILD AND ADOLESCENT PSYCHIATRY MULTIDISCIPLINARY DRUG COUNSELLING AND TREATMENT FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS Dr. Camilla Urhammer-Weltz. Psychologist. Copenhagen, Denmark. MULTIDISCIPLINARY WORK EFFORTS Dr. Camilla Urhammer-Weltz. Psychologist. Copenhagen, Denmark. DIAGNOSING CLIENTS HAVING SUBSTANCE USE, WITH PSYCHIATRIC Dr. Mie Bonde. Consultant of Child- and Adolescent Psychiatry and Drug Advisory Counsellor. Copenhagen, Denmark. EXISTENTIAL PSYCHOTHERAPY Dr. Silas Houlberg. Psychologist. Copenhagen, Denmark. Room 2 17:30 19:00 SYMPOSIUM S1-07 Track 27 THE FORENSIC PERSPECTIVE IN DUAL DIAGNOSIS LEGAL ASPECTS IN DUAL DIAGNOSIS Chairs: Prof. Leopoldo Ortega-Monasterio. Universidad Internacional de Cataluña e IMLC. Barcelona, Spain. Dr. Esperanza L. Gómez Durán. Universidad Internacional de Cataluña y CAEM. Barcelona, Spain. IMPUTABILITY IN DUAL DIAGNOSIS Prof. Leopoldo Ortega-Monasterio. Universidad Internacional de Cataluña e IMLC. Barcelona, Spain. CRIMINOLOGIC ASPECTS IN DUAL DIAGNOSIS Dr. Esperanza L. Gómez Durán. Universidad Internacional de Cataluña y CAEM. Barcelona, Spain. SAFETY MEASURES IN DUAL DIAGNOSIS Dr. Amadeo Pujol Robinat. Jefe del Servicio de Clínica Médico-Forense. Institut de Medicina Legal de Catalunya. Barcelona, Spain. 31

30 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 3 17:30 19:00 WORKSHOP W1-04 Track 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS MANAGEMENT OF THE PATIENT WITH DUAL DIAGNOSIS IN HOSPITAL EMERGENCY DEPARTMENT Dr. Helen Dolengevich Segal. Hospital de Henares. Madrid, Spain. DILEMMAS IN THE MANAGEMENT OF PATIENTS WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Helen Dolengevich Segal. Hospital de Henares. Madrid, Spain. THE PSYCHOTIC PATIIENT WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Fernando Mora Mínguez. Hospital Infanta Leonor. Madrid, Spain. THE AGITATED PATIENT WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Javier Correas Lauffer. Hospital de Henares. Madrid, Spain. THE PATIENT WITH EATING AND DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Rodrigo Puente García. Hospital de Henares. Madrid, Spain. CHILDREN AND ADOLESCENTS WITH DUAL DIAGNOSIS IN THE EMERGENCY DEPARTMENT Dr. Javier Quintero Gutiérrez del Álamo. Hospital Infanta Leonor. Madrid, Spain. 32

31 WEDNESDAY 05th OCTOBER 05 Room 4 17:30 19:00 WORKSHOP W1-05 Track 29 BEHAVIORAL ADDICTIONS AND GAMBLING CURRENT TENDENCIES IN THE INTEGRAL MANAGEMENT OF PATHOLOGICAL GAMBLING Chair/Presenter: Dr. César A. Sánchez Bello. Sección de Juego Patológico y Otras Adicciones Comportamentales APAL. Unidad de Atención Integral de Juego Patológico, Hospital I.V.S.S. Luis Ortega, Porlamar, Isla de Margarita, Venezuela. Room 6 17:30 19:00 SYMPOSIUM S1-05 Track 09 EATING ADDICTIVE AND FOOD : NEW BIOLOGICAL, CLINICAL AND PHARMACOLOGICAL PERSPECTIVES Prof. Luis Fernando Alguacil Merino. Professor of Pharmacology, Universidad San Pablo CEU, Madrid. Spain. AN EVOLUTIONARY PERSPECTIVE ON HUMAN BEHAVIOUR: THE CASE OF EATING BEHAVIOUR Prof. Laureano Castro Nogueira. Professor at UNED, Madrid. Spain. ADDICTION MODEL OF EATING Dr. Luis Beato Fernández. Director of the Eating Disorders Unit. General Hospital. Ciudad Real. Spain. EXPERIMENTAL MODELS OF ADDICTION AND EATING : BRIDGING THE GAP BETWEEN BASIC AND CLINICAL RESEARCH Prof. Luis Fernando Alguacil Merino. Professor of Pharmacology, Universidad San Pablo CEU, Madrid. Spain. NEW TRENDS IN THE PHARMACOLOGICAL TREATMENT OF ADDICTION AND EATING Prof. Cecilio Álamo González. Pharmacology Professor. University of Alcalá. Madrid, Spain. 33

32 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 8 17:30 19:00 SYMPOSIUM S1-80 Track 19 TOBACCO AND DUAL DIAGNOSIS HUMAN MODELS IN TOBACCO AND ITS RELATIONSHIP WITH DUAL DIAGNOSES Prof. Robert West. Department of Epidemiology and Public Health. University College London, UK. TOBACCO ADDICTION AND CANNABIS CONSUMTION AND DUAL Dr. Arkaitz Colina. Centre de soins en addictologie Bizia. DESS de Neuropsychopharmacologie et addictologie. Bayonne Cedex, France. DEPENDENCIA DE TABACO Prof. Benedicto Crespo. Universidad de Santander, Spain. DEPENDENCIA DE TABACO Y SOMATIZACIONES Dr. García Campayo. Liaison Psychiatry Service and Psychosomatics. Hospital Clinico Universitario. Zaragoza, Spain. Room 9 17:30 19:00 WORKSHOP W1-06 Track 19 IMPLEMENTING A SMOKE-FREE PSYCHIATRIC UNIT TOBACCO AND DUAL DIAGNOSIS Chairs: Dr. Margarita Cano. Drug Addiction Care Center. Psychiatry Service. Hospital de Mataró. Barcelona. Spain. Dr. Sílvia Mondon. Psychiatrist. Alcohology Unit. Hospital Clínic de Barcelona. Barcelona. Spain. Room 11 17:30 18:30 BOOK PRESENTATION PL1 01 Chairs: Dr. Carlos Roncero. Hosp. Univ. Vall d Hebron-ASPB. UAB. Spain. Dr. Pablo Vega. Instituto de Adicciones. Madrid, Spain. Dra. Carmen Barral. Hosp. Univ. Vall d Hebron-ASPB. UAB. Spain. 34

33 WEDNESDAY 05th OCTOBER 05 TREATING DRUG PROBLEMS. A GUIDE TO THE THERAPIST. HOW TO OVERCOME TOBACCO, ALOCHOL AND DRUGS? Miguel del Nogal Tomé. Psychologist. Drug Center Dr. Santanero. Cruz Roja. Madrid, Spain. EMOTION WORK IN ADDICTIVE Prof. Dr. Humberto Guajardo Sáinz. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. CLINICAL AND THERAPEUTIC ASPECTS OF ADDICTIVE COMORBIDITY Dr. Mario Souza y Machorro. Academia Mexicana de Patología Dual. México, D.F. Mexico. Dr. Jorge Ocampo. Academia Mexicana de Patología Dual, AMEPAD. Mexico City, Mexico. Room 12 17:30 19:00 SYMPOSIUM S1-12 Track 16 ALCOHOL AND DUAL DIAGNOSIS TREATMENT OF ALCOHOLIC PATIENS PRESENTING DUAL DIAGNOSIS Dr. Josep Guardia Serecigni. Addictive Behaviors Unit. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, Spain. TREATMENT OF ALCOHOLIC PATIENS PRESENTING DUAL DIAGNOSIS Dr. Enriqueta Ochoa Mangado. Psychiatrist. Psychiatrist. Department of Psychiatry Ramón y Cajal Hospital in Madrid. Spain. IS A SHIFT POSSIBLE IN THE PARADIGM OF ALCOHOLISM TREATMENT? Dr. Josep Guardia Serecigni. Addictive Behaviors Unit. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, Spain. HARM REDUCTION PROGRAMS IN ALCOHOLIC PATIENTS WITH DUAL DIAGNOSIS Dr. Pedro Cuadrado Callejo. Psychiatrist. Centro de Salud Mental del Retiro de Madrid. Spain. 35

34 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 16 17:30 19:00 ORAL COMMUNICATIONS CO2 ALCOHOL Dr. Gideoni Fusté. AS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain THE ALCOHOL PROBLEM IN SPAIN. HOW TO PREVENT IT? María Del Sol Roncero Rodríguez Centro De Salud Mental Alcorcón. Spain ASSESSING LEVELS OF FAMILY COHESION WITH THE PRESENCE OF AN ALCOHOLIC; METHODOLOGICAL PROGRESS IN THE INTERVENTION PROGRAMS: DESIGN- ANALYSIS INTERRELATION Publio Virgilio Salinas Carrizales 1 Universidad Autónoma De Tamulipas. Mexico AXIS I COMORBIDITY IN ALCOHOL DEPENDENCE Aravind Vaithiyam 1, Krishnaram Devendran, Thasneem Zainab Ram Psychiatry Hospital. India DIFFICULT DIAGNOSIS: ANXIETY VS ADHD INADEQUATE TREATMENT: BZB VS METHYLPHENIDATE IN THE ALCOHOLIC PATIENT Anna Lligoña Garreta Hospital Clínic De Barcelona. Spain DIFFERENT SUBSTANCE USE MOTIVES PREDICT INTERNALIZING VS. EXTERNALIZING MENTAL HEALTH CO-MORBID WITH SUBSTANCE USE IN A CLINICAL SAMPLE OF ADOLESCENTS Sherry H. Stewart 1, S. Battista 1, A. Pencer 1, 2, H. Durdle 1, 2, M. McGonnell 1, J. Alaghband-rad 1, 2, A. M. Joyce 2, A. Brochu 1 S. Doucette 1 1 Dalhousie University, Halifax, Nova Scotia, Canada. 2 IWK Health Centre, Halifax, Nova Scotia, Canada. 36

35 WEDNESDAY 05th OCTOBER PERSONALITY AND GRAVITY IN THE ALCOHOL DEPENDENCE. PSYCHOMETRIC FINDINGS OF THE NEO-PI-R Sergi Solé Plans 1, Vicky Sánchez López 2, Daniel Fernández Rodríguez 3, Federico Arévalo 2, Cristina Salanova Otero 2, Teresa Aparicio Reinoso 2, Diego Barral Tafalla 2, Estefanía Cotrina González 2 Félix Poyo Calvo 2 1 Centro de Salud Mental de Adultos Horta, Barcelona. Spain. 2 Hospital Dr. Rodríguez Lafora, Madrid. Spain. 3 Facultad de Psicología, Universidad Autónoma de Madrid, Madrid. Spain RESPONSE INHIBITION AS A MODERATOR OF THERELATIONSHIP BETWEEN IMPULSIVITY AND ALCOHOL USE Linda Dinc, Andrew Cooper Goldsmith s College, University of London, United Kingdom EVALUATIVE STUDY OF THE STANDARDS OF ALCOHOL CONSUMPTION AND PSYCHOPATHOLOGY IN PATIENTS INSERTED IN OPIOID SUBSTITUTION PROGRAMS IN CENTRO DAS TAIPAS Lucas Manarte 1, Inês Cargaleiro 2, Luisa Mendes 3, Domingos Duran 3, Luis Patricio 3 1 Hospital De Santa Maria. Portugal. 2 Centro Hospitalar Lisboa Ocidental. Portugal. 3 Centro das Taipas - I.D.T. Portugal FAMILY AS A FACTOR IN RELATION BETWEEN DEPRESSION AND ALCHOHOLISM Snezana Svetozarevic, Jasmina Barisic, Perisa Simonovic, Slobodan Simic Institute Of Mental Health, Belgrade, Serbia MULTIPLE SUBSTANCE USE AND POLYDRUG USE IN A CLINICAL SAMPLE OF ADOLESCENTS Christopher Martin Western Psychiatric Institute And Clinic, Department of Psychiatry, University Of Pittsburgh. USA. Room 11 18:30 20:00 ASSEMBLY OF THE SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL 37

36 THURSDAY OCTOBER 06th II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL

37 THURSDAY OCTOBER 6th 2011 Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Room 1 (Translation) Room 2 (Translation) Room 5 (Translation) Room 3 (Translation) Room 4 (Translation) Colloquium with Dra. Nora Volkow (Invitation-only access) Breakfast with the Expert in DD and ADHD Breakfast with the Expert in DD and Opioid System 08:30 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 Meeting with the expert in Dual D. and Anxiety S2-16 Multidisciplinary Approaches S2-85 Opioid System Oral Comunications CO3 Rethinking Dual Diagnosis SS2-12 S3-48 Evaluation S2-14 Opioid System S2-18 Psychoestimulants and Dual Diagnosis W2-07 Tobacco S2-17 Impaired Doctors Oral Comunications CO5 S2-33 Tobacco Presentation SEPD ME2-01 SS2-04 Oral Anxiety Comunications ME2-02 CO4 SW2-01 Tobacco ME2-03 Lunch with Prof. Pedro Ruiz (Invitation-only access) S2-24 School Failure CC2-04 Clinical Case Contest in DD Working lunch: Tobacco S2-23 Psychoestimulants and Dual Diagnosis S2-19 ADHD S2-22 Impaired Doctors S3-34 Spirituality and Dual Diagnosis Oral Comunications CO6 SS2-20 Opioid System SS2-01 Bipolar Disorder Oral Comunications CO7 Self - Medication Hypothesis 17:30 18:00 18:30 19:00 S2-26 ADHD S2-83 W2-09 Impaired Doctors CCC2-01 Clinical Case Contest in ADHD S2-28 Bipolar Disorder CCC2-02 Clinical Case Contest in Opioid System I have a question for Dr. Nora Volkow S2-25 Bipolar Disorder S2-90 Spirituality and Dual Diagnosis S2-27 Opioid System S2-29 Tobacco S3-40 Epidemiology Oral Comunications CO8 Oral Comunications CO9 W2-10 Evaluation S2-32 Resources Mangement SS2-08 Depression S2-31 ADHD SS2-03 Bipolar Disorder S2-30 Psychoestimulants and Dual Diagnosis

38 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER TRACK INDEX Track 00 SELF-MEDICATION 15:00 18:00 SELF MEDICATION HYPOTHESIS Room 6 Track 02 DEPRESSION 16:30 18:30 AGOMELATINE, NEW EXPECTATIONS FOR PATIENTS WITH DEPRESSION Room 5 Track 03 BIPOLAR 11:30 13:30 ASENAPINE IN DUAL BIPOLAR PATIENTS Room 3 13:30 15:30 DUAL BIPOLARITY: CLINICAL AND THERAPEUTICAL PROGRESS Room 3 15:30 17:00 BIPOLAR DISORDER AND COMORBIDITY VIEWED BY PSYCHOPHARMACOLOGY, NEUROIMAGING, NEUROPSYCHOLOGY AND PSYCHOTHERAPY Room 12 17:00 19:00 TWO SIDES OF DUAL DIAGNOSIS IN BIPOLAR DISORDER: PRESENT AND FUTURE Room 3 Track 04 ANXIETY 09:00 10:30 DUAL DIAGNOSIS AND GAD: INSOMNIA AS A CONSTANT Room 9 11:00 12:30 THE APPROACH TO GENERALIZED ANXIETY AND ITS COMORBIDITIES IN DAILY CLINCAL PRACTICE: CLINICAL WORKSHOPS Room 9 14:00 15:00 GAD, TOBACCO AND SUBSTANCE ABUSE: EPIDEMIOLOGICAL ANC CLINICAL IMPLICATIONS Room 9 Track 06 ADHD 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND ADHD Room 5 11:00 13:00 NEUROBIOLOGICAL BASIS OF COMORBIDITY BETWEEN ADHD AND SUBSTANCE USE Room 1 13:00 14:30 ADVANCES IN DUAL ADHD Room 1 14:30 16:00 CLINICAL CASE IN DUAL DIAGNOSIS IN ADHD CONTEST CCC2 01 Room 1 16:30 18:30 ADHD SYMPOMTS IN HIGH RISK ADULT POPULATIONS: COCAINE USERS AND PARENTS OF CHILDREN WITH ADHD Room 4 Track 13 IMPAIRED DOCTORS AND DUAL DIAGNOSIS 10:30 12:30 NEW CHALLENGES IN TREATING ADDICTIONS IN HEALTH CARE WORKERS Room 4 12:30 14:30 DOCTORS WITH DUAL DIAGNOSIS? PAIME (PROGRAMA DE ATENCIÓN INTEGRAL AL MÉDICO ENFERMO) CASES Room 4 14:30 16:30 STRATEGIES FOR PREVENTING, DIAGNOSING AND TREATING DUAL PATHOLOGY IN HEALTH CARE PROFESSIONALS Room 4 Track 14 EVALUATION PROCESSES 09:30 11:00 EVALUATION PROCESSES IN DUAL DIAGNOSIS Room 1 17:00 18:30 USING ELECTRONIC MEDICAL RECORD REMOTE DATA ACCESS TO COMPARE INPATIENT BED UTILIZATION IN THE 12 MONTHS PRE AND POST RESIDENTIAL SUBSTANCE ABUSE TREAMTMENT (RRTP) Room 11 40

39 THURSDAY 06th OCTOBER 06 Track 15 OPIOID SYSTEM AND DUAL DIAGNOSIS 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND OPIOIDS Room 4 09:30 11:30 OPIOIDS, ALCOHOL AND PSYCHIATRIC COMORBIDITY Room 2 09:30 11:30 SUPPORT FOR OPIOID DEPENDENT PATIENTS Room 11 11:30 13:30 BUPRENORPHINE/NALOXONE: AN OPIOID WITH USEFUL PSYCHOTROPIC PROPERTIES IN DUALLY DIAGNOSED OPIATE-DEPENDENT PATIENTS Room 2 13:30 15:00 CLINICAL CASE IN DUAL DIAGNOSIS AND OPIOIDS CONTEST CCC2 02 Room 2 15:00 17:00 DUAL DIAGNOSIS IN HEROIN AND COCAINE ADDICTS: FROM PAST TO PRESENT. CHALLENGES FOR THE FUTURE Room 2 Track 17 PSYCHOESTIMULANTS AND DUAL DIAGNOSIS 10:30 12:30 DUAL DIAGNOSIS AND STIMULANTS (COCAINE, PACO, PASTA, BASE) IN THE CITY OF BUENOS AIRES, ARGENTINA Room 5 12:30 14:30 PSYCHOSTIMULANTS IN DUAL PATIENTS Room 5 17:00 18:30 COCAINE MANAGEMENT AND DUAL DIAGNOSIS: A BRIDGE BETWEEN RESEARCH AND CLINICAL PRACTICE Room 9 Track 19 TOBACCO AND DUAL DIAGNOSIS 09:30 11:30 INTEGRATING SMOKING PROHIBITION IN PSYCHIATRIC UNITS: A COMPLEX BUT NOT IMPOSSIBLE GOAL Room 3 11:30 13:00 TOBACCO CONSUMPTION AND PSYCHIATRIC PATHOLOGY: AN UPDATE OF THE SELF-MEDICATION HYPOTHESIS Room 12 12:30 13:30 PHARMACOLOGICAL TREATMENT OF NICOTINE DEPENDENCE IN THE PSYCHIATRIC PATIENT Room 9 14:00 15:00 GAD, TOBACCO AND SUBSTANCE ABUSE: EPIDEMIOLOGICAL ANC CLINICAL IMPLICATIONS Room 9 15:30 17:00 PSYCHIATRIC AND TOBACCO SMOKING Room 9 Track 23 MULTIDISCIPLINARY APPROACHES 09:30 11:30 DUAL CARE. DIVERSITY OF MODELS OF INTERVENTION IN DUAL DIAGNOSIS IN THE AUTONOMIES IN SPAIN Room 12 Track 25 SPIRITUALITY AND DUAL DIAGNOSIS 14:00 15:30 SPIRITUALITY AND DUAL Room 11 Track 28 RESOURCE MANAGEMENT 17:00 19:00 TREATMENT MODELS IN DUAL DIAGNOSIS: INTEGRATED OR UNIFIED TREATMENT Room 2 Track 30 EPIDEMIOLOGY AND DUAL DIAGNOSIS 15:30 17:00 EVIDENCE OF DUAL DIAGNOSIS IN THE NESARC? Room 3 Track 32 SCHOOL FAILURE 13:00 15:00 ACADEMIC FAILURE Room 12 41

40 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 4 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND OPIOIDS Track 15 Sponsored by Reckitt-Benckiser Pharmaceuticals TDAH OPIOID SYSTEM AND DUAL DIAGNOSIS Room 5 Dr. Ricardo Ortega García. Psychiatrist. Head of Section, Drug Addiction Unit. Hospital Nuestra Señora del Rosell. Murcia, Spain. 08:30 09:30 BREAKFAST WITH THE EXPERT IN DUAL DIAGNOSIS AND ADHD Track 06 Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Dr. Alfredo Gurrea Escajeda. Psychiatrist. UASA Huesca (Unidad de Atención y Seguimiento de Adicciones). Psychiatry service. Spain. Room 15 08:30 10:00 COLLOQUIUM WITH DR. NORA VOLKOW Invitation-only access Room 9 09:00 10:30 MEETING WITH THE EXPERT Track 04 DUAL DIAGNOSIS AND GAD: INSOMNIA AS A CONSTANT Sponsored by Pfizer ANXIETY Dr. Fermín Ordoño. Neurophysiology Service Hospital Arnau de Vilanova. Valencia, Spain. Dr. César Pereiro. Inpatient Psychiatric Unit. Complexo Hospitalario Arquitecto Marcide-Profesor Novoa Santos. Ferrol, A Coruña, Spain. 42

41 THURSDAY 06th OCTOBER 06 Room 1 09:30 11:00 SYMPOSIUM S3-48 Track 14 EVALUATION PROCESSES IN DUAL DIAGNOSIS EVALUATION PROCESSES Chairs: Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona. Spain. DIAGNOSIS OF PSYCHIATRIC COMORBIDITY IN SUD, WHAT ABOUT DSM-V? Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. SCREENING INSTRUMENTS OF PSYCHIATRIC COMORBIDITY: THE DDSI Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona. Spain. EVALUATION OF AN INTEGRATED SYSTEM FOR DUAL DIAGNOSED PATIENTS: MADRID S MODEL Dr. Beatriz Mesías Pérez. Head of Care Service. Instituto de Adicciones. Madrid, Spain. DUAL DIAGNOSIS IN THE ELDERLY: TREATMENT GOALS AND OUTCOMES Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. 43

42 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 2 09:30 11:30 SYMPOSIUM S2-14 Track 15 OPIOIDS, ALCOHOL AND PSYCHIATRIC COMORBIDITY OPIOID SYSTEM AND DUAL DIAGNOSIS Dr. Luís Patrício. Psychiatrist. Clinic Chief. Centro das Taipas IDT, Lisbon, Portugal. POORLY HEALED HEROIN ADDICT, ALCOHOLIC ENSURED? Dr. Juan Francisco Ramírez López. Psychiatrist. Provincial Drug Dependence and Addiction Services, Huelva, Spain. UNKNOWN PSYCHIATRIC AND POLYDRUG USE Dr. Pascal Courty. Director. Clermont Ferrand, France. MAINTENANCE OPIOID, ALCOHOL CONSUMPTION AND PSYCHIATRIC COMORBIDITY TREATMENT Dr. Antonio Costa. Psychiatrist. IDT, IP, Lisbon, Portugal. Room 3 09:30 11:30 WORKSHOP W2-07 Track 19 TOBACCO AND DUAL DIAGNOSIS INTEGRATING SMOKING PROHIBITION IN PSYCHIATRIC UNITS: A COMPLEX BUT NOT IMPOSSIBLE GOAL Chairs/Presenters: Dr. Nelson Feldman. Psychiatrist, MD, associate physician, Addictionology Service, University Hospital of Geneva, Switzerland. Dr. Sophia Achab. Psychiatrist. Head of clinic. Addictionology Service. University Hospital of Geneva. Switzerland. 44

43 THURSDAY 06th OCTOBER 06 Room 6 09:30 11:00 RETHINKING THE DUAL DIAGNOSIS Invitation-only access President: Prof. Pedro Ruiz. Professor and Executive Vice Chair. Department of Psychiatry and Behavioral Sciences. University of Miami. Miller School of Medicine. USA. Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. Dr. Célia Franco. Psychiatrist, Coordinator of the Addiction Service (SA) of CHPC; APPD s President. Portugal. Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. 45

44 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Spain. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Spain. Dr. Nora Volkow. NIDA Director. USA. Room 8 09:30 11:00 ORAL COMMUNICATIONS CO3 DEPRESSSION, ADHD, OPIOIDS Dr. Luis Alfonzo. CICAD - Organización de Estados Americanos. Washington, USA LEVELS OF DEPRESSION IN THE DIFFERENT PHASES OF PROCESS OF ALCOHOL DEPENDENCY TREATMENT Maja Rus-Makovec University Psychiatric Hospital Ljubljana 2.00 GENETIC VULNERABILITY TO DEPRESSION IN ALCOHOL DEPENDENT PATIENTS Osama Abulseoud, Joanna Biernacka, Mark Frye, Doo-Sup Choi, Jennifer Geske, J M Cunningham, Daniel Hall-Flavin, Terry Schneekloth David Mrazek Victor Karpyak Mayo Clinic. USA EMERGENCE OF MELANCHOLIC DEPRESSION DUE TO ALCOHOL ABSTINENCE Cristo Manuel Cruz Alonso CAS De Sarria Sant Gervassi 46

45 THURSDAY 06th OCTOBER DEPRESSION AND non-fatal overdoses IN REGULAR USERS OF HEROIN Luis Sordo 1, 6, Marcela Chahua 2, Albert Espelt 3, 6, Antonia Domingo-salvany 3, 6, Gemma Molist 1, 6, M Teresa Brugal 4, 5, 6, Anna Guitard 4, 5, 6, Gregorio Barrio 2, 6 M José Bravo 1, 6 1 Centro Nacional De Epidemiología, Instituto De Salud Carlos III. Madrid, Spain. 2 Escuela Nacional de Salud, Instituto de Salud Carlos III 3 Unidad de Servicios Sanitarios. IMIM-Hospital del Mar. Barcelona. Spain. 4 Agència de Salut Pública de Barcelona. Spain. 5 Institut d Investigació Biomèdica (IIB Sant Pau). Barcelona. Spain. 6 CIBER en Epidemiología y Salud Pública (CIBERESP). Spain SIMILARITIES AND DIFFERENCES BETWEEN PATIENTS - IV DRUG ADDICTS WITH AND WITHOUT SUBSTITUTION THERAPY IN PROGRAMMES FOR TREATMENT OF HEPATITIS C WITH PEGINTERFERON ALFA - 2A Jelena Brkovic 1, Katarina Mitic 2, Petar Svorcan 3 1 Special Hospital For Addicition, Belgrade, Serbia 2 Ministry of Health of Republic of Serbia, Belgrade, Serbia 3 KBC Zvezdara, Belgrade, Serbia 6.00 ASSESSMENT ROLE OF OPIATE DEPENDENT S PARTICIPATION IN NARCOTIC ANONYMOUS IN AMOUNT OF RELAPSE Mohammad Nazer, Ahmad Alhpor, Ahmad Reza Sayyadi Psychiatry Ward. Iran SERVICES FOR TREATMENT OF PATIENTS WITH COMPLEX NEEDS; PRESENTATION OF INTEGRATIVE OUTPATIENT PROGRAM IN CENTRE FOR TREATMENT OF DRUG ADDICTION UNIVERSITY PSYCHIATRIC CLINIC, LJUBLJANA Nusa Segrec, Andrej Kastelic Center For Treatmen Of Drug Addiction. Slovenia. 47

46 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 8.00 ADDICTION SEVERITY AND DUAL DIAGNOSIS IN OPIOID DEPENDENT WOMEN Amparo Sanchez Mañez UCA Paterna (Valencia). Spain DRUG ABUSE TREATMENT MARKET IN TEHRAN: FROM THEIR NONGOVERNMENTAL MEDIA TO ECONOMIC CIRCULATION Sobhan Rezaee 1,2,3, Hamed Ekhtiari 1,3,4, Saeed Sefatian 3,5, Shiva Alinaghian 2, Mehri Noori 1 1 Iranian National Center for Addiction Studies. Iran. 2 Allame Tabatabai University. Iran. 3 IRSA Institute for Psychology and Addiction Sciences. Iran. 4 Institute for Cognitive Science Studies. Iran. 5 Iran Drug Control Headquarter. Iran. Room 11 09:30 11:30 SYMPOSIUM S2-85 Track 15 SUPPORT FOR OPIOID DEPENDENT PATIENTS OPIOID SYSTEM AND DUAL DIAGNOSIS Prof. José Manuel Menchón. Psychiatry Service. Hospital Bellvitge. Universidad de Barcelona. Spain. USE OF BUPRENORPHINE IN DUAL PATIENTS Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. MAINTENANCE PROGRAMS IN WOMEN WITH OPIOID DEPENDENCE Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. ASSISTANCE ORGANIZATION FOR OPIOID DEPENDENT PATIENTS César Pascual Fernández. Managing Director. Hospital Universitario Marqués de Valdecilla. Santander, Spain. 48

47 THURSDAY 06th OCTOBER 06 Room 12 09:30 11:30 SYMPOSIUM S2-16 Track 23 MULTIDISCIPLINARY APPROACHES DUAL CARE. DIVERSITY OF MODELS OF INTERVENTION IN DUAL DIAGNOSIS IN THE AUTONOMIES IN SPAIN Dr. Carlos Álvarez Vara. Comisión Clínica de la Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid, Spain. AN ORIGINAL GALLEGO MODEL Dr. Víctor Pedreira. Head of Psychiatry, Complejo Hospitalario de Pontevedra, Spain. THE ASTONISHING EXPERIENCE OF MURCIA Dr. Juan Jiménez Rosset. Responsable del Plan de Drogodependencias. Murcia, Spain. THE PECULIAR HISTORY OF NAVARRA S MENTAL HEALTH Dr. Fermín Castiella. Director del Programa de Drogodependencias del Gobierno de Navarra, Spain. Room 4 10:30 12:30 SYMPOSIUM S2-17 Track 13 IMPAIRED DOCTORS AND DUAL DIAGNOSIS NEW CHALLENGES IN TREATING ADDICTIONS IN HEALTH CARE WORKERS Chairs/Presenters: Prof. Dr. Humberto Guajardo Sáinz. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. Diana Kushner Lanis. Antropologist. Addictions Unit, Faculty of Medical Sciences, University of Santiago de Chile, Chile. 49

48 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 5 10:30 12:30 SYMPOSIUM S2-18 Track 17 PSYCHOESTIMULANTS AND DUAL DIAGNOSIS DUAL DIAGNOSIS AND STIMULANTS (COCAINE, PACO, PASTA, BASE) IN THE CITY OF BUENOS AIRES, ARGENTINA Dr. José Capece, Casa Tomada Buenos Aires, Argentina. MOTIVATIONAL INTERVIEWING AND DUAL DIAGNOSIS: THERAPEUTIC ALTERNATIVE FOR RESISTANT CASES Lic. Maximiliano Fanton. CONICET, Buenos Aires, Argentina. BIPOLARITY AND COCAINE: UPDATES IN DRUG TREATMENT IN THE PORTEÑO CONTEXT Dr. Federico Pavlovsky, Casa Tomada Buenos Aires, Argentina, ATTENTION DEFICIT DISORDER AND SUBSTANCE USE: TREATMENT DIFFICULTIES Dr. José Capece, Casa Tomada Buenos Aires, Argentina. INTERDISCIPLINARY TEAMS IN THE TREATMENT IN VULNERABLE COMMUNITIES OF PACO ADDCITS OF THE CITY OF BUENOS AIRES Dr. Ignacio O Donnell, Ministerio de Desarrollo Social, Ciudad de Buenos Aires, Argentina. 50

49 THURSDAY 06th OCTOBER 06 Room 1 11:00 13:00 SYMPOSIUM S2-19 Track 06 NEUROBIOLOGICAL BASIS OF COMORBIDITY BETWEEN ADHD AND SUBSTANCE USE Dr. Josep Antoni Ramos-Quiroga. ADHD Program Coordinator. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. TDAH THE PREVALENCE OF ADHD IN TREATMENT SEEKING PATIENTS WITH SUBSTANCE USE IN EUROPE, THE USA, AUSTRALIA AND SOUTH AFRICA: PRELIMINARY RESULTS OF THE IASP STUDY Dr. Guert van de Glind. ICASA Foundations. Utrecht, The Netherlands. NEUROIMAGING THE ACTIONS OF METHYLPHENIDATE TREATMENT IN ADHD WITH AND WITHOUT SUBSTANCE USE Dr. Cleo L. Crunelle. Psychiatry Department and Department of Nuclear Medicine. Academic Medical Center, University of Amsterdam, The Netherlands. ADULT ADHD AND SUD: COMMON GENETIC VULNERABILITY Dr. Josep Antoni Ramos-Quiroga. ADHD Program Coordinator. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. PREVALENCE OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN SUBSTANCE USE DISORDER PATIENTS: A META-ANALYSIS AND META-REGRESSION ANALYSIS Dr. Katelijne van Emmerik van Oortmerssen. Arkin Mental Health and Addiction Research Department. Amsterdam, The Netherlands. Room 11 11:00 12:00 MEETING WITH THE EXPERT ME2-01 Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. 51

50 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 11:00 12:30 SYMPOSIUM SS2-04 Track 04 ANXIETY THE APPROACH TO GENERALIZED ANXIETY AND ITS COMORBIDITIES IN DAILY CLINCAL PRACTICE: CLINICAL WORKSHOPS Sponsored by Pfizer Dr. Antonio Terán. Coordinator of the Centro Ambulatorio de Atención a Drogodependientes San Juan de Dios. Palencia, Spain. Dr. Anna Lligoña. Alcohology and Addictions Unit. Hospital Clínico. Barcelona, Spain. Dr. Josep Guardia. Unit of Addictive Behaviors. Psychiatry Service. Hospital de la Santa Creu i Sant Pau. Barcelona, Spain. Room 11 11:00 12:30 SATELLITE SYMPOSIUM SS2-12 INTERVENTION PROTOCOLS IN DUAL DIAGNOSIS Sponsored por Brainpharma (Grupo Ferrer) Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. DUAL DIAGNOSIS IN SCHIZOPHRENIA Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. DUAL DIAGNOSIS IN ANXIETY Prof. Pilar A. Sáiz Martínez. Professor of Psychiatry. Universidad Oviedo. Spain. DUAL DIAGNOSIS IN ADHD Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. 52

51 THURSDAY 06th OCTOBER 06 Room 2 11:30 13:30 SATELLITE SYMPOSIUM SS2-20 Track 15 OPIOID SYSTEM AND DUAL DIAGNOSIS BUPRENORPHINE/NALOXONE: AN OPIOID WITH USEFUL PSYCHOTROPIC PROPERTIES IN DUALLY DIAGNOSED OPIATE-DEPENDENT PATIENTS Sponsored by Reckitt-Benckiser Pharmaceuticals Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. PSYCHIATRIC COMORBIDITIES AND THERAPEUTIC MANAGEMENT IN OPIATE-DEPENDENT PATIENTS UNDERGOING A REPLACEMENT THERAPY PROGRAM IN SPAIN: THE PROTEUS STUDY Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. BUPRENOPHINE AND DUALLY DIAGNOSED OPIATE- DEPENDENT PATIENTS: CLINICAL IMPLICATIONS Dr. Francisco González-Saiz. Unidad de Salud Mental Comunitaria Villarmartin, UGC Hospital de jerez. Cadiz. Spain. TREATMENT OF DUAL DIAGNOSIS PATIENTS IN SPAIN: FEATURES AND OUTCOMES Dr. Rafael Forcada. Unit of Addictive Behaviors. Health Center San Marcelino. Valencia, Spain. 53

52 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 3 11:30 13:30 SATELLITE SYMPOSIUM SS2-01 Track 03 ASENAPINE IN DUAL BIPOLAR PATIENTS Sponsored by Lundbeck BIPOLAR Prof. Julio Vallejo. Professor of Psychiatry. Universitat de Barcelona. Spain. CLINIC AND DIAGNOSIS OF THE DUAL BIPOLAR DISORDER Dr. Roser Martínez-Riera. Psychiatrist. Unidad de Patología Dual- Instituto de Neuropsiquiatria y Adicciones (INA), Parc de Salut MaR. Barcelona, Spain. DRUG TREATMENT OF THE DUAL BIPOLAR DISORDER. ROLE OF THE SECOND GENERATION ANTIPSYCHOTICS Dr. José Manuel Goikolea Alberdi. Psychiatrist. Unidad Trastorno Bipolar. Hospital Clínic. Barcelona, Spain. COMPLIANCE IN DUAL BIPOLAR PATIENTS: BEYOND ORAL TREATMENT Dr. Francesc Colom Victoriano. Psychologist. Unidad Trastorno Bipolar. Hospital Clínic. Barcelona, Spain. Room 8 11:30 13:00 ORAL COMMUNICATIONS CO4 TRANSCULTURAL PSYCHIATRY, MULTIDISCIPLINARY APPROACHES Dra. Rosa Fernández Marcote. Unidad de Conductas Adictivas de Toledo. Spain 1.00 ATTITUDE OF ADDICTS SPOUSES TO THE RELATED EFFECTIVE FACTORS IN TENDENCY TO DRUG ADDICTION IN ADDICTS COMMENCING TREATMENT CENTERS IN YAZD, IRAN Zahra Pourmovahed, mehdi Roozbeh, S Mojtaba Yassini A, Hamideh Dehghani, Khadijeh Dehghani, Mohammad hossein Baghiani moghaddam Yazd Shahid Sadoughi University Of Medical Sciences. Iran. 54

53 THURSDAY 06th OCTOBER EPIDEMIOLOGY OF SUBSTANCE ABUSE AMONG MIGRANTS COMPARED TO NATIVE BORN POPULATION Francisco José Eiroá-Orosa 1,2, Adil Qureshi 1, Francisco Collazos Sánchez 1,2, Patricia Martinena Palacio 2, Hilda Wara Revollo Escudero 2, Miguel Casas 1,2 1 Psychiatry Department, Hospital Universitari Vall D Hebron. Spain. 2 Universitat Autònoma de Barcelona. Spain PRISON RETRAINING,GENDER AND ADDICTION Ali Ghalehiha 2, Mehdi Damaliamiri 1, Ahmad Tajfar 2, Firouzeh Akbari 3 1 Bu-Ali Sina University,hamadan,iran 2 University of medical science,hamadan,iran 3 Islamic azad university,hamedan branch,iran 4.00 TRATAMIENTO DE PACIENTES DUALES GRAVES, INTERNACIÓN Y AMBULATORIO Fabian Alejandro Molina, Pablo Berrettoni, Cristina Velasquez Hospita Neuropsiquiatrico Braulio Moyano. Argentina DUAL OF CIRCADIAN RHYTHM, ALCOHOL, TOBACCO AND SUBSTANCES Causenge Cangin 1, Purcell Taylor 1, Gaetano Pasqua 2 1 Declare Therapy Center 2 Italy 6.00 DUAL DIAGNOSIS AND HOMELESSNESS: A STUDY OF THE CURRENT SITUATION IN LLEIDA (SPAIN) AND PROPOSED MODEL OF CARE Fco. Javier Samper Villar 1, Sergi Godia Ribes 2, Josep Pifarre Paradero 3, Anna Iglesias Duran 4, Joan Canut 2 1 Unidad de Conductas Adictivas Lleida. Spain 2 Psiquiatria- PSI 3 Jefe de Servicio Psiquiatría 4 Ayuntamiento de Lleida. Spain 7.00 THE RECOVERY PARADIGM: BRIDGING ADDICTION AND MENTAL HEALTH Nady El-Guebaly University Of Calgary. Canadá 55

54 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 8.00 EVOLUTION OF PATIENTS WITH DUAL PATHOLOGY IN A THERAPEUTIC HOUSE AS SUPPORT TO HOSPITAL-DAY FOR ADDICTION Victor Puente Pazos, Ana isabel Ramírez Gorostiza, Fernando Manzanos Ruiz de Eguino, Mª Lourdes Aguirrebeitia Rodriguez, Mª isabel Martinez Vela, Mª Angeles Larriba Barrena, Arantzazu Ruiz de Vergara Nieto, Martina Niso Bravo Servicio Toxicomanias de Alava. Spain LA INTERVENCIÓN DE PACIENTES DUALES DESDE LA VISIÓN DEL OPERADOR SOCIO-TERAPÉUTICO Jose María Nieto Fundación Araucaria. San Vicente. Argentina WORKING TOGETHER (DRUG USER PARTICIPATION IN THE LOCAL MANAGEMENT OF DAMAGE REDUCTION PROGRAMS AS A MEANS OF PREVENTION AND REDUCTION OF VULNERABILITY TO MENTAL HEALTH ) Antoni Llort Suárez, Tre Borràs Cabacés, Sara Ferrando Esquerré, Alex Pérez Folch Servei De Drogodependencies Hospital Universitari Sant Joan Reus (Tarragona). Spain THE APPLICATION OF ART THERAPY IN A GROUP WITH DUAL : ARTISTIC CREATION AS A PROCESS OF REHABILITATION AID Mª Ángeles Herrero Fernández CAS De Sarriá, ADB). Barcelona. Spain. 56

55 THURSDAY 06th OCTOBER 06 Room 12 11:30 13:00 SYMPOSIUM S2-33 Track 19 TOBACCO AND DUAL DIAGNOSIS TOBACCO CONSUMPTION AND PSYCHIATRIC PATHOLOGY: AN UPDATE OF THE SELF-MEDICATION HYPOTHESIS Prof. Miguel Gutiérrez Fraile. Professor of Psychiatry. Universidad del País Vasco. Head of Psychiatry. Hospital Santiago Apóstol. Osakidetza. Vitoria & CIBERSAM Mental Health Network. Spain. DEPRESSED AND SMOKER OR SMOKER AND DEPRESSED. SELF-MEDICATION OR COMORBIDITY Dr. José Manuel García Basterrechea. Jefe de Sección de MI Drogodependencias. Hospital General Universitario Reina Sofía. Murcia, Spain. THE COGNITIVE APPROACH TO SELF-MEDICATION HYPOTHESIS IN SCHIZOPHRENIA Dr. Arantzazu Zabala. Universidad del País Vasco. Center for Biomedical Research CIBERSAM Mental Health Network. Vizcaya, Spain. SMOKING AND NEUROCOGNITION IN THE EUTHYMIC PHASE OF BIPOLAR DISORDER Dr. Vicent Balanzá. Teaching Unit of Psychiatry, Department of Medicine, University of Valencia - Center for Biomedical Research CIBERSAM Mental Health Network. Valencia, Spain. 57

56 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 16 11:30 13:30 ORAL COMMUNICATIONS CO5 CHILD AND ADOLESCENT PSYCHIATRY Dr. Luis Alfonso Nuñez Dominguez. Clínica San Francisco Javier. Pamplona. Spain. Sociedad Española de Patología Dual. Spain ANXIETY AND BENZODIAZEPINES, A NEW DUAL PATHOLOGY DIAGNOSTIC? Miguel Angel Dorta Alvarez, Marisela Cejas Cejas, Teresa de la Rosa Vilar, Mª De Los Angeles Rodriguez Perez UCA De Ofra, ACJ San Miguel. Spain A CROSS-SECTIONAL STUDY OF PATIENTS WITH AND WITHOUT SUBSTANCE USE IN COMMUNITY MENTAL HEALTH CENTRES Linda Elise Wüsthoff 1, Helge Waal 1, Torleif Ruud 2, 3, Rolf W. Gråwe 1, 4 1 Norwegian Centre For Addiction Research, University Of Oslo. Norway. 2 Akershus University Hospital, Lørenskog, Norway 3 Institute of Clinical Medicine, University of Oslo, Oslo, Norway 4 Alcohol and Drug Treatment Health Trust in Central Norway, Trondheim, Norway 3.00 COMORBIDITY OF ANXIETY AND TEMPORAL AND EXTRATEMPORAL PARTIAL EPILEPSIES Perisa Simonovic, Snezana Svetozarevic Institute Of Mental Health, Belgrade, Serbia and Ministry of Health, Republic of Serbia. Israel PREDICTIVE FACTORS FOR SUICIDE ATTEMPTS IN DUAL DIAGNOSIS PATIENTS Yuri Gimelfarb, Zipi Natan Abarbanel Mental Health Center 58

57 THURSDAY 06th OCTOBER DIFFERENCES IN PATTERNS OF IMPULSIVITY IN COCAINE DEPENDENT PURE BPD OR SCHIZOPHRENIA Sonia Francés Olmos 1, Francisco Traver Torres 1, Rafael Mora Marín 1, Javier Manzanares Robles 2, Gabriel Rubio Valladolid 3, 4, Ana M Benito Delegido 5 1 Consorcio Hospitalario Provincial Castellon. Spain. 2 Universidad Miguel Hernández, Elche (Alicante). Spain. 3 Hospital Universitario 12 de Octubre, Madrid. Spain. 4 Universidad Complutense, Madrid. Spain. 5 Hospital Provincial Pla, Alicante. Spain BORDERLINE PERSONALITY DISORDER, SUBSTANCE USE AND DELAY DISCOUNTING Aniko Maraz 1, Peter Rigo 2, Janos Harmatta 3, Gaspar Takach 4, Zsolt Zalka 5, Istvan Boncz 6, Balint Ando 6, Zsuzsa Laczko 4 Zsolt Demetrovics 1 1 Institutional Group On Addiction Research Institute Of Psychology, Eötvös Loránd University, Budapest, Hungary 2 Department of Psychiatry at NyírÐ Gyula Hospital, Budapest, Hungary 3 Center for Psychotherapy at the National Institute of Psychiatry and Neurology, Budapest, Hungary 4 Merényi Gusztáv Hospital, Department of Pathological Addictions, Budapest, Hungary 5 The Thalassa House Therapeutic Community, Budapest, Hungary 6 Department of Psychiatry, University of Szeged Faculty of Medicine, Szeged, Hungary 59

58 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 7.00 CLINICAL AND IMMUNOLOGICAL CORRELATES IN PTSD DYNAMIC Margarit Tadevosyan 1, Samvel Sukiasyan 1, Lilit Hovhannisyan 2, Gohar Mkrtchyan 2, Anna Boyajyan 2 Center Of Mental Health STRESS Institute of Molecular Biology 8.00 DOES PARTIAL OR SUBSYNDROMAL PTSD HAVE RELEVANCE AS A DISTINCT ENTITY? Manish Bajpayee, Vijay Pande Command Hospital Kolkata 9.00 SUBSTANCE USE AND MISUSE IN BURN PATIENTS: TESTING THE CLASSICAL HYPOTHESES Francisco José Eiroá-Orosa, Sara Guila Fidel-Kinorri, Anna Gianonni-Pastor, Ruth Tasqué-Cebrián, Jose María Argüello-Alonso Psychiatry Department, Hospital Universitari Vall D Hebron. Barcelona, Spain THE CONTRIBUTIONS OF CHILDHOOD TRAUMA AND POSTTRAUMATIC STRESS DISORDER SYMPTOMS TO SUBSTANCE ABUSE Claire-Emmanuelle Laguerre 1, Rachel Rodgers 1,2, Aimé Charles-Nicolas, Louis Jehel, Laurent Schmitt, Jérome Lacoste, Philippe Birmes, Laboratoire Du Stress Traumatique (LST EA 4560) CERPP, Université Toulouse-2, France Service de Psychiatrie et d Addictologie, CHU de Fort-de- France, France Service de Psychiatrie et d Addictologie, CHU de Fort-de- France, France Service de Psychiatrie et d Addictologie, CHU de Fort-de- France, France Laboratoire Du Stress Traumatique (LST EA 4560) 60

59 THURSDAY 06th OCTOBER ADDICTION HAS TO BE STOPPED FROM CHILDHOOD AND ADOLESCENCE Mercedes López Rico 1, Daniel Ballesteros Sanz 2, José Luis Jiménez Hernández 2 1 Facultad de Medicina. Universidad de Salamanca. Salamanca 2 CSM Arganzuela. Hospital Doce de Octubre. Madrid SUBSTANCE USE AND FAMILY DYNAMICS AS BIOPSYCHOSOCIAL VARIABLES THAT INFLUENCE ADOLESCENT CONDUCT ETIOPATHOGENY Angel M Turbi Pinazo 1, Matias Real López 2, Gonzalo Haro Cortés 2, Gema Calvo Orenga 2, Sonia Francés Olmos 2, Ana M Benito Delegido 3 1 Univ Católica De Valencia San Vicente Mártir 2 Consorcio Hospitalario Provincial de Castellón 3 Hospital Provincial Pla Alicante Room 6 12:00 13:00 MEETING WITH THE EXPERT ME2-02 Prof. Roger Weiss. Professor of Psychiatry, Harvard Medical School. Boston, USA. 61

60 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 4 12:30 14:30 SYMPOSIUM S2-22 Track 13 IMPAIRED DOCTORS AND DUAL DIAGNOSIS DOCTORS WITH DUAL DIAGNOSIS? PAIME (PROGRAMA DE ATENCIÓN INTEGRAL AL MÉDICO ENFERMO) CASES Dr. Mª Pilar Lusilla. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. PREVALENCE OF DUAL DIAGNOSIS IN THE PHYSICIAN AND ITS IMPLICATIONS IN CLINICAL PRACTICE Dr. Mar Sánchez. Director of the Addictive Behaviors Unit. Psychiaty Service. Hospital Provincial de Ciudad Real. Spain. Responsable Regional PAIME de Castilla La Mancha. Spain DUAL DIAGNOSIS AND SELF-MEDICATION: THE ROLE IN THE SAD TRIAD ALCOHOL-DEPRESSION-SUICIDE Dr. Mª Pilar Lusilla. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. ASSESSMENT OF DUAL DIAGNOSIS IN THE SICK DOCTOR Dr. Marina Comín. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. A MODEL OF INTEGRAL AND INTENSIVE CARE IN THE PATIENT PHYSICIAN WITH DUAL DIAGNOSIS Dr. Eugeni Bruguera. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. 62

61 THURSDAY 06th OCTOBER 06 Room 5 12:30 14:30 SYMPOSIUM S2-23 Track 17 PSYCHOSTIMULANTS IN DUAL PATIENTS PSYCHOESTIMULANTS AND DUAL DIAGNOSIS Prof. Javier Álvarez. Pharmacology Department. University of Valladolid. Spain. PSYCHOSTIMULANTS DETOX IN DUAL PATIENTS Dr. Lara Grau-López. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. REHABILITATION OF DUAL PATIENTS IN AN ECONOMIC CRISIS CONTEXT Dr. Oriol Esculies. Director of Proyecto Hombre Cataluña. Barcelona, Spain. PSYCHOTIC CLINIC IN COCAINE AUTOINJECTORS Dr. Nieves Martínez-Luna.CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. Room 9 12:30 13:30 SATELLITE WORKSHOP SW2-01 Track 19 TOBACCO AND DUAL DIAGNOSIS PHARMACOLOGICAL TREATMENT OF NICOTINE DEPENDENCE IN THE PSYCHIATRIC PATIENT Sponsored by Pfizer Dr. Antonio Terán. Coordinador del Centro Ambulatorio de Atención a Drogodependientes San Juan de Dios. Palencia, Spain. Dr. Eugeni Bruguera. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Dr. José Antonio Navarro Sanchis. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Spain. 63

62 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 11 12:30 13:00 PRESENTATION OF THE STUDY OF THE SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL RESOURCES IN DUAL DIAGNOSIS Chairs/Presenters: Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Spain. Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Room 1 13:00 14:30 SYMPOSIUM S2-26 Track 06 ADVANCES IN DUAL ADHD Dr. Philip Asherson. Professor of Molecular Psychiatry. Kings College London. UK. TDAH NEUROIMAGING AND DUAL ADHD Dr. Philip Shaw. Staff Clinician. Child Psychiatry Branch. Intramural Program. NIMH. USA. ADHD AND BIPOLAR DISORDER IN CHILDREN: RISK FACTORS FOR SUBSTANCE ABUSE Dr. César Soutullo. Head of Child Psychiatry at the Hospital Universitario de Navarra. Spain. GENETIC RESEARCH IN THE DUAL ADHD Dr. Josep Antoni Ramos-Quiroga. ADHD Program Coordinator. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Room 6 13:00 14:00 MEETING WITH THE EXPERT ME2-03 Prof. Gabreiele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. 64

63 THURSDAY 06th OCTOBER 06 Room 11 13:00 14:00 NATIONAL CONTEST ON CLINICAL CASES ON DUAL DIAGNOSIS CCC2-04 President: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Coordinador: Dr. Ignacio Basurte Villamor. Psychiatry Service. Hospital Gregorio Marañón. Madrid. Spain. Room 12 13:00 15:00 SYMPOSIUM S2-24 Track 32 ACADEMIC FAILURE SCHOOL FAILURE Chairs: Dr. Cristina Pellisé. Departament de Educació. Generalitat de Catalunya. Barcelona, Spain. Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. PSYCHIATRIC, SUBSTANCE ABUSE AND SCHOOL FAILURE Dr. Rosa Bosch. Psychiatry Service. Hospital Universitari Vall d Hebron, Barcelona, Spain. SUBSTANCE USE IN CHILDREN AND ADOLESCENTS: RISK FACTORS AND PREVENTION STRATEGIES Dr. Nuria Yáñez Ferrer. Psychiatrist. Unidad de Salud Mental Infanto-Juvenil (USMI) Miguel Servet de Benicalap. Valencia, Spain CANNABIS USE AND SCHOOL FAILURE Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. LEARNING AND SUBSTANCE ABUSE Dr. Ana Sans Fito. Child Psychiatry Service. Hospital San Joan de Deu. Barcelona, Spain. 65

64 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 15 13:00 15:00 LUNCH WITH PROF. PEDRO RUIZ Invitation-only access Room 2 13:30 15:00 CLINICAL CASE IN DUAL DIAGNOSIS AND OPIOIDS CONTEST CCC2 02 Track 15 OPIOID SYSTEM AND DUAL DIAGNOSIS President: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Coordinator: Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Spain. Room 3 13:30 15:30 SYMPOSIUM S2-25 Track 03 BIPOLAR DUAL BIPOLARITY: CLINICAL AND THERAPEUTICAL PROGRESS Prof. Jerónimo Saiz. Professor of Psychiatry. University of Alcalá de Henares. Madrid, Spain. DUAL DIAGNOSIS IN FIRST EPISODES OF THE BIPOLAR DISORDER Prof. Ana González-Pinto. Head of Section. Psychiatry Service. Hospital Santiago Apóstol. Vitoria, Spain. ADDICTIONS AND BIPOLAR DISORDER: NEUROCOGNITIVE AN THERAPEUTIC ASPECTS Prof. Eduard Vieta. Psychiatry Service. Hospital Clínic de Barcelona. Universitat de Barcelona, Spain. INTEGRATED GROUP THERAPY FOR BIPOLAR DISORDER AND SUBSTANCE ABUSE: AN EMPIRICALLY VALIDATED TREATMENT Prof. Roger Weiss. Professor of Psychiatry, Harvard Medical School. Boston, USA. 66

65 THURSDAY 06th OCTOBER 06 Room 8 13:30 15:00 ORAL COMMUNICATIONS CO6 PERSONALITY, GENDER Dr. Gregorio Martín Carmona. Cruz Roja. Madrid. Spain. Sociedad Española de Patología Dual. Dr. Francisco Collazos. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autonoma de Barcelona. Espana EL ENFERMO DUAL, UN PROBLEMA SIN SOLUCIÓN ADECUADA AÚN Fabian Alejandro Molina, Cristina Velasquez Hospita Neuropsiquiatrico Braulio Moyano. Argentina RELACIÓN ENTRE PATRONES DESADAPTATIVOS DE PERSONALIDAD, CONSUMO DE SUSTANCIAS Y ASPECTOS SOCIOPERSONALES: UN ESTUDIO MEDIANTE EL CUESTIONARIO MCMI-II Abel Baquero Escribano 1, Gonzalo Haro Cortés 1, Gema Calvo Orenga 1, Sonia Francés Olmos 1, Ana M. Benito Delegido 3, Rafael Ballester Arnal 2 1 Consorcio Hospitalario Provincial Castellon. Spain. 2 Universidad Jaume I. Spain. 3 Hospital Provincial Pla Alicante. Spain DUAL DIAGNOSIS AND PERSONALITY DISORDER IN HOSPITALIZED PATIENTS IN AN ACUTE UNIT David Fachal Vázquez, Tania Isabel Blanco Pena, Carmen Rozados Villaverde, Elisa Mariño Díaz, José María Blanco Lobeiras, Víctor Pedreira Crespo Complejo Hospitalario De Pontevedra-Servicio de Psiquiatría. Spain BIG FIVE PERSONALITY FACTORS IN ADDICTS Narges Razeghi 1, Narjes Sardabi 2 1 Islamic Azad University, Tafresh Branch, Iran 2 Ershad Damavand University. Iran. 67

66 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 5.00 VARIABILIDAD ATENCIONAL EN CONSUMIDORES DE COCAÍNA CON TRASTORNOS DE PERSONALIDAD DEL CLUSTER B Natalia Albein Urios 1, Jose Miguel Martínez González 2, Óscar Lozano Rojas 3, Antonio Verdejo García 1 1 Universidad Granada, Granada. Spain. 2 Centro Provincial de Drogas, Granada. Spain. 3 Universidad de Huelva, Huelva. Spain BÚSQUEDA DE SENSACIONES EN CONSUMIDORES DE COCAÍNA CON TRASTORNOS DE PERSONALIDAD COMÓRBIDOS Natalia Albein Urios 1, Jose Miguel Martínez González 2, Óscar Lozano Rojas 3, Antonio Verdejo García 1 1 Facultad De Psicología, Universidad de Granada. Spain. 2 Centro Provincial de Drogas, Granada. Spain. 3 Facultad de Psicología, Universidad de Huelva. Spain REDUCCIÓN DE MATERIA GRIS EN CONSUMIDORES DE COCAÍNA CON TRASTORNOS DE PERSONALIDAD Natalia Albein Urios 1, Laura Moreno López, Jose Miguel Martínez González 2, Juan Verdejo, Miguel Pérez García, Antonio Verdejo García 1 Universidad De Granada, Granada. Spain. 2 Centro Provincial de Drogas, Granada. Spain RESIDENTIAL TREATMENT MODEL FOR WOMEN WITH DUAL IN PUERTO RICO Delia P. González 1, 3, Sydnia Rosado 1,2, Virmarie Correa 4 1 Universidad Carlos Albizu 2 ASSMCA, Puerto Rico 3 Universidad Central del Caribe 4 University of Puerto Rico 68

67 THURSDAY 06th OCTOBER INFLUENCIA DEL GÉNERO EN LA DEPRESIÓN ENTRE USUARIOS REGULARES DE HEROÍNA Luis Sordo del Castillo 1, 6, Marcela Chaua 2, Yolanda Castellanos 3, 6, M Teresa Brugal 4, 5, 6, Gemma Molist 1, 6, Antonia Domingo-Salvany 3, 6, Anna Guitart 4, 5, 6, Luis de la Fuente 1, 6 M José Bravo 1, 6 1 Centro Nacional De Epidemiología. Instituto De Salud Carlos III. Spain. 2 Escuela Nacional de Sanidad. Instituto de Salud Carlos III. 3 Unidad de Servicios Sanitarios. IMIM-Hospital del Mar. Barcelona. Spain. 4 Agència de Salut Pública de Barcelona. Spain. 5 Institut d Investigació Biomèdica (IIB Sant Pau). Barcelona. Spain. 6 CIBER en Epidemiología y Salud Pública (CIBERESP). Spain FACTORS ASSOCIATED WITH THE PERPETRATION OF INTIMATE PARTNER VIOLENCE BY MALE SUBSTANCE USERS: A MIXED METHODS STUDY Gail Gilchrist 1, 2, Alicia Blazquez 1, Lidia Segura 3, Hienrich Geldschläger 3, Ester Valls 3, Joan Colom 3, Marta Torrens 1,4,5 1 Substance Use Disorders Research Group, Institut Municipal d Investigació Mèdica (IMIM)-Hospital del Mar, Barcelona, Spain 2 University Of Greenwich, London, UK 3 Subdirecció General de Drogodependències, Departament de Salut, Barcelona, Spain 4 Institut de Neuropsiquiatria I Adiccions (INAD); Parc de Salut Mar, Barcelona, Spain 5 Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain RASGOS DE PERSONALIDAD, CONSUMO DE SUSTANCIAS Y TRANSEXUALIDAD. Trinidad Bergero Miguel 1, José Guzmán Parra 1, Susana Asiain Vierge 2, Antonio Neila Boyer 1, Isabel Esteva de Antonio 1, Guadalupe Cano Oncala 1 1 Hospital Carlos Haya, Malaga. Spain. 2 Hospital de Navarra. Spain. 69

68 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER TRANSEXUALIDAD Y CONSUMO DE DROGAS. COMPARACIÓN CON POBLACIÓN GENERAL Trinidad Bergero Miguel 1, Jose Guzman Parra 1, Susana Asiain Vierge 2, Antonio Neila Boyer 1, Guadalupe Cano Oncala 1, Isabel Esteve de Antonio 1 1 Hospital Universitario Carlos Haya, Malaga. Spain. 2 Hospital de Navarra. Spain TRANSEXUALIDAD, CONSUMO DE DROGAS Y COMPARACIÓN SEGUN SEXO BIOLÓGICO Trinidad Bergero Miguel 1, Jose Guzman Parra 1, Susana Asiain Vierge 2, Antonio Neila Boyer 1, Guadalupe Cano Oncala 1, Isabel Esteva de Antonio 1 1 Hospital Universitario Carlos Haya, Malaga. Spain. 2 Hospital de Navarra. Spain. Room 9 14:00 15:00 WORKING LUNCH Track 19 TOBACCO AND DUAL DIAGNOSIS GAD, TOBACCO AND SUBSTANCE ABUSE: EPIDEMIOLOGICAL ANC CLINICAL IMPLICATIONS Sponsored by Pfizer Dr. Javier García Campayo. Liaison Psychiatry Service and Psychosomatics. Hospital Clinico Universitario. Zaragoza, Spain. Dr. Eugeni Bruguera. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. 70

69 THURSDAY 06th OCTOBER 06 Room 11 14:00 15:30 SYMPOSIUM S3-34 Track 25 SPIRITUALITY AND DUAL SPIRITUALITY AND DUAL DIAGNOSIS Prof. Juan José López-Ibor. Professor of Psychiatry. Universidad Complutense de Madrid. Spain. ABNORMAL STATES OF CONSCIOUSNESS AND PSYCHOTROPIC SUBSTANCE ABUSE Dr. Julia García-Albea, Dr. Sara González Vives and Prof. Juan José López-Ibor. Madrid, Spain. SPIRITUALITY AND DUAL Prof. Marc Galanter. Professor of Psychiatry and Director. Division of Alcoholism and Drug Abuse. NYU School of Medicine. New York, USA. ESTUDIO DE LA ESPIRITUALIDAD EN ADICTOS ESPAÑOLES Dr. Gideoni Fusté. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. SPIRITUALITY AND IMMIGRATION Dr. Adil Qureshi. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. 71

70 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 16 14:00 16:00 ORAL COMMUNICATIONS CO7 CANNABIS, TOBACCO, LEGAL ASPECTS Dr. Gerardo Gastón Pacheco Otoya. Instituto de Adicciones Madrid-Salud. Spain. Sociedad Española de Patología Dual 1.00 USO DEL CANNABIS Y TRASTORNOS MENTALES EN LA POBLACION MARROQUI Mehdi Paes 1, Fatima Elomari 2 1 Consulta Privada. Marruecos. 2 Hospital Universitario Arrazi de Rabat-Salé. Marruecos PROGRAMA DE PREVENCIÓN DE RECAÍDAS. DROGADICCIÓN Ángela Rita Martin Caballero, Mónica Gómez Pérez, Román Morales de Armas Centro de Día San Miguel. Tenerife. Spain CANNABIS-RELATED PSYCHOSIS: EFFECT OF ABSTINENCE ON PSYCHOPATHOLOGY Rohit Verma 1, Yatan Pal Singh Balhara 1, Shaily Mina 2 1 Post Graduate Institute Of Medical Education And Research, Dr Ram Manohar Lohia Hospital, New Delhi, India 2 G. B. Pant Hospital, Maulana Azad Medical College, New Delhi, India 4.00 SMOKING IS LINKED TO POSITIVE SYMPTOMS IN PSYCHIATRIC PATIENTS - A REEVALUATION OF THE SELFMEDICATION HYPOTHESIS Renaud de Beaurepaire, Pascal Rat, Robert Molimard GH Paul Guiraud. Villejuif. France. 72

71 THURSDAY 06th OCTOBER FACTORES DE PERSONALIDAD PROTECTORES RESPECTO AL CONSUMO DE NICOTINA EN POBLACIÓN DROGODEPENDIENTE. Sara García Chulbi 1, Gonzalo Haro Cortés 1, César Mateu Hernández 2, Ana M Benito Delegido 3, Sonia Francés Olmos 1, Gema Calvo Orenga 1 1 Consorcio Hospitalario Provincial Castellon. Spain. 2 Grupo de Investigación TXP, Castellón. Spain. 3 Hospital Provincial Pla, Alicante. Spain REFERRAL TO SMOKING CESSATION AT PEDRO HISPANO HOSPITAL: EVALUATION OF THE FIRST 137 SMOKING PATIENTS Anabela Machado, Joana Amado, Teresa Mota Hospital Pedro Hispano. Porto. Portugal RESPUESTA A LA TERAPIA MULTICOMPONENTE PARA LA DESHABITUACIÓN TABÁQUICA EN PACIENTES CON ANTECEDENTES PSIQUIÁTRICOS M. Antònia Raich Soriguera 1, Esteve Fernandez Muñoz 2, Jose Maria Martinez-Sanchez 2, Amàlia Molina Jimenez 1, Rosa Cobacho Casafont 1, Carme Viladrich Pujol 1, Anna Capsada Juanola 1, Rosa Taulé Malé 1 1 ALTHAIA Xarxa Assistencial de Manresa. Barcelona. Spain. 2 Institut Català d Oncologia. Barcelona. Spain TACKLING TOBACCO IN MENTAL HEALTH John Allan NSW Health. Sidney. Australia Comorbidity by sex in patients of a Smoking Cessation Clinic Adriana Marqueta Baile 1, Adriana Jiménez-Muro Franco 1, Isabel Nerín de la Puerta 1, Pilar Gargallo Valero 2, Asunción Beamonte San Agustín 2 1 Unidad De Tabaquismo FMZ. Facultad de medicina, Universidad de Zaragoza. Spain. 2 Departamento de Métodos Estadísticos. Escuela Universitaria de Estudios Empresariales. Universidad de Zaragoza. Spain. 73

72 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER SMOKING CESSATION OUTCOMES IN PATIENTS WITH PSYCHIATRIC COMORBIDITY Adriana Marqueta Baile 1, Adriana Jiménez-Muro Franco 1, Isabel Nerín de la Puerta 1, Asunción Beamonte San Agustín 2, Pilar Gargallo Valero 2 1 Unidad De Tabaquismo FMZ. Spain. 2 Escuela Universitaria de Estudios Empresariales. Universidad de Zaragoza. Spain DUAL DIAGNOSIS AND SAFEGUARDING - PARENTING ISSUES Lois Dugmore, Jackie Channell Leicestershire Partnership Nhs Trust. UK INCIDENCIA DE PATOLOGÍA DUAL EN PACIENTES DE MEDIDAS PENALES ALTERNATIVAS Tre Borràs Cabacés, Ester Martos Fraile, Artur Sardà Garcia, Antoni Llort Suárez Servicio Drogodependencias Hospital Universitario Sant Joan Reus. Tarragona. Spain. Room 1 14:30 16:00 CLINICAL CASE IN DUAL DIAGNOSIS IN ADHD CONTEST CCC2 01 Track 06 President: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. TDAH Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Coordinator: Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. 74

73 THURSDAY 06th OCTOBER 06 Room 4 14:30 16:30 WORKSHOP W2-09 Track 13 IMPAIRED DOCTORS AND DUAL DIAGNOSIS STRATEGIES FOR PREVENTING, DIAGNOSING AND TREATING DUAL PATHOLOGY IN HEALTH CARE PROFESSIONALS Chairs/Presenters: Dr. Mª Dolores Braquehais Conesa. Psychiatrist. Jefa Clínica. Unidad Hospitalización. PAIMM Barcelona. Spain. Dr. Miquel Jordi Bel Aguado. PAIMM. Barcelona. Psychiatrist. Unidad de Hospitalización y de Consultas Externas. PAIMM Barcelona. Spain. Room 5 14:30 16:00 SYMPOSIUM S2-83 TRAINING IN DUAL DIAGNOSIS Prof. Antoni Bulbena. Professor of Psychiatry. Universidad Autónoma de Barcelona. Spain. TRAINING IN DUAL DIAGNOSIS IN DETOX UNITS Dr. Gaspar Cervera. Unidad Hospitalaria de Desintoxicación. Hospital Clínico Universitario de Valencia. Spain. TRAINING IN DUAL DIAGNOSIS IN MASTERS DEGREEES Dr. Xavier Ferrer. Director del Máster en Drogodependencias. Universidad de Barcelona. Spain. TRAINING IN DUAL DIAGNOSIS IN ACUTE PSYCHIATRY UNITS Dr. Manuel Alfonso. Chief of Psychiatry Service. Hospital San Rafael. Barcelona, Spain. 75

74 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 2 15:00 17:00 SYMPOSIUM S2-27 Track 15 OPIOID SYSTEM AND DUAL DIAGNOSIS DUAL DIAGNOSIS IN HEROIN AND COCAINE ADDICTS: FROM PAST TO PRESENT. CHALLENGES FOR THE FUTURE Dr. Luis Patrício. Psychiatrist. Clinical Head. Centro das Taipas IDT, Lisbon, Portugal. ADULT ADHD AND COCAINE CONSUMPTION IN HEROIN ADDICTS IN MM Dr. Juan Francisco Ramirez López. Psychiatrist. Provincial Drug Dependence and Addiction Services, Huelva, Spain. DUAL DIAGNOSIS IN HEROIN AND COCAINE ADDICTS: FROM PAST TO PRESENT. CHALLENGES FOR THE FUTURE Dr. José Pádua. Psychiatrist. IDT, IP, Lisbon, Portugal. COMORBIDITY IN PATIENTS RECEIVING OPIOID TREATMENT Dr. Antonio Felisberto. Psychiatrist, IDT CRI, Coimbra, Portugal. 76

75 THURSDAY 06th OCTOBER 06 Room 6 15:00 18:00 SELF MEDICATION HYPOTHESIS Track 00 General Director: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. SELF-MEDICATION Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texass, USA. Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. 77

76 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 3 15:30 17:00 SYMPOSIUM S3-40 Track 30 EVIDENCE OF DUAL DIAGNOSIS IN THE NESARC? EPIDEMIOLOGY AND DUAL DIAGNOSIS Dr. José Manuel Torrecilla. Manager of Madrid Salud. Madrid, Spain. EPIDEMIOLOGICAL EVIDENCE OF DUAL PATHOLOGY IN THE NESARC STUDY Prof. Deborah Hasin. Columbia University Department of Psychiatry. New York, USA. Room 8 15:00 17:30 ORAL COMMUNICATIONS CO8 BASIC RESEARCH IN DUAL DIAGNOSIS Dra. Pilar Sáiz Martínez. Universidad de Oviedo. Spain PSYCHIATRIC COMORBIDITY IN PATIENTS WITH SUBSTANCE DEPENDENCE SOCIO- DEMOGRAPHIC & RELATIONSHIP CHARACTERISTICS Abdul Majid Gania 1, AW Khan 1, Mushtaq Margoob 2, Akash Yousuf Khan 2 1 Sher-I-Kashmir Institute Of Medical Sciences Medical College 2 Govt Medical college Srinagar, Kashmir. India PSYCHOACTIVE SUBSTANCE USE AND RISKY SEXUAL BEHAVIOR AMONG STUDENTS OF THE UNIVERSITY OF MAIDUGURI, - BORNO STATE, NIGERIA, 2009 Abdulaziz Mohammed 1, Kabir Sabitu 2, Patrick Nguku 3, Abba Wakil 4, Babatunde Omotara 5 1 Federal Neuro-Psychiatric Hospital 2 Department of Community Medicine, Ahmadu Bello University, Zaria, Kaduna state, Nigeria 3 Nigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria 4 University of Maiduguri Teaching Hospital, Maiduguri, Borno state, Nigeria 5 University of Maiduguri Teaching Hospital, Maiduguri, Borno state, Nigeria 78

77 THURSDAY 06th OCTOBER A STUDY TO EXPLORE THE RELATIONSHIP BETWEEN HAPPINESS ORIENTATIONS AND DYSFUNTIONAL THINKING IN THE DUAL DIAGNOSIS POPULATION Massimo Bertacco 1, Francesc Sorribes 2, Mas-Bagà Manolo 1 1 Cat-Barcelona/ Therapeutic Centre 2 Institut RET Barcelona. Spain THE FUNCTIONAL PHYSIOPATHOLOGY IN THE BIOLOGICAL ORGANISATION Venga Enrico, Venga Daniela Clinica Neuropsichiatrica. Italy MODELOS PRECLÍNICOS PARA EL ESTUDIO DE LA PATOLOGÍA DUAL: CONSUMO DE ALCOHOL Y PSICOESTIMULANTES. Olga Valverde Granados Universitat Pompeu Fabra. Barcelona. Spain A STUDY OF STRUCTURAL RELATIONS OF SOME PSYCHOLOGICAL RISK AND PROTECTIVE FACTORS OF ADDICTION POTENTIAL Iran Davoudi, Tayebeh Eshrati, Yadollah zargar, Esmael Hashemi sheikh shabani University Of Shahid Chamran, Ahvaz, Khozestan, Iran 7.00 AN EXPLORATION INTO ADDICTIONS COUNSELLOR TURNOVER IN MANITOBA: A NARRATIVE INQUIRY Shannon Winters The University Of Western Ontario. Canada COGNITIVE FUNCTIONING ON DUAL DIAGNOSIS PATIENTS. NEEDS FOR FUTURE RESEARCH Irina Benaiges Fusté 1, Gemma Prat Vigué 1, Ana Adan Puig 1, 2 1 Universidad De Barcelona. Spain. 2 Institut for Brain, cognition and Behavior (IR3C) 79

78 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 9.00 EVALUACIÓN DE LA EFICACIA DE LA INTERVENCIÓN A CORTO, MEDIO Y LARGO PLAZO DEL TRATAMIENTO EN COMUNIDAD TERAPÈUTICA PARA PERSONAS CON PROBLEMAS DE CONDUCTA ADICTIVA Judith Sanjuan Satorra 1, Maite Tudela Marí 2, Mercè Cervantes Sanjuan 3 1 ATART - Grup Atra. Barcelona. Spain. 2 FSiC Fundació Salut i Comunitat. Barcelona. Spain. 3 ATRA. Barcelona. Spain DUAL DIAGNOSIS CHALLENGES FOR PRACTITIONERS IN AN ASSERTIVE OUTREACH SETTING WITHIN AN INNER LONDON CITY AREA Elliot C Ndengeya 2 Camden & Islington NHS Mental Health Foundation Trust, London, United Kingdom Middlesex university, London, UK. Room 9 15:30 17:00 SYMPOSIUM S2-29 Track 19 PSYCHIATRIC AND TOBACCO SMOKING TOBACCO AND DUAL DIAGNOSIS Prof. Manuel Gurpegui, Department of Psychiatry and Institute of Neurosciences, University of Granada, Granada, Spain. CORRELATES OF SMOKING AND OF NICOTINE DEPENDENCE IN NON-PSYCHIATRIC POPULATION Dr. José María Martínez-Ortega. Department of Psychiatry and Institute of Neurosciences, University of Granada. Spain. NICOTINE DEPENDENCE AND DEPRESSION: A COMPLEX RELATIONSHIP Dr. Eugeni Bruguera. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. TOBACCO SMOKING IN PATIENTS WITH BIPOLAR DISORDER: ASSOCIATION WITH MEANINGFUL VARIABLES Dr. Luis Gutiérrez-Rojas. Community Mental Health Unit, Servicio Andaluz de Salud, Loja, Spain. SCHIZOPHRENIA AND SMOKING: BETWEEN SHARED VULNERABILITY AND SEL-MEDICATION Prof. Manuel Gurpegui. Department of Psychiatry and Institute of Neurosciences, University of Granada. Spain. 80

79 THURSDAY 06th OCTOBER 06 Room 11 15:30-17:00 SYMPOSIUM S2-90 Track 25 SPIRITUALITY AND DUAL DIAGNOSIS Prof. Adolf Tobeña. Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona. Spain. RELIGIONS, DRUG ABUSE AND PSYCHOPATHOLOGY Dr. Luis Caballero. Servicio de Psiquiatría. Hospital Puerta de Hierro. Madrid, Spain. BIOLOGICAL BASIS OF SPIRITUALITY Prof. Adolf Tobeña. Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona. Spain. IMMIGRATION, RELIGION, PSYCHOPATHOLOGY AND DRUG ABUSE Dr. Adil Qureshi. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Room 12 15:30 17:00 SYMPOSIUM S2-28 Track 03 BIPOLAR BIPOLAR DISORDER AND COMORBIDITY VIEWED BY PSYCHOPHARMACOLOGY, NEUROIMAGING, NEUROPSYCHOLOGY AND PSYCHOTHERAPY Dr. Josep Solé Puig, Complejo de Salud Mental Benito Menni, Sant Boi de Llobregat. Barcelona, Spain. LATEST DEVELOPMENTS IN THE PSYCHOPHARMACOLOGY OF ADDICTIONS-COMORBID BIPOLAR DISORDER Dr. Benedikt Amann, Benito Menni CASM, CIBERSAM, Germany. NEUROIMAGING IN BIPOLAR DISORDER WITH AND WITHOUT DUAL DIAGNOSIS: CURRENT DATA Dr. Paloma Fernández Corcuera, Benito Menni CASM, Sant Boi, Spain. NEUROPSYCHOLOGY AND BIPOLAR DISORDER WITH AND WITHOUT DUAL DIAGNOSIS: STATE OF THE ART Dr. Laura Blanco Presas, Benito Menni CASM, Sant Boi, Spain. COMORBID BIPOLAR DISORDER: INTEGRATED OR HYBRID PSYCHOTHERAPY? Dr. Josep Solé Puig, Benito Menni CASM, Sant Boi, Spain. 81

80 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 1 16:00 18:00 I HAVE A QUESTION FOR DR. NORA VOLKOW Room 4 16:30 18:30 SYMPOSIUM S2-31 Track 06 ADHD SYMPOMTS IN HIGH RISK ADULT POPULATIONS: COCAINE USERS AND PARENTS OF CHILDREN WITH ADHD Chair/Presenter: Dr. José Ramón Gutiérrez Casares. Hospital Perpetuo Socorro. Complejo Hospitalario Universitario de Badajoz. Spain. DEPRESSION TDAH Dra. María Teresa Martín Lunar, Fundación Sorapán de Rieros, Badajoz, Spain. Dr. José Miguel Zoido Ramos, CEDEX-SES, Badajoz, Spain. Room 5 16:30 18:30 SATELLITE SYMPOSIUM SS2-08 Track 02 AGOMELATINE, NEW EXPECTATIONS FOR PATIENTS WITH DEPRESSION Sponsored by Servier- Rovi Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. AGOMELATINE: DIFFERENTIAL CLINICAL BENEFITS IN DEPRESSION Prof. Gabriel Rubio. Professor of Psychiatry. Universidad Complutense. Hospital Doce de Octubre. Madrid, Spain. USE OF AGOMELATINE AND DUAL DEPRESSION Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. 82

81 THURSDAY 06th OCTOBER 06 Room 16 16:30 18:30 ORAL COMMUNICATIONS CO9 EVALUATION PROCESSES, EPIDEMIOLOGY Dra. Nieves Martínez. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain PERFIL NEUROPSICOLÓGICO EN SUJETOS CON DEPENDENCIA DE ALCOHOL Y/O COCAÍNA Laura Blanco Presas 1, Peter Mckenna 2, Silvia Alonso Lana 2, Mª Dolores Iglesias Fernández 3 1 CASM Benito Menni ( Unidad Patología Dual); Sant Boi de Llobregat, Barcelona. Spain. 2 FIDMAG Fundación para la Investigación y la Docencia Mª Angustias Giménez, Barcelona. Spain. 3 Fundación Proyecto Hombre, Navarra. Spain HEALTH- RELATED QUALITY OF LIFE IN PATIENTS WITH DUAL DIAGNOSIS Irina Benaiges 1, Laura Rio 1, Gemma Prat 1, Ana Adan 1, 2 1 Universidad De Barcelona. Spain. 2 Institut for Brain, cognition and Behavior (IR 3 C) 3.00 IMPLEMENTATION OF ADDICTION TREATMENT IN A PSYCHIATRIC HOSPITAL Tevje Revheim Telemark Hospital. Skien. Norway EFECTO DEL DIAGNÓSTICO Y TRATAMIENTO DE LA PATOLOGÍA DUAL EN EL TIEMPO DE ADHERENCIA A PROGRAMA AMBULATORIO DE REHABILITACIÓN Marisol Orocio-Contreras 1, Amado Nieto Caraveo 2, Antonio Gordillo Moscoso 3 1 Instituto Temazcalli Prevencion y Rehabilitación, San Luis Potosí, Mexico 2 Facultad de Medicina de la UASLP, México 3 Facultad de Medicina de la UASLP, México 83

82 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 5.00 THE RECOGNITION AND THE PREVALENCE OF ALCOHOL ABUSE, SUICIDAL IDEATION AND MENTAL IN PRIMARY CARE PATIENTS Jurate Peceliuniene, Adomas Bunevicius, Robertas Bunevicius The Institute of Psychophysiology And Rehabilitation c/o Medical Academy of Lithuanian University Of Health Sciences. Lithuania CARACTERIZACIÓN DE LA POBLACIÓN Y PRESENCIA DE PATOLOGÍA DUAL EN LOS PACIENTES ATENDIDOS EN CLÍNICA CASA SERENIDAD, COSTA RICA DURANTE LOS ÚLTIMOS 18 MESES Carlos Araya Cuadra Clínica Casa Serenidad. Costa Rica PSYCHIATRIC COMORBIDITY IN PATIENTS WITH SUBSTANCE DEPENDENCE: SOCIO- DEMOGRAPHIC & RELATIONSHIP CHARACTERISTICS. STUDY FROM KASHMIR, INDIA Abdul Majid Gania Sher-I-Kashmir Institute Of Medical Sciences Medical College. India DUAL PATHOLOGY: ECONOMIC IMPACT OF PSYCHIATRIC HOSPITALIZATION IN A GENERAL HOSPITAL Carmen Rozados Villaverde 1, 2, Pablo Barrio Giménez 1, Diego Hidalgo Mazzei 1, Marta García Acuña 1, Iria Grande Fullana 1, Mercè Balcells Olivera 1, Santiago Salvat Blanco 1, Carolina Franco Porras 1, 3 Rocío Martín-Santos Laffon 1 1 Servicio de Psiquiatría, Institut clínic de neurociencias, Hospital Clínic, IDIBAPS, CIBERSAM, Barcelona. Spain. 2 Servicio de psiquiatría, complejo hospitalario de Pontevedra. Spain. 3 Centre d`higiene Mental Les Corts, Barcelona. Spain. 84

83 THURSDAY 06th OCTOBER THE HOTEL STUDY: ADDICTION, PSYCHOSIS, AND VIRAL INFECTION Fidel Vila, Willough Jenkins, Jen Li, Karine Paquet, Alaisdair Barr, Ric Procyshyn, Donna Lang, Julio Montaner William MacEwan William Honer University Of British Columbia, Dpt. Of Psychiatry. USA SUBSTANCE USE IN HOSPITALIZED PATIENTS: DUAL DIAGNOSIS? Tania Isabel Blanco Pena, Carmen Rozados Villaverde, Elisa Mariño Diaz, David Fachal Vázquez, José Mª Blanco Lobeiras, Víctor Pedreira Crespo Complejo Hospitalario de Pontevedra. Spain DUAL DIAGNOSIS: A STUDY IN AN EMERGENCY SERVICE Carmen Rozados Villaverde 1, Elisa Mariño Díaz 1, David Fachal Vázquez 1, Tania Isabel Blanco Pena 1, Carlos Pino Serrano 1, 2, José María Blanco Lobeiras 1, Víctor Pedreira Crespo 1, 1 Complejo Hospitalario De Pontevedra-Servicio de Psiquiatría. Spain. 2 Unidad de Atención al drogodependiente-pontevedra. Spain TRAUMATIC BRAIN INJURY AMONG PEOPLE WITH COOCCURRING SERIOUS MENTAL ILLNESS AND SUBSTANCE ABUSE Gregory McHugo 1, Sarah Krassenbaum 2, Sachiko Donley 2, Robert Drake 1 1 Dartmouth College, Hanover, New Hampshire, USA 2 Community Connections, Washington, DC, USA PSYCHIATRIC COMORBIDITY, SEVERITY OF ADDICTION AND QUALITY OF LIFE IN OPIATE DEPENDENT TREATED PATIENTS: A ONE-YEAR PROSPECTIVE STUDY Marc Auriacombe, Melina Fatséas Université Bordeaux Segalen. France. 85

84 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 2 17:00 19:00 SYMPOSIUM S2-32 Track 28 RESOURCE MANAGEMENT TREATMENT MODELS IN DUAL DIAGNOSIS: INTEGRATED OR UNIFIED TREATMENT Dr. Carlos Álvarez Vara. Comisión Clínica de la Delegación del Gobierno para el Plan Nacional sobre Drogas. Madrid, Spain. MANAGEMENT OF CONCURRENT IN ADDICTION AND MENTAL HEALTH: THE ALBERTA CASE STUDY Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. THE MODEL OF THE CITY OF MADRID Dr. José Manuel Torrecilla Jiménez. Gerente Madrid Salud. Spain. MANGEMENT OF THE DUAL PATIENT IN FRANCE. THE BIARRITZ EXPERIENCE. Dr. Jean-Pierre Daulouede. Psychiatre. Directeur du center de soins. Bayonne, France. Room 3 17:00 19:00 SATELLITE SYMPOSIUM SS2-03 Track 03 BIPOLAR TWO SIDES OF DUAL DIAGNOSIS IN BIPOLAR DISORDER: PRESENT AND FUTURE Sponsored by Bristol-Myers Squibb Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Spain. DUAL DISORDER: NEW CHALLENGES IN PATIENTS WITH BIPOLAR DISORDER Prof. Ana González Pinto. Head of Section. Psychiatry Service. Hospital Santiago Apóstol. Vitoria, Spain. CLINICAL MANAGEMENT OF DUALLY DIAGNOSED PATIENTS IN CLINICAL PRACTICE Dr. José María Vázquez. Psychiatrist. CAS Sants (ASPB- ABD). Vocal for Catalonia of the SEPD. Barcelona. Spain. QUALITY OF LIFE IN DUAL PATIENTS: MEDICAL AND PSYCHIATRIC COMORBIDITIES Dr. Francina Fonseca. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma de Barcelona, Spain. 86

85 THURSDAY 06th OCTOBER 06 Room 9 17:00 18:30 SYMPOSIUM S2-30 Track 17 PSYCHOESTIMULANTS AND DUAL DIAGNOSIS COCAINE MANAGEMENT AND DUAL DIAGNOSIS: A BRIDGE BETWEEN RESEARCH AND CLINICAL PRACTICE Dr. Joan Colom. Subdirecció General de Drogodependències. Departament de Salut. Generalitat de Catalunya. Barcelona. Spain. CLINICAL PRACTICE GUIDELINES. GPC METHODOLOGY OF COCAINE Dr. Ivan Solà. Centro Chrocane Iberoamericano. Barcelona, Spain. NEW LINES OF RESEARCH PROPOSALS AND TREATMENT OF COCAINE DEPENDENCY AND DUAL DIAGNOSIS Dr. Miquel del Rio. Psychiatry Department. Hospital Mutua de Terrasa. Barcelona, Spain. PILOT PROJECTS IN CATALONIA ON THE OUTPATIENT TREATMENT OF COCAINE DEPENDENCE Dr. Marta Coronado. Subdirecció General de Drogodependències. Departament de Salut. Generalitat de Catalunya. Barcelona. Spain. Room 11 17:00 18:30 WORKSHOP W2-10 Track 14 EVALUATION PROCESSES USING ELECTRONIC MEDICAL RECORD REMOTE DATA ACCESS TO COMPARE INPATIENT BED UTILIZATION IN THE 12 MONTHS PRE AND POST RESIDENTIAL SUBSTANCE ABUSE TREAMTMENT (RRTP) Chair/Presenter: Dr. Kathleen Stack & Dr. Jose Edwin Nieves. Psychiatrists. Veterans Affairs Medical Center, Hampton, VA, USA. 87

86 FRIDAY OCTOBER 07th II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL

87 08:00 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 18:00 18:30 19:00 Room 1 (Translation) S3-87 Multidisciplinary Approaches S3-50 Multidisciplinary Approaches S3-51 Cannabis S3-57 Cannabis Room 2 (Translation) S1-08 Sexual Dysfunction S3-39 Transcultural Psychiatry S3-52 Epidemiology S3-58 Psychotherapeutic Treatment Room 3 (Translation) S3-78 Basic Research S3-86 Psychopharmac. Treatment SS3-05 Psychopharmac. Treatment Room 4 (Translation) S3-35 PTSD S3-42 PTSD W3-11 Psychopharmac. Treatment S3-81 Psychopharmac. Treatment S3-59 Impulsivity FRIDAY OCTOBER 7th 2011 Room 5 (traducción) Room 6-7 Room 8 Room 9-10 Room 11 Room 12 Room 15 Room 16 Institutional Activity Breakfast The Brain and Dual Diagnosis. DRA. NORA VOLKOW S3-76 Sleep Disorders Lunch with S3-56 Cannabis S3-43 Evaluation ME3-05 S3-37 Basic Research ME3-06 the Expert S3-44 Psychosis W3-29 Psychopharmac. Treatment S3-53 Suicide S3-60 Suicide Rethinking the Dual Diagnosis S3-61 Multidisciplinary Approaches S2-13 Personality Disorders W3-30 Psychopharmac. Treatment S3-82 Multidisciplinary Approaches Self-Medication Hypothesis S3-38 Child and Adolescent Psychiatry S13-01 Oral CCC3-03 Best Poster in DD Contest S3-84 Psychosis S3-45 Basic Research W3-12 Psychopharmac. Treatment S3-77 Legal Aspects W3-13 Legal Aspects S3-46 Child and Adolescent Psychiatry Communications CO10 SS3-06 Oral Communications CO11 S3-63 Useful Psychotropic Drugs S3-62 Basic Research Oral Communications CO12

88 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER TRACK INDEX Track 01 PSYCHOSIS 08:00 09:00 PSYCHOTIC PATIENT MANAGEMENT Room 11 13:00 15:00 WHY DO PSYCHOTICS CONSUME CANNABIS IF CANNABIS CAUSES PSYCHOSIS? Room 9 15:00 16:30 BEST POSTER IN DUAL DIAGNOSIS IN PSYCHOSIS CONTEST CCC3 03 Room 9 16:30 18:00 SERIOUS ADDICTION AND PSYCHOSIS Room 9 Track 05 PERSONALITY 17:30 19:30 FROM PERSONALITY TO ADDICTION THROUGH NEUROBIOLOGY Room 6 Track 07 IMPULSIVITY 17:00 18:30 IMPULSIVITY AND DUAL DIAGNOSIS Room 4 Track 08 POST-TRAUMATIC STRESS 11:00 12:30 PTSD, SELF MEDICATION AND CONTEXT: FUNCTIONAL RELATIONSHIPS BETWEEN PTSD CLUSTER CHANGES AND ALCOHOL AND STIMULANT OUTCOMES IN THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK WOMEN AND TRAUMA STUDY Room 4 12:30 14:00 UPDATES IN PTSD COMORBIDITY AND ADDICTIONS Room 4 Track 10 CHILD AND ADOLESCENT PSYCHIATRY 11:00 12:30 UPDATES IN ADOLESCENTS AND DUAL DIAGNOSIS Room 12 12:30 14:00 CHILD AND ADOLESCENTS AND DUAL DIAGNOSIS Room 12 Track 11 TRANSCULTURAL PSYCHIATRY 14:30 16:00 CURRENT TRENDS IN TRANSCULTURAL ADDICTION RESEARCH Room 2 Track 14 EVALUATION PROCESSES 12:30-14:00 EVALUATION AND TREATMENT OF DUAL PATIENTS IN CATALUÑA Room 5 Track 18 CANNABIS AND DUAL DIAGNOSIS 11:00 12:30 CANNABIS CONSUMPTION IN FIRST PSYCHOTIC EPISODES Room 6 16:00 17:30 CANNABIS: PSYCHOSIS OR NEUROTOXICITY Room 1 17:30 19:00 CANNABIS AND DUAL DIAGNOSIS Room 1 Track 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS 15:30 17:00 DRUGS IN DUAL DIAGNOSIS Room 12 16:00 17:30 FUTURE PHARMACOLOGICAL ADVANCES IN THE TREATMENT OF ADHD Room 3 90

89 FRIDAY 07th OCTOBER 07 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS 14:00 15:30 SPECIFIC CONTROL TECHNICS OF POST-TRAUMATIC PATIENTS WITH DUAL DIAGNOSIS Room 4 14:00 15:30 GRIEF WORK AND RECONSTRUCTION OF MEANING IN THE PSYCHOTHERAPEUTIC APPROACH IN DUAL Room 5 14:00 15:30 THERAPEUTIC STRATEGIES AND COMMUNICATION SKILLS. PERSONALIZED ECLECTIC PSYCHOTHERAPY Room 8 14:00 15:30 WORKING WITH EMOTIONS IN THE REHABILITATION OF ADDICTIVE Room 11 14:00 15:30 THERAPEUTIC STRATEGIES AND COMMUNICATION SKILLS. PERSONALIZED ECLECTIC PSYCHOTHERAPY Room 8 15:30 17:00 DUAL DIAGNOSIS AND THERAPY GROUP TREATMENT Room 4 17:30 19:00 SOCIAL DETERMINANTS AND DUAL DIAGNOSIS Room 2 Track 23 MULTIDISCIPLINARY APPROACHES 13:00 14:30 SPECIAL SITUATIONS INTERVENTIONS Room 1 14:30 16:00 SPECIFIC APPROACHES TO PATIENTS WITH DUAL DIAGNOSIS Room 1 16:00 17:30 TOWARDS INTEGRATED DUAL DISORDER TREATMENT IN THE NETHERLANDS Room 6 15:30 17:00 DRUG AND ALCOHOL IMPACT IN EMERGENCIES Room 8 Track 24 BASIC RESEARCH IN DUAL DIAGNOSIS 11:00 12:30 CHRONOBIOLOGICAL ASPECTS IN DUAL PATHOLOGY Room 11 12:30 14:00 PRECLINICAL RESEARCH IN ADICTIONS AND ITS CLINICAL TRASLATION IN DUAL DIAGNOSIS Room 11 13:00 14:30 GENETICS AND BIOLOGICAL MARKERS IN ADDICTION AND DUAL DIAGNOSIS Room 3 17:00 18:30 WHAT CAN BASIC RESEARCH ADD TO A BETTER UNDERSTAING OF DUAL DIAGNOSIS? Room 12 Track 26 SEXUAL DYSFUNCTION AND DUAL DIAGNOSIS 13:00 14:30 SEXUAL DYSFUNCTION Room 2 Track 27 LEGAL ASPECTS IN DUAL DIAGNOSIS 15:30 17:00 DUAL DIAGNOSIS Y PRISIÓN Room 11 17:00 18:30 HISTORY OF FORENCIS PSYCHIATRY IN CHILE AND IN THE PSYCHIATRIC HOSPITAL PHILIPPE PINEL: A CASE OF PSYCHOSIS. Room 11 Track 30 EPIDEMIOLOGY AND DUAL DIAGNOSIS 16:00 17:30 DUAL DIAGNOSIS IN THE DSM5 AND ICD11 Room 2 Track 31 SUICIDE 15:30 17:00 SUBSTANCE USE AND SUICIDE Room 5 17:00 18:30 SUICIDE Room 5 Track 33 SLEEP AND DUAL DIAGNOSIS 11:00 12:30 SLEEP DISORDER, PSYCOPATHOLOGY AND SUBSTANCE USE Room 5 91

90 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 11 08:00 09:00 BREAKFAST WITH THE EXPERT Track 01 PSYCHOTIC PATIENT MANAGEMENT PSYCHOSIS Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Lara Grau-López. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. Room 1 09:00 09:30 INSTITUTIONAL ACTIVITY Room 1 09:30 11:00 MAIN LECTURE THE BRAIN AND DUAL DIAGNOSIS Dr. Nora Volkow. NIDA Director. USA. Room 4 11:00 12:30 SYMPOSIUM S3-35 Track 08 POST-TRAUMATIC STRESS PTSD, SELF MEDICATION AND CONTEXT: FUNCTIONAL RELATIONSHIPS BETWEEN PTSD CLUSTER CHANGES AND ALCOHOL AND STIMULANT OUTCOMES IN THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK WOMEN AND TRAUMA STUDY Dr. Denise Hien, Ph.D., City University of New York and Columbia University College of Physicians and Surgeons. New York, USA. AN OVERVIEW OF THE SELF MEDICATION MODEL IN THE TREATMENT OF PTSD AND SUD Dr. Denise Hien, Ph.D., City University of New York and Columbia University College of Physicians and Surgeons. New York, USA. THE ROLE OF ALCOHOL MISUSE IN PTSD OUTCOMES Dr. Aimee N. C. Campbell, Ph.D., Columbia University College of Physicians and Surgeons, NY, USA. 92

91 FRIDAY 07th OCTOBER 07 ASSOCIATIONS BETWEEN PTSD SYMPTOMS AND STIMULANT USE Dr. Lesia M. Ruglass, Ph.D., City University of New York, NY, USA. CONTEXTUAL FACTORS IN THE TREATMENT OF PTSD AND SUD Dr. Lisa Cohen, Ph.D., New York State Psychiatric Institute at Columbia University Medical Center, NY, USA. CLINICAL AND SUPERVISORY CHALLENGES IN IMPLEMENTING EVIDENCE BASED PRACTICES FOR PTSD AND SUD IN COMMUNITY ADDICTION TREATMENT PROGRAMS Dr. Lisa Litt, Ph.D., Columbia University College of Physicians and Surgeons, NY, USA. Room 5 11:00 12:30 SYMPOSIUM S3-76 Track 33 SLEEP AND DUAL DIAGNOSIS SLEEP DISORDER, PSYCOPATHOLOGY AND SUBSTANCE USE Dr. Miquel Roca. Psychiatry Service. Hospital Joan March. Universitat Illes Balears. Spain. SUBTANCE ABUSE AND SLEEP Prof. Tarek A. ASAAD. Institute of Psychiatry. Ain Shams University. Cairo, Egypt. BENZODIACEPINE DEPENDENCE AND COMORBIDITY Dr. Francesca Cañellas. Coordinadora Área de Salud Mental. Hospital Universitario Son Espases. Palma de Mallorca. Spain. SLEEP AND PSYCOPATHOLOGY Prof. Margaret L. Griffin. Associate Clinical Professor in Psychiatry. Harvard Medical School. McLean Hospital. Belmont, USA. 93

92 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 6 11:00 12:30 SYMPOSIUM S3-56 Track 18 CANNABIS AND DUAL DIAGNOSIS CANNABIS CONSUMPTION IN FIRST PSYCHOTIC EPISODES Dr. Judith Usall Rodié. Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat. Barcelona. CIBERSAM, Spain. GENETIC VULNERABILITY, CANNABIS USE AND ITS RELATIONSHIP WITH PSYCHOSIS Dr. Mar Fatjó-Vilas. Unitat d Antropologia, Departament de Biologia Animal. Facultat de Biologia, Universitat de Barcelona. IBUB. CIBERSAM. Spain. RELATIONSHIP BETWEEN CANNABIS CONSUMPTION AND COGNITION, EVOLUTION AND FUNCTIONING IN FIRST PSYCHOTIC EPISODES Dr. Sara Barbeito Resa y Dra Sonia Ruiz de Azua. Unidad de Investigación en Psiquiatría, Hospital Santiago Apóstol. CIBERSAM. Vitoria-Gasteiz, Spain. CLINICAL AND FUNCTIONING DIFFERENCES IN CANNABIS USE IN FIRST EPISODE PSYCHOSIS Dr. Susana Ochoa Güerre, Unidad de Investigación y Desarrollo de Parc Sanitari Sant Joan de Déu, Barcelona. CIBERSAM. Spain. Room 8 11:00 12:00 MEETING WITH THE EXPERT ME3-05 Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. 94

93 FRIDAY 07th OCTOBER 07 Room 11 11:00 12:30 SYMPOSIUM S3-37 Track 24 CHRONOBIOLOGICAL ASPECTS IN DUAL PATHOLOGY BASIC RESEARCH IN DUAL DIAGNOSIS Chair/Presenter: Dr. Gemma Prat. Universitat de Barcelona. Fundació Althaia. Manresa. Barcelona. Spain. CHRONOBIOLOGY: METHODOLOGICAL ASPECTS Prof. Juan Antonio Madrid. University of Murcia. Spain. PSYCHOPATHOLOGY AND SLEEP-WAKE CYCLE Prof. Eduard Estivill. Unitat d Alteracions del Son. Clínica Dexeus. Barcelona, Spain. CIRCADIAN RHYTHMICITY AND DUAL PATHOLOGY: CHRONOBIOLOGICAL THERAPEUTIC APPROACHES Prof. Ana Adan. Universitat de Barcelona. Spain. Room 12 11:00 12:30 SYMPOSIUM S3-38 Track 10 UPDATES IN ADOLESCENTS AND DUAL DIAGNOSIS CHILD AND ADOLESCENT PSYCHIATRY Dr. Lluis San Molina. Hospital Sant Joan de Deu Servei de Psiquiatria i Psicología. Barcelona. Spain. SUBSTANCE USE AMONG ADOLESCENT FIRST EPISODE PSYCHOTIC PATIENTS Dr. Marta Pardo. Unitat de Conductes Addictives de l Adolescent. Servei de Psiquiatria i Psicología. Hospital Sant Joan de Deu. Barcelona. Spain. DUAL DIAGNOSIS IN ADOLESCENTS: ADHD, CANNABIS AND COCAINE, CHALLENGES IN THE INTERVENTION Dr. Javier Goti Elejalde. Servei de Psiquiatria i Psicología Infantil i Juvenil. Hospital Clínic Barcelona. Spain. SUBSTANCE USE IN ADOLESCENTS WITH BORDERLINE PERSONALITY DISORDER Dr. Marc Ferrer. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. IMPACT OF ADOLESCENT SUBSTANCE USE IN CHILD AND ADOLESCENT PSYCHIATRIC EMERGENCIES Dr. Josep Matalí Costa. Unitat de Conductes Addictives de l Adolescent. Servei de Psiquiatria i Psicología. Hospital Sant Joan de Deu. Barcelona. Spain. 95

94 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 11:00 12:30 SYMPOSIUM SI3-01 THE CHALLENGE OF PHARMACEUTICAL INDUSTRY FARMACÉUTICA IN FACE OF THE ADVANCES OF DUAL DIAGNOSIS: A NEGLECTED EVIDENCE FOR DECADES Despite the retoric of certain media, stating that any collaboration between the Scientific and Academic Community with the Pharmaceutical Industry is by definition not very ethical, this committee shares the opinion of the NIMH (National Institute of Mental Health) from the USA, on the need of collaboration between these two Interest groups jointly with the Administration, with the aim of a New Biotech focussed in attaining new and innovative therapeutic instruments for treating mental illnesses. This is the purpose and direction of this symposium organized by invitation of the Scientific Committee and the SEPD. President: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Dr. José Ramón Luis-Yagüé. Director de Farmaindustria. Spain. Presenters: Mr. Eric Patrouillard. President Lilly, Spain. Mrs. Elvira Sanz. President Pfizer, Spain. Mr. Martín Selles. President Janssen, Spain. 96

95 FRIDAY 07th OCTOBER 07 Room 16 11:30 13:30 ORAL COMMUNICATIONS CO10 PSYCHOTHERAPEUTIC TREATMENT Dra. Amparo Sánchez. UCA- Paterna. Valencia. Spain 1.00 ABORDAJE PSICOTERAPÉUTICO PARA PACIENTES GRAVES Cristina Strifezza Centro De Atenciòn Psicoterapèutica Mar Del Plata. Buenos Aires. Argentina 2.00 TERAPIA DE ACEPTACIÓN Y COMPROMISO APLICADA A UN CASO DE PATOLOGIA DUAL. Bartolomé Marín Romero, Magdalena De Miguel Fernandez, Luciano Cobos Luna Unidad De Conductas Adictivas. Instituto Provincial de Bienestar Social. Cordoba. Spain IN-PATIENT TREATMENT FOR DUAL DIAGNOSES Grete Larsen TEDD, Centro Psiquiatrico Regional, Diakonhjemmet Sykehus. Oslo. Norway INTEGRATING GOAL SETTING WITHIN CARE PLANNING FOR FAMILIES WITH COMPLEX NEEDS. Darryl Maybery, Andrea Reupert, Melinda Goodyear, Marilyn Harkness Monash University. Victoria. Australia LAS PAUTAS DE INTERACCIÓN ESQUIZOFRENIZANTES EN EL HOLON PARENTAL MADRES E HIJOS (AS) ADICTOS EN REHABILITACIÓN EN UNA CLINICA PRIVADA Hazel Gutierrez Gonzalez Clinica Casa Serenidad. Costa Rica LA ADHERENCIA AL TRATAMIENTO EN PATOLOGÍA DUAL: ESTRATEGIAS DESDE LA UNIDAD ESPECÍFICA Jessica Morral Benavente, Sergi Vilardell Falcón, Rosa Cortina Cunill, Josep Maria Fàbregas Centro De Investigación y Tratamiento de Adicciones. Barcelona. Spain. 97

96 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 7.00 HOW MOTIVATIONAL IS THE TREATMENT PROGRAM? James Bott St. Luke s/roosevelt Hospital. New York. USA DUAL DIAGNOSIS PATIENT S NEEDS OF SOCIAL SUPPORT: A SURVEY Sonia Fuertes Ledesma Fundación Salud y Comunidad. Barcelona. Spain A STAGE MODEL FOR THE TREATMENT OF PUERTO RICAN ADOLESCENTS WITH DUAL Sydnia Rosado Torres 1, 2, Delia P. González 1, 3, Virmarie Correa 4 1 Universidad Carlos Albizu- San Juan Campus 2 Administración Servicios de Salud Mental y contra la Adicción 3 Universidad Central del caribe - Bayamón, PR 4 Universidad de Puerto Rico ABORDAJE PSICOTERAPÉUTICO DE UN PACIENTE DUAL CON VIH DESDE UN CAS Cristo Manuel Cruz Alonso CAS de Sarria Sant Gervassi. Barcelona, Spain. Room 8 12:00 13:00 MEETING WITH THE EXPERT ME3-06 Prof. Robert West. Department of Epidemiology and Public Health. University College London, UK. 98

97 FRIDAY 07th OCTOBER 07 Room 4 12:30 14:00 SYMPOSIUM S3-42 Track 08 UPDATES IN PTSD COMORBIDITY AND ADDICTIONS POST-TRAUMATIC STRESS Chairs: Dr. Sara Guila Fidel Kinori. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Dr. Francisco José Eiroa-Orosa. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. PREVALENCE OF EARLY TRAUMA AND PTSD IN SUBSTANCE DEPENDENCE Dr. Martin Driessen. Ev. Hospital Bielefeld. University of Bielefeld. Bethel, Germany. CHILDHOOD TRAUMA, PTSD AND ALCOHOL USE Dr. Willie Langeland. Deptartment of Psychiatry, Vrije Universiteit Medical Center. Amsterdam, The Netherlands. INTEGRATED TREATMENT FOR PTSD AND SUBSTANCE ABUSE Dr. Ingo Schäfer. Deptartment of Psychiatry and Psychotherapy- University Medical Center Hamburg- Eppendorf. Center for Interdisciplinary Addiction Research (CIAR), University of Hamburg. Germany. CO-MORBID ADHD, DEPRESSION, PTSD, AND SUBSTANCE ABUSE Dr. Causenge Cangin, Declare Therapy Center, Covington, USA. Room 5 12:30-14:00 SYMPOSIUM S3-43 Track 14 EVALUATION PROCESSES EVALUATION AND TREATMENT OF DUAL PATIENTS IN CATALUÑA Chair/Presenter: Dr. Diego Palao. Chief of Psychiatry Service. Hospital Parc Taulí Sabadell. President of the Sociedad Catalana de Psiquiatría. Barcelona, Spain. DUAL PATIENT EVALUATION IN THE DRUG DEPENDENCY NETWORK Dra. Pilar Duro. Direcció General de Salut Pública. Departamen de Salut. Generalitat de Catalunya. Spain. EVALUATION AND SCREENING OF DUAL PATIENTS IN THE CATALUÑA S MENTAL HEALTH NETWORK Dr. Josep Cañete. Director. Ámbito de Salud Mental y Adicciones. Hospital de Mataró. Consorci Sanitari del Maresme. Spain. 99

98 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 11 12:30 14:00 SYMPOSIUM S3-45 Track 24 BASIC RESEARCH IN DUAL DIAGNOSIS PRECLINICAL RESEARCH IN ADICTIONS AND ITS CLINICAL TRASLATION IN DUAL DIAGNOSIS Prof. Emilio Ambrosio Flores. Professor. Department of Psicobiology. UNED. Madrid, Spain. ANIMAL MODELS FOR STUDYING DUAL DIAGNOSIS: EFFECTS OF ALCOHOL AND PSYCHOSTIMULANTS Prof. Olga Valverde Granados. Professor of Psicobiology. Universidad Pompeu Fabra de Barcelona. Spain. SUSCEPTIBILITY TO COCAINE ADDICTION IN AN ANIMAL MODEL OF SCHIZOPHRENIA Prof. Alejandro Higuera Matas. Department of Psicobiology. Facultad de Psicología. UNED. Madrid, Spain. ADVANCES IN THE TREATMENT OF DUAL DIAGNOSIS Dr. Iván Montoya. Clinical Director of Pharmacotherapies and Medical Consequences of Drug Abuse. National Institute on Drug Abuse (NIDA). Bethesda, Maryland, USA. Room 12 12:30 14:00 SYMPOSIUM S3-46 Track 10 CHILD AND ADOLESCENTS AND DUAL DIAGNOSIS CHILD AND ADOLESCENT PSYCHIATRY Dr. Celso Arango. Head of Child and Adolescent Psychiatry. Hospital General Universitario Gregorio Marañón. Madrid, Spain. USE OF CANNABIS IN THE ADOLESCENCE AND PSYCHOSIS Dr. Inmaculada Baeza. Hospital Clínico Universitario (HCU). Barcelona, Spain. INFLUENCE OF PSYCHOPATHOLOGY IN ADOLESCENTS DETOXIFICATION Dr. Javier Goti Elejalde. Servei de Psiquiatria i Psicologia Infantil i Juvenil. Hospital Clinic Barcelona. Spain. ADOLESCENTS WITH ADHD. DO THEY USE DRUGS? Dr. Montserrat Pamias. Head of Child Psychiatry. Hospital Parc Taulí Sabadell. Barcelona, Spain. GENETIC INFLUENCE ON DUAL ADHD Dr. Josep Antoni Ramos-Quiroga. ADHD Program Coordinator. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. 100

99 FRIDAY 07th OCTOBER 07 Room 1 13:00 14:30 SYMPOSIUM S3-87 Track 23 SPECIAL SITUATIONS INTERVENTIONS MULTIDISCIPLINARY APPROACHES Prof. Rafael Torrubia. Universidad Autónoma de Barcelona. Spain. APPROACH TO DUAL PATINENTS IN PRISIONS Dr. Frances Perez-Arnau. Servicios de Psiquiatría Penitenciarios. Hosptial San Joan de Deu. Barcelona, Spain. APPROACH TO THE DUAL PATIENT IN THERAPEUTIC COMMUNITIES Dr. Indalecio Carrera. Medical Services Responsible of CT de ACLAD, A Coruña. Professor. Department of Psychiatry. Universidad Santiago de Compostela. Spain. APPROACH TO THE DUAL PATIENT IN OUTPATIENT CENTERS Dr. Mikel Landabaso. Psychiatrist. Centro de Salud Mental (Unidad de toxicomanías) de Uribe. Getxo Bizkaia, Spain. Room 2 13:00 14:30 SYMPOSIUM S1-08 Track 26 SEXUAL DYSFUNCTION SEXUAL DISFUNCTION AND DUAL DIAGNOSIS Prof. Michel Reynaud. Département de Psychiatrie et d Addictologie. Hôpital Universitaire Paul Brousse. Villejuif, France. SEXUAL ADDICTION AND AFFECTIVE DEPENDENCE: ITS CLINICAL SYMPTOMS AND RISK FACTORS Prof. Michel Reynaud. Département de Psychiatrie et d Addictologie. Hôpital Universitaire Paul Brousse. Villejuif, France. EMOTIONAL DEPENDENCE AND MENTAL HEALTH Dr. Francisco Cabello Santamaría. Director of the Instituto Andaluz de Sexología y Psicología. Professor of Asesoramiento y Terapia Sexual. Universidad de Almería. Spain. 101

100 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 3 13:00 14:30 SYMPOSIUM S3-78 Track 24 BASIC RESEARCH IN DUAL DIAGNOSIS GENETICS AND BIOLOGICAL MARKERS IN ADDICTION AND DUAL DIAGNOSIS Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. COCAINE DEPENDENCE, GENETIC MARKERS Dr. Marta Ribases. Unidad de Genética Psiquiátrica. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. THE APOMORPHINE TEST AS A BIOLOGICAL MARKER OF RELAPSE Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. NEUROIMAGE AND DUAL DIAGNOSIS Prof. Manuel Trujillo. Department of Psychiatry. New York University, USA. 102

101 FRIDAY 07th OCTOBER 07 Room 6 13:00 14:00 LUNCH WITH THE EXPERT USE AND CLINICAL EXPERIENCE OF PROLONGED RELEASE NOVEL ANTIPSYCHOTICS Sponsored by Lilly Moderador: Prof. Julio Bobes. Professor of Psychiatry. University of Oviedo. Spain. Dr. Juan A. Guisado. Psychiatry Service. Hospital Infanta Cristina. Badajoz, Spain. Dr. Alberto Domínguez. Psychiatry Service. Hospital Universitario La Fe. Valencia, Spain. Carmen Sánchez. Hospital Infanta Cristina de Badajoz. Dr. Antonio Ciudad. Sr. Medical Advisor. Eli Lilly Spain. Room 9 13:00 15:00 SYMPOSIUM S3-44 Track 01 WHY DO PSYCHOTICS CONSUME CANNABIS IF CANNABIS CAUSES PSYCHOSIS? Prof. Gabriel Rubio. Professor of Psychiatry. Universidad Complutense. Hospital Doce de Octubre. Madrid, Spain. PSYCHOSIS Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Dr. Carlos Pino. Psychiatrist. Drug Addiction Unit of Pontevedra. Spain. Dr. José María Vázquez. Psychiatrist. CAS Sants (ASPB- ABD). Vocal for Catalonia of the SEPD. Barcelona. Spain. 103

102 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 4 14:00 15:30 WORKSHOP W3-11 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS SPECIFIC CONTROL TECHNICS OF POST-TRAUMATIC PATIENTS WITH DUAL DIAGNOSIS Dr. Sara Guila Fidel Kinori. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Anna Giannoni Pastor. Programa de Trastorno por Estrés Post-Traumático. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Ruth Tasqué Cebrian. Programa de Trastorno por Estrés Post-Traumático. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Francisco José Eiroa-Orosa. Programa de Trastorno por Estrés Post-Traumático. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. Room 5 14:00 15:30 WORKSHOP W3-29 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS GRIEF WORK AND RECONSTRUCTION OF MEANING IN THE PSYCHOTHERAPEUTIC APPROACH IN DUAL Chair/Presenter: Mr. Ignacio González Jiménez. Psychologist. Addictive Behavior Unit of Villena. Valencia Health Agency. Villena, Alicante, Spain. 104

103 FRIDAY 07th OCTOBER 07 Room 6 14:30 16:00 RETHINKING THE DUAL DIAGNOSIS Invitation-only access President: Prof. Pedro Ruiz. Professor and Executive Vice Chair. Department of Psychiatry and Behavioral Sciences. University of Miami. Miller School of Medicine. USA. Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. Dr. Célia Franco. Psychiatrist, Coordinator of the Addiction Service (SA) of CHPC; APPD s President. Portugal. Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. 105

104 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Spain. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Spain. Dr. Nora Volkow. NIDA Director. USA. Room 8 14:00 15:30 WORKSHOP W3-30 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS THERAPEUTIC STRATEGIES AND COMMUNICATION SKILLS. PERSONALIZED ECLECTIC PSYCHOTHERAPY Chair/Presenter: Mr. Maximino Portela Freire. Director of the Unidad Asistencial de Drogodependencias, Cangas, Pontevedra, Spain. 106

105 FRIDAY 07th OCTOBER 07 Room 11 14:00 15:30 WORKSHOP W3-12 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS WORKING WITH EMOTIONS IN THE REHABILITATION OF ADDICTIVE Chair/Presenter: Prof. Humberto Guajardo Sáinz. Professor of Psychiatry. Unidad de Adicciones Facultad de Ciencias Médicas University of Santiago de Chile. Room 12 14:00 15:30 SATELLITE SYMPOSIUM SS3-06 TOWARDS A PSYCHIATRIC CARE OF EXCELLENCE Sponsored by Neurofarmagen Dr. Salvador Ros. Hospital del Mar. Universidad Autónoma de Barcelona. Spain. ClLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS ATTENDING A PSYCHIATRIC PRIVATE PRACTICE. (PRELIMINARY DATA FROM THE FIRST NATIONAL SURVEY ASEPP) Dr. José Ramón Doménech. Psychiatrist. Hospital Creu Roja. Barcelona, Spain. BIOLOGICAL MARKERS IN PSYCHIATRY. FROM PHARMACOGENETICS TO PHARMACOGENOMICS Dr. José Antonio López Rodríguez. Private practice. Madrid, Spain. ETHICS IN PSYCHIATRY. CHALLENGES AND CONFLICTS IN PRIVATE PRACTICE Dr. Blanca Morera. Psychiatrist. Formadora en Bioética Departamento de Política Social de la Diputación de Guipuzcoa, Spain. 107

106 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 16 14:00 16:00 ORAL COMMUNICATIONS CO11 SELF-MEDICATION, RESOURCE MANAGEMENT, SUICIDE Dr. José Miguel Zoido Ramos. CEDEX-SES. Badajoz. Spain SUPPORTING SIBLINGS WITH DISABILITIES AND MENTAL HEALTH ISSUES: A CASE STUDY OF LOVE, LABOUR AND LOYALTY Bonnie Lashewicz, Laura Mooney University Of Calgary. Canada GRAY S PERSONALITY MODEL IN THE VULNERABILITY TO DUAL DIAGNOSIS. SUSCEPTIBILITY TO PUNISHMENT AND REWARD José Luis Trujillo Valdivia Unidad De Patologia Dual De Martorell. Barcelona. Spain RELATIONSHIP BETWEEN ANXIETY AND OPIATE DEPENDENCE: IMPLICATIONS FOR DIAGNOSIS AND TREATMENT Marc Auriacombe, Melina Fatséas Université Bordeaux Segalen. France THE ASSOCIATION OF MOTIVATIONS FOR SUBSTANCE USE WITH DRUG OF CHOICE AND PSYCHOPATHOLOGY Marc Auriacombe, Melina Fatséas Université Bordeaux Segalen. France NON GOVERNMENTAL ORGANIZATION (NGO) COORDINATION BETWEEN A PUBLIC NETWORK AND MENTAL HEALTH OF LA RIOJA GOVERNMENT IS POSSIBLE Jose Luis Rabadan Rituerto, Antonio Domínguez Santamaría, Belén Pacheco Santaolalla, María Milagro Saénz, Leyre Mendizábal Benito ARAD (Asociacion Riojana Para La Atencion A Personas Con Problemas De Drogas). La Rioja. Spain. 108

107 FRIDAY 07th OCTOBER BUILDING THE MENTAL HEALTH CAPACITY OF DRUG AND ALCOHOL SERVICES IN AUSTRALIA Robert Stirling Network Of Alcohol And Other Drugs Agencies (NADA). NSW. Australia HARM REDUCTION AND DUAL : ASPECTS TO CONSIDER Belén Sánchez Garcés, M. Beltrán Negre Centro de Intervención de Baja Exigencia de Castellón. Spain ALCOHOL AND SUICIDE: CLINICAL ASPECTS Leo Sher Mount Sinai School Of Medicine / James J. Peters Veterans Administration Medica. USA MOOD AND SMOKING: ITS RELATINSHIP WITH SUICIDAL BEHAVIOUR Zoltan Rihmer Semmelweis University. Budapest. Hungary AFFECTIVE TEMPERAMENTS, SUICIDAL BEHAVIOURS AND SUBSTANCE USE Gianluca Serafini 1, Maurizio Pompili 1, 2, Marco Innamorati 1, Paolo Girardi 1 Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center Sant Andrea Hospital, Sapienza University of Rome, Italy McLean Hospital Harvard Medical School, USA 109

108 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 1 14:30 16:00 SYMPOSIUM S3-50 Track 23 MULTIDISCIPLINARY APPROACHES SPECIFIC APPROACHES TO PATIENTS WITH DUAL DIAGNOSIS Sponsored by the Portuguese Association of Dual Pathology Dr. Célia Franco. Psychiatrist, Coordinator of the Addiction Service (SA) of CHPC; APPD s President. Portugal. APPROACH AND TREATMENT OF ADDICTED AND DUAL DIAGNOSED PATIENTS IN PORTUGAL Dr. Carla Silva. Psychiatrist and Dr. Célia Franco. Psychiatrist. Coordinator of Addiction Service (SA) CHPC. President APPD. Portugal. PSYCHOTHERAPY IN PATIENTS WITH DUAL DIAGNOSIS Dr. Vera Raposo. Clinical Psychologist of SA, Bureau of APPD. Portugal. THE ROLE OF NURSES IN THE MULTIDISCIPLINARY TEAM MANAGING DUAL DIAGNOSIS PATIENTS Dr. Vladimiro Andrade. Nurse Chief of SA. Vice-President of APPD. Portugal. 110

109 FRIDAY 07th OCTOBER 07 Room 2 14:30 16:00 SYMPOSIUM S3-39 Track 11 TRANSCULTURAL PSYCHIATRY CURRENT TRENDS IN TRANSCULTURAL ADDICTION RESEARCH Dr. Francisco Collazos. Coordinador del Programa de Psiquiatría Transcultural. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. THE EPIDEMIOLOGIC PERSPECTIVE IN THE RESEARCH OF IMMIGRATION AND DRUG USE Dr. María Teresa Brugal. Director of Addictions. Agencia de Salud Pública de Barcelona (ASPB). Barcelona, Spain. EMIC VISION OF ADDICTIONS Dr. Joan Obiols. Mental Health Services Director. Andorra. Spain. CURRENT TRENDS OF TRANSCULTURAL RESEARCH ON ADDICTIONS Dr. Iván Montoya. Clinical Director of Pharmacotherapies and Medical Consequences of Drug Abuse. National Institute on Drug Abuse (NIDA). Bethesda, Maryland, USA. Room 3 14:30 16:00 SYMPOSIUM S3-86 THE USE OF DRUGS IN DUAL PATIENTS Prof. Adolf Tobeña. Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona. Spain. FARMACOLOGICAL INTERACTIONS: DRUG-MEDICINE Prof. Juan Gibert-Rahola. Departamento de Farmacología. Universidad de Cádiz. Spain. THE USE OF POLYPHARMACIES IN DUAL DIAGNOSIS UNITS Dr. Xavier Valls. Servicio de Patología Dual. Hospital de Martorell. Barcelona, Spain. COCAINE AND ALCOHOL: BDNF EVALUATION IN DUAL PATIENTS Dr. Margarita Corominas. Servicio de Psiquiatría. Hospital Universitario Vall d Hebron. Barcelona, Spain. 111

110 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 15:00 16:30 BEST POSTER IN DUAL DIAGNOSIS IN PSYCHOSIS CONTEST CCC3 03 Track 01 President: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. PSYCHOSIS Vicepresident: Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Coordinator: Dr. Begoña Gonzalvo. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB, Barcelona, Spain. Room 4 15:30 17:00 SYMPOSIUM S3-81 Track 22 DUAL DIAGNOSIS AND THERAPY GROUP TREATMENT PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS Prof. Roberto Secades. University of Oviedo, Spain. A PRELIMINARY EXPLORATION OF AN OUTPATIENT DUAL DIAGNOSIS RECOVERY GROUP PROGRAMME Mr. John Chilton Royal College of Nursing, Progress UK, Visiting lecturer at the University of Gloucester, and the University of the West of England. AMBULATORY GROUP THERAPY FOR DUAL BIPOLAR PATIENTS Diana Bachiller. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. COMORBIDITY INFLUENCE ON THE MANAGEMENT OF CONTIGENCY IN ADDICTS Prof. Roberto Secades. University of Oviedo, Spain. 112

111 FRIDAY 07th OCTOBER 07 Room 5 15:30 17:00 SYMPOSIUM S3-53 Track 31 SUBSTANCE USE AND SUICIDE Chairs/Presenters: Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. SUICIDE Dr. M. Dolores Braquehais. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. THE UNCOUNTED CASUALTIES OF WAR: SUICIDE IN WAR VETERANS WITH SUBSTANCE USE Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. CHILDHOOD ABUSE, IMPULSIVITY, SUBSTANCE ABUSE AND SUICIDE Dr. M. Dolores Braquehais. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. MOOD AND SMOKING - ITS RELATIONSHIP WITH SUICIDAL BEHAVIOR Dr. Zoltan Rihmer, M.D., Ph.D., Semmelweis University. Budapest, Hungary. BIPOLAR DISORDER, ALCOHOL AND SUICIDE. WHAT ARE THE RELATIONS? Dr. Brit Haver, M.D., Ph.D., University of Bergen. Norway. 113

112 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 6 16:00 17:30 SYMPOSIUM S3-61 Track 23 MULTIDISCIPLINARY APPROACHES TOWARDS INTEGRATED DUAL DISORDER TREATMENT IN THE NETHERLANDS Dr. Sonja van Rooijen, Projectleader LEDD, Senior Research Associate. Trimbos-Institute. Utrecht, The Netherlands. IMPLEMENTING INTEGRATED TREATMENT IN THE NETHERLANDS, THE DUTCH EXPERIENCE Mrs. Anneke van Wamel. Research Associate. Programme Reintegration Trimbos-Institute. Utrecht, The Netherlands. THE NEED FOR A NATIONAL CENTRE OF EXPERTISE ON DUAL DISORDER Mr. Bas van der Hoorn. Psychiatrist. Palier, part of Parnassia Bavogroep. The Hague, The Netherlands. INTEGRATED TREATMENT FOR PATIENTS WITH PERSONALITY AND ADDICTION Mr. Albert Dijkhuizen. Psychiatrist, GGz Eindhoven en de Kempen Eindhoven. The Netherlands. GROUP TREATMENT FOR DUAL DISORDER PATIENTS Mrs. Martje van Giffen. Projectmanager Dual Disorders. Mentrum, part of Arkin. Amsterdam, The Netherlands. HOUSING FOR DUAL DISORDER PATIENTS IN THE NETHERLANDS Mrs. Christien Muusse. Research associate. Programme Reintegration. Trimbos-Institute. Utrecht, The Netherlands. 114

113 FRIDAY 07th OCTOBER 07 Room 8 15:30 17:00 SYMPOSIUM S3-82 Track 23 DRUG AND ALCOHOL IMPACT IN EMERGENCIES MULTIDISCIPLINARY APPROACHES Dr. Frutos del Nogal Sáez. Medical Specialist in Intensive Care. Intensive Care Service.Hospital Universitario Severo Ochoa. Leganés, Madrid, Spain. DESIGNER DRUGS AND PHARMING IN HOSPITAL EMERGENCIES Dr. Miguel Galicia. Emergency Department. Hospital Clinic. Barcelona, Spain. DRUGS AND ALCOHOL IN POLITRAUMA PATIENTS Dr. Emilio Alted López. Specialist in intensive care. Head of the trauma patients. Intensive Care Service. Hospital Universitario 12 de Octubre. Madrid, Spain. IMPACT OF DOUBLE-DIAGNOSIS AND ILLICIT DRUG ABUSE ON THE OUTCOME OF HEPATITIS-C-TREATMENT IN PATIENTS ON OPIATE-SUBSTITUTION-THERAPY (OST) Dr. Stephan Kurt Walcher. Clinical Director. CONCEPT Center for Addiction Treatment. Munich, Germany. 115

114 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 11 15:30 17:00 SYMPOSIUM S3-77 Track 27 DUAL DIAGNOSIS Y PRISIÓN LEGAL ASPECTS IN DUAL DIAGNOSIS Dr. Antonio López Burgos. President, Sociedad Española de Sanidad Penitenciaria. Sevilla, Spain. DUAL DIAGNOSIS AND DELINQUENCY: CHARACTERISTICS OF PRISON PSYCHIATRIC CARE Dr. Manuel Sanz Cuenca. Psychiatrist, Hospital Psiquiátrico Penitenciario de Sevilla. Spain. DUAL DIAGNOSIS AND ADDICTIVE BEHAVIORS IN PRISON Dr. Pedro Seijo Ceballos. Consulting Psychiatrist, Centro Penitenciario de Sevilla. Spain. OPIOID SUBSTITUTION PROGRAMS IN PRISON, ANOTHER ALTERNATIVE TO METHADONE Dr. José Joaquín Antón Basantas. Physician, Centro Penitenciario de Albolote. Granada, Spain. 116

115 FRIDAY 07th OCTOBER 07 Room 12 15:30 17:00 SYMPOSIUM S3-63 Track 20 DRUGS IN DUAL DIAGNOSIS USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS Prof. Carmen Leal. Professor of Psychiatry. Universidad de Valencia. Spain. PSYCHOLOGICAL PROFILE OF PAINKILLERS DEPENDENT SUBJECTS Mrs. Susana Gómez-Baeza. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. BENZODIAZEPINE DEPENDENCE AND DUAL DIAGNOSIS Dr. Gonzalo Haro. Dual Disorders Program. Hospital of Castellón. Spain. BENZODIAZEPINE ABUSE IN PREGNANT WOMAN Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. BENZODIAZEPINE ABUSE IN PATIENTS WITH SEVERE MENTAL Dr. Carmen Barral. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. 117

116 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 1 16:00 17:30 SYMPOSIUM S3-51 Track 18 CANNABIS: PSYCHOSIS OR NEUROTOXICITY CANNABIS AND DUAL DIAGNOSIS Chairs: Dr. Rocío Martín-Santos. Department of Psychiatry. Hospital Clínic. Institute Clínic of Neuroscience. IDIBAPS, CIBERSAM. Barcelona, Spain. Dr. Sagnik Bhattachryya. Department of Psychosis Studies. Institute of Psychiatry. King s College. London, UK. GENETIC MODULATION OF THE NEUROCOGNITIVE EFFECTS OF CANNABIS IN MAN? Dr. Sagnik Bhattachryya. Department of Psychosis Studies. Institute of Psychiatry. King s College. London, UK. CANNABIS, PSYCHOSIS AND INTER-SUBJECT VARIABILITY? Dr. Zerrin Atakan. MD, PhD, Psychosis. Institute of Psychiatry. King s College. London, UK. CHRONIC CANNABIS USERS, NEUROIMAGING AND COMT MODULATION. Dr. Rocío Martín-Santos. Department of Psychiatry. Hospital Clínic. Institute Clínic of Neuroscience. IDIBAPS, CIBERSAM. Barcelona, Spain. INTERACTION BETWEEN COMT HAPLOTYPES AND CANNABIS IN SCHIZOPHRENIA Prof. Julio Sanjuan, MD, PhD, Hospital Clínic, UV, CIBERSAM. Valencia, Spain. Room 2 16:00 17:30 SYMPOSIUM S3-52 Track 30 DUAL DIAGNOSIS IN THE DSM5 AND ICD11 EPIDEMIOLOGY AND DUAL DIAGNOSIS Prof. Alfredo Calcedo Barba. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Speaker: Prof. Gabriel Rubio. Professor of Psychiatry. Universidad Complutense. Hospital Doce de Octubre. Madrid, Spain. Discussant: Prof. Marc Galanter. Professor of Psychiatry and Director. Division of Alcoholism and Drug Abuse, NYU School of Medicine. New York, USA. 118

117 FRIDAY 07th OCTOBER 07 Room 3 16:00 17:30 SATELLITE SYMPOSIUM SS3-05 Track 20 USEFUL PSYCHOTROPIC DRUGS AND DUAL DIAGNOSIS FUTURE PHARMACOLOGICAL ADVANCES IN THE TREATMENT OF ADHD Sponsored by Shire Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. FUTURE STIMULANT DRUGS FOR THE ADHD TREATMENT Dr. César Soutullo. Head of Child Psychiatry at the University Hospital of Navarra. Spain. FUTURE NON-STIMULANT DRUGS FOR THE ADHD TREATMENT Dr. Josep Antoni Ramos-Quiroga. ADHD Program Coordinator. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. TREATMENT OF ADHD PATIENTS WITH SUBSTANCE ABUSE Dr. Mats Johnson. Child Neuropsychiatry Unit. Queen Silvia s Hospital for Children. Göteborg, Sweden. 119

118 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 16:30 18:00 SYMPOSIUM S3-84 Track 1 SERIOUS ADDICTION AND PSYCHOSIS Dr. Carlos Mur de Víu. Coordinador Asistencial de la Oficina Reginal de Salud Mental. Dirección General de Hopsitales. Consejería de Sanidad. Madrid, Spain. BINGE OF CANNABIS AND PSYCHOSIS Prof. Mehdi Paes. Professor of Psychiatry. Ar-Razi Hospital. Rabat, Morroco. SEVERITY OF ADDICTION AND PSYCHOTIC CLINIC IN SUBSIDIARIES Laía Rodríguez-Cintas. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. PSYCHOTIC COMPLICATIONS OF COCAINE CONSUMPTION Dr. Francisco González-Saiz. Fundación Andaluza para Atención e Incorporación Social. Junta de Andalucía. Sevilla, Spain. Room 16 16:30 18:30 ORAL COMMUNICATIONS CO12 PSYCHOSIS Dra. Laia Miquel de Montagut. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain PROCESSES OF ADDICTION & TREATMENT OF WOMEN OPIOID DEPENDENCE IN HAMADAN - IRAN Mohammad Ahmadpanah, Ali ghaleiha, Mohammad Haghighi, Ahmad Heida Pahlavian Hamadan Medical Sciences University. Iran USO DE CANNABIS EN LA ESQUIZOFRENIA AUTOMEDICACIÓN? Luis Alfonso Núñez Domínguez Centro Médico. Spain. 120

119 FRIDAY 07th OCTOBER MENTAL AND CHILD-REARING STYLES BETWEEN CANDIDATE ADULT FOR ADDICTION WITHDRAWAL IN COMPARISON WITH NON-ADDICTEDADULTS HEALTH Fateme Raiisi University.Iran.Tehran 4.00 TREATING PSYCHOTIC PATIENTS WITH A OPIOID AGONIST THERAPY AND ATYPICAL ANTIPSYCHOTICS Maria Chiara Pieri MD Coordinator Head Education Office,Drug Addiction service Ausl Bologna. Italy 5.00 RISK BEHAVIORS OF INTRAVENOUS DRUG USERS D. Berbesi Fernández 1, L. Montoya Velez 1, A. Segura Cardona 1, P. Mateu-Gelabert 2 1 Docente- Investigador, Universidad CES, Medellín- Colombia 2 National Development Research Institutes 6.00 PSYCHOSIS AND DUAL DIAGNOSIS: SOCIODEMOGRAPHIC CHARACTERISTICS AND INCOME Elisa Mariño Díaz, Tania Isabel Blanco Pena, David Fachal Vázquez, Carmen Rozados Villaverde, José María Blanco Lobeiras, Víctor Pedreira Crespo Complejo Hospitalario De Pontevedra-Servicio de Psiquiatría. Spain DOES THE DALI SCALE SHOW GREATER PREDICTIVE WEIGHT FOR HOSPITAL READMISSION THAN A URINE SAMPLE? A SURVIVAL ANALYSIS IN FIRST EPISODE PSYCHOSIS Albert Batalla Cases 1, Clemente García-Rizo 1, Pere Castellví 2, Emili Fernández-Egea 3, Eduard Parellada 1, Brian Kirkpatrick 4, Rocío Martín-Santos 5, Miguel Bernardo 1 1 Clinic Schizophrenia Program, Hospital Clinic, University of Barcelona, Barcelona, Spain 2 Bellvitge University Hospital. University of Barcelona, Barcelona, Spain 3 University of Cambridge, Addenbrooke s Hospital, CB2 0QQ Cambridge, UK 4 Texas A&M University College of Medicine and Scott & White Healthcare, Temple, Texas, USA 5 Inpatient Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain 121

120 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER 8.00 SUPPORT FOR THE INVOLVEMENT OF CALRETICULIN GENE IN THE EVOLUTION OF COGNITION IN HUMANS Tayebeh Farokhashtiani, Mina Ohadi Genetics Research Center, University Of Social Welfare And Rehabilitation Sciences. Iran TREATMENT OUTCOMES OF AN INTEGRATED RESIDENTIAL PROGRAM FOR PATIENTS WITH SCHIZOPHRENIA AND SUBSTANCE USE DISORDER Geert Dom Antwerp University. Belgium. Room 4 17:00 18:30 SYMPOSIUM S3-59 Track 07 IMPULSIVITY AND DUAL DIAGNOSIS Prof. Manuel Trujillo. Department of Psychiatry. New York University, USA. IMPULSIVITY STIMULANTS AND IMPULSIVITY Dr. Constanza Daigre. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. IMPULSIVITIY AND DEPRESSANT DRUGS Prof. Manuel Trujillo. Department of Psychiatry. New York University, USA. IMPULSIVITY, COGNITION AND ADDICTION Dr. Carlos Jacas. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. 122

121 FRIDAY 07th OCTOBER 07 Room 5 17:00 18:30 SYMPOSIUM S3-60 Track 31 SUICIDE Prof. José Giner. Professor of Clinical Psychology. University of Sevilla, Spain. SUICIDE RISK FACTORS IDENTIFIED IN SUICIDE Dr. Lucas Giner. University of Sevilla, Spain. SUICIDAL BEHAVIOR IN THE FIELD OF DRUG ADDICTION Dra. Marta Quesada. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. SIX MONTH FOLLOW-UP ON RISK FACTORS FOR SUICIDAL IDEATION AMONG COLLEGE STUDENTS: A LONGITUDINAL EXAMINATION Dr. Oren Shtayermman. Mental Health Couseling Program Director. New York Institute of Technology. New York, USA. Room 6 17:30 19:30 SYMPOSIUM S2-13 Track 05 PERSONALITY FROM PERSONALITY TO ADDICTION THROUGH NEUROBIOLOGY Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. INTRODUCTION Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. DO WE STILL SUPPORT THE MAIN ROLE OF IMPULSIVITY IN ADDICTION? Prof. Rafael Maldonado, Professor. Universidad Pompeu y Fabra. Barcelona, Spain. CANNABIS, CLUSTER A AND SCHIZOPHRENIA: SOME LIGHT ON THE CONTROVERSY? Dr. Fernando Cañas. Chief of Psychiatry. Hospital Rodriguez Lafora, Madrid, Spain. BORDERLINE PERSONALITY DISORDER AND OPIOIDS: A PARADIGM OF THE PERSONALITY-ADDICTION INTERRELATION Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. 123

122 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 8 17:00 19:00 SELF MEDICATION HYPOTHESIS General Director: Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texass, USA. Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. 124

123 FRIDAY 07th OCTOBER 07 Room 11 17:00 18:30 WORKSHOP W3-13 Track 27 LEGAL ASPECTS IN DUAL DIAGNOSIS HISTORY OF FORENCIS PSYCHIATRY IN CHILE AND IN THE PSYCHIATRIC HOSPITAL PHILIPPE PINEL: A CASE OF PSYCHOSIS. Chairs/Presenters: Mrs. María José López Sepulveda. Clinical Psychologist. Hospital Psiquiátrico Philippe Pinel. San Felipe Putaendo, Chile. Mr. Cristian Magnan García. San Felipe Putaendo, Chile. Room 12 17:00 18:30 SYMPOSIUM S3-62 Track 24 BASIC RESEARCH IN DUAL DIAGNOSIS WHAT CAN BASIC RESEARCH ADD TO A BETTER UNDERSTAING OF DUAL DIAGNOSIS? Prof. José Antonio Ramos Atance, Professor, Department of Biochemistry and Molecular Biology, Facultad de Odontología, Universidad Complutense, Madrid, Spain. IMPLICATION OF THE ENDOCANNABINOID SYSTEM DURING THE DEVELOPMENT AND ONSET OF SCHIZOPHRENIA Prof. Ismael Galve Ropert, Professor, Department of Biochemistry and Molecular Biology. Facultad de Ciencias Biológicas. Universidad Complutense, Madrid, Spain. USE OF CANNABIS AND DRUGS OF ABUSE AT YOUNGER AGES IN RELATIONSHIP WITH AN EARLIER ONSET OF SCHIZOPHRENIA Prof. Maria Paz Viveros. Professor of University. Department of Physiology (Animal Physiology II). Faculty of Biology. Universidad Complutense. Madrid, Spain. INFLUENCE OF DRUGS OF ABUSE IN THE TREATMENT OF SCHIZOPHRENIA Dr. Francisco Arias Horcajada. Psychiatry Service. Fundación Hospital de Alcorcón. Madrid, Spain. 125

124 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 1 17:30 19:00 SYMPOSIUM S3-57 Track 18 CANNABIS AND DUAL DIAGNOSIS CANNABIS AND DUAL DIAGNOSIS Prof. Miguel Bernardo. Psychiatry Service. Hospital Clínic de Barcelona. Universitat de Barcelona. Spain. CANNABIS USE AND MENTAL ILLNESS IN A SOCIETY OF HUNTERS AND COLLECTORS (THE HATZABE) Dr. Luis Caballero. Psychiatry Department. Hospital Puerta de Hierro. Madrid, Spain. INFLUENCE OF DUAL DIAGNOSIS IN THE TERAPEUTIC ADHERENCE IN CANNABIS ADDICTS Dr. Begoña Gonzalvo. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. CANNABIS CONSUMPTION AND MENTAL Dr. Amine Benyamina. Centre d Enseignement, de Recherche et De Traitement des Addictions. Hôpital Universitaire Paul Brousse. Villejuif, France. 126

125 FRIDAY 07th OCTOBER 07 Room 2 17:30 19:00 SYMPOSIUM S3-58 Track 22 SOCIAL DETERMINANTS AND DUAL DIAGNOSIS PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS Chair/Presenter: Prof. John Fox. Douglas College. New Westminster, Canada. THE SOCIAL DETERMINANTS OF HEALTH: RECOVERY AND RELAPSE PREVENTION IN REAL TIME Prof. John Fox. Douglas College. New Westminster, Canada. PSYCHOTHERAPEUTIC TREATMENTS IN DUAL. DIALECTICAL BEHAVIORAL THERAPY AND MOTIVATIONAL INTERVIEWING IN PATIENTS WITH DUAL DIAGNOSIS Dr. Susana E. Mendez. MAOM, LCDC, CAS, ABMPP, NBCHH, ENTERHEALTH, LLC. USA. DUAL DIAGNOSIS AND MENTAL IN SUBSTANCE-USING INMATES María José Casares López. Psychologist. University of Oviedo. Spain. 127

126 SATURDAY OCTOBER 08th II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVIORS AND OTHER MENTAL

127 09:30 10:00 10:30 11:00 11:30 12:00 12:30 13:00 13:30 14:00 Room 1 (Translation) S4-64 Gender S4-66 Gender Room 2 (Translation) W4-14 Personality Disorders S4-67 Personality Disorders S4-72 Personality Disorders Room 3 (Translation) W4-15 Multidisciplinary Approaches S4-68 Resource Management S4-73 Resource Management Room 4 (Translation) W4-16 Psychotherapeutic Treatment S4-69 Resource Management W4-24 Psychotherapeutic Treatment SATURDAY OCTOBER 8th 2011 Room 5 (Translation) Room 6-7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 15 W4-23 Gender W4-27 Child & Adolescent Psychiatry S4-65 Multidisciplinary Approaches W4-17 Multidisciplinary Approaches W4-18 Child & Adolescent Psychiatry W4-19 Multidisciplinary Approaches W4-20 Psychotherapeutic Treatment S2-55 Depression S4-70 Multidisciplinary Approaches W4-21 Multidisciplinary Approaches S4-71 Child & Adolescent Psychiatry W4-22 Multidisciplinary Approaches W4-25 Psychotherapeutic Treatment S4-74 Multidisciplinary Approaches W4-26 ADHD S4-88 Child & Adolescent Psychiatry W4-28 Multidisciplinary Approaches

128 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER TRACK INDEX Track 02 DEPRESSION 11:00 12:30 DEPRESSION AND ADDICTIVE Room 6 Track 05 PERSONALITY 09:30 11:00 THE TREATMENT OF PATIENTS WITH A (SEVERE) PERSONALITY DISORDER AND SUBSTANCE USE DISORDER Room 2 11:00 12:30 DUAL EFFECT OF PATHOLOGY AND SUBSTANCE ABUSE IN THE PATHOPYSHIOLOGY AND PROGNOSIS OF BORDERLINE PERSONALITY DISORDER Room 2 12:30 14:00 DRUG, PERSONALITY AND RELATIONSHIP WITH MENTAL HEALTH, CRITERIA FOR YOUNG PEOPLE Room 2 Track 06 ADHD 12:30 14:00 DUAL DIAGNOSIS IN DEVELOPMENTAL DISORDER (AUTISM SPECTRUM ADHD) Room 10 Track 10 CHILD AND ADOLESCENT PSYCHIATRY 09:30 11:00 DUAL JOY: MULTIMODAL INTERVENTION PROGRAM FOR CHILDREN AND ADOLESCENTS IN STATE STREET IN THE CITY OF MEDELLIN, COLOMBIA Room 11 11:00 12:30 EPIGENETICS AND DUAL DIAGNOSIS: ECOSYSTEMIC INFLUENCE IN CHILDREN AND ADOLESCENTS Room 11 12:30 14:00 ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL PATHOLOGY: A COMPARATIVE DIAGNOSTIC STUDY Room 11 12:30-14:00 ADDICTED TEENS Room 11 Track 12 GENDER AND DUAL DIAGNOSIS 09:30 11:00 EMPHASIZING WOMEN IN DUAL DIAGNOSIS. RESEARCH ON GENDER ASPECTS OF DUAL DIAGNOSIS Room 1 09:30 11:00 DUAL DIAGNOSIS AND TRAUMA SURVIVORS OF CHILDHOOD SEXUAL ABUSE- IMPLICATIONS FOR PRACTICE Room 5 11:00 12:30 YOUNG WOMEN AND DUAL DIAGNOSIS Room 1 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS 09:30 11:00 SOCIAL COMPETENCE TRAINNING AND CHANGE PROCESS Room 4 11:00 12:30 DESIGNING AND IMPLEMENTING CONTINGENCY MANAGEMENT INTERVENTIONS FOR ADDICTIVE BEHAVIORS Room 5 12:30 14:00 FAMILY INTERVENTION IN DUAL DIAGNOSIS Room 4 12:30 14:00 EFFECTIVE TOOLS OF POSITIVE PSYCHOLOGY, RESILIENCE AND ETHICS FOR DUAL DIAGNOSIS PSYCHOEDUCATIONAL PROGRAM Room 5 130

129 SATURDAY 08th OCTOBER 08 Track 23 MULTIDISCIPLINARY APPROACHES 09:30 11:00 THE TRANSLATION OF DUAL DIAGNOSIS THEORY TO CLINICAL PRACTICE WITH UNDERGRADUATE STUDENT NURSES: THE AUSTRALIAN EXPERIENCE Room 3 09:30 11:00 RESEARCH AND THERAPEUTIC APPROACH TO ADDICTIVE PATHOLOGY IN MEXICO Room 9 09:30 11:00 DUAL DIAGNOSIS: DIAGNOSIS FOR DIFFERENT OR THE SAME ISSUES Room 10 09:30 11:00 HOSPITAL ADDICTIONS. DUAL DIAGNOSIS Room 12 11:00 12:30 ADDICTIVE BEHAVIORS AND OTHER MENTAL IN ILLEGAL-DRUG USERS IN DEPREVIED SOCIAL SITUATION Room 9 11:00 12:30 THERAPEUTIC COMMUNITY AND DUAL DIAGNOSIS Room 10 11:00 12:30 DUAL DISORDER GROUP TREATMENT Room 12 12:30 14:00 MULTIDISCIPLINARY MANAGEMENT OF DUAL PATHOLOGY COMMUNITY THERAPEUTIC FOR TREATMENT OF ADDICTION AND AMBULATORY NETWORK. EXPERIENCE OF TWO YEARS IN BOARDING PHARMACOLOGICAL AND PSYCHOTHERAPEUTIC AND SOCIAL Room 9 12:30 14:00 IMPLEMENTING INTEGRATED TREATMENT FOR DUAL IN THE NETHERLANDS: LESSONS LEARNED Room 12 Track 28 RESOURCE MANAGEMENT 11:00 12:30 INTERNATIONAL COOPERATION IN THE IMPROVEMENT OF CARE OF DUAL PATIENTS IN LATINAMERICA Room 3 11:00 12:30 DUAL PATHOLOGY BY DRUG CONSUMPTION AND IN AN OUT PATIENT IN DIFFERENTS RESOURCES OF TREATMENT IN CANARY ISLANDS Room 4 12:30 14:00 UK PERSPECTIVES IN DUAL SERVICE DEVELOPMENT Room 3 131

130 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 1 09:30 11:00 SYMPOSIUM S4-64 Track 12 GENDER AND DUAL DIAGNOSIS EMPHASIZING WOMEN IN DUAL DIAGNOSIS. RESEARCH ON GENDER ASPECTS OF DUAL DIAGNOSIS Dr. Mª Cristina Pinet Ogué. Unit of Addictive Behaviors. Psychiatry Service. Hospital Sant Creu i Sant Pau. Barcelona, Spain. GENDER DIFFERENCES IN DUAL DIAGNOSIS Dr. Laia Miquel de Montagut. CAS Vall d Hebron. Servei de Psiquiatria. Hospital Universitari Vall d Hebron-ASPB. Universitat Autònoma de Barcelona. Spain. VIOLENCE, GENDER AND DUAL DIAGNOSIS Dr. Gail Gilchrist, University of Greenwich, London, Reino Unido. IMIM-Parc de Salut Mar. Barcelona, Spain. GENDER AND SUBSTANCE USE IN BIPOLAR DISORDER Dr. Jesús Vicente Cobo Gómez. Psychaitry Service. Hospital Parc Taulí, Sabadell. Barcelona, Spain. PREGNANCY RELATED SUBSTANCE USE AND POSTPARTUM DEPRESSION Dr. Mª Llüisa Imaz. Psychiatry Service. Hospital Clínic. Barcelona, Spain. Room 2 09:30 11:00 WORKSHOP W4-14 Track 05 PERSONALITY THE TREATMENT OF PATIENTS WITH A (SEVERE) PERSONALITY DISORDER AND SUBSTANCE USE DISORDER Chairs/Presenters: Dr. Albert Dijkhuizen. Psychiatrist, GGz Eindhoven en de Kempen, Eindhoven, The Netherlands. Mrs. Anneke van Wamel. Research Associate, Programme Reintegration, Trimbos-Institute, Utrecht, The Netherlands. 132

131 SATURDAY 08th OCTOBER 08 Room 3 09:30 11:00 WORKSHOP W4-15 Track 23 MULTIDISCIPLINARY APPROACHES THE TRANSLATION OF DUAL DIAGNOSIS THEORY TO CLINICAL PRACTICE WITH UNDERGRADUATE STUDENT NURSES: THE AUSTRALIAN EXPERIENCE Chairs/Presenters: Mr. Richard Bostwick. Course Coordinator/Senior Lecturer (Mental Health). School of Nursing, Midwifery and Postgraduate Medicine Edith Cowan University, Perth, Western Australia. Dr. Michael Monisse-Redman. Lecturer (Mental Health). School of Nursing, Midwifery and Postgraduate Medicine Edith Cowan University, Perth, Western Australia. Room 4 09:30 11:00 WORKSHOP W4-16 Track 22 SOCIAL COMPETENCE TRAINNING AND CHANGE PROCESS PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS Dr. A. Rita Martín Caballero. Clinical Psychologist ACJ SAN MIGUEL Collaborative Professor of ULL. Tenerife, Spain. TRAINING PROGRAMS R & R2 IN SHORT VERSION FOR ADULTS, PROMOTE SOCIAL COMPETENCES AND CHANGE Dr. A. Rita Martín Caballero. Clinical Psychologist ACJ SAN MIGUEL Collaborative Professor of ULL. Tenerife, Spain. IMPORTANCE OF SOCIAL COMPETENCE PROGRAMS IN MENTAL HEALTH Prof. Juan Martínez Torvisco. Department of Social and Organizational Psychology, University of La Laguna. Tenerife, Spain. THE EXPERIENCE OF APPLYING A SHORT PROGRAM FOR THE PREVENTION OF RELAPSE TO DRUG ADDICTS WITH MENTAL ASSOCIATED Román Morales de Armas and Mónica Gómez Pérez. University of La Laguna. Tenerife, Spain. 133

132 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 5 09:30 11:00 WORKSHOP W4-23 Track 12 GENDER AND DUAL DIAGNOSIS DUAL DIAGNOSIS AND TRAUMA SURVIVORS OF CHILDHOOD SEXUAL ABUSE- IMPLICATIONS FOR PRACTICE Chairs/Presenters: Mrs. Lois Dugmore. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, United Kingdom. Mrs. Jackie Channell. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, United Kingdom. Room 6 09:30 11:00 RETHINKING THE DUAL DIAGNOSIS Invitation-only access President: Prof. Pedro Ruiz. Professor and Executive Vice Chair. Department of Psychiatry and Behavioral Sciences. University of Miami. Miller School of Medicine. USA. Prof. Miguel Casas. Professor of Psychiatry. Universitat Autònoma de Barcelona. Chief of the Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Barcelona, Spain. Prof. Marc Auriacombe. Professeur des Universtités. Université Victor Segalen. Bordeaux, France. Dr. Javier Didia Attas. Coordinator of the Addictive Disorders and Dual Pathology Unit. Hospital Italiano de Buenos Aires & University of Buenos Aires. Argentina. Prof. Nady el-guebaly. Professor of Psychiatry. Faculty of Medicine. University of Calgary. Canada. Prof. Gabriele Fischer. Professor of Psychiatry. Medical Director of Addiction Clinic. Department of Psychiatry. Medical University Vienna. Austria. Dr. Célia Franco. Psychiatrist, Coordinator of the Addiction Service (SA) of CHPC; APPD s President. Portugal. 134

133 SATURDAY 08th OCTOBER 08 Prof. Alan I. Green. Raymond Sobel Professor of Psychiatry. Professor of Pharmacology and Toxicology. Chairman, Department of Psychiatry Dartmouth Medical School. USA. Prof. Thomas Kosten. Professor of Psychiatry and Neuroscience. Baylor College of Medicine. Houston, Texas, USA. Dr. José Martínez-Raga. Psychiatrist. Addictive Behaviors Unit of Gandia & University CEU Cardenal Herrera, Valencia, Spain. Prof. Charles O Brien. Kenneth Appel Professor. Department of Psychiatry. University of Pennsylvania. USA. Dr. Lola Peris. Centre Neuchâtelois du Psychiatrie. Neuchâtel, Switzerland. Dr. Carlos Roncero. CAS Vall d Hebron. Psychiatry Service. Hospital Universitari Vall d Hebron - ASPB. Universitat Autònoma de Barcelona. Spain. Dr. Leo Sher. Associate Professor of Psychiatry. Mount Sinai School of Medicine. Co-Director of Inpatient Psychiatry, James J. Peters Veterans Administration Medical Center. New York, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Spain. Prof. Ambros Uchtenhagen. Research Institute for Public Health and Addiction. Zurich, Switzerland. Dr. Pablo Vega Astudillo. Instituto de Adicciones. Madrid, Spain. Dr. Nora Volkow. NIDA Director. USA. 135

134 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 09:30 11:00 SYMPOSIUM S4-65 Track 23 MULTIDISCIPLINARY APPROACHES RESEARCH AND THERAPEUTIC APPROACH TO ADDICTIVE PATHOLOGY IN MEXICO Dr. Mario Souza y Machorro. Academia Mexicana de Patología Dual. Mexico City, Mexico. ADDICTIVE PATHOLOGY CO-MORBID TO ANXIETY. PSYCHOPATHOLOGY AND TREATMENT Dr. Mario Souza y Machorro. Academia Mexicana de Patología Dual, AMEPAD. Ciudad de México. Mexico. DUAL DISORDER IN MEXICO UNIVERSITY STUDENTS WITH ALCOHOL DEPENDENCE Lic. Rosa Díaz Martínez. Psychiatry and Mental Health Department. Faculty of Medicine of the Universidad Nacional Autónoma de México. Mexico. MIRTAZAPINE IN ADOLESCENTS AND YOUNG ADULTS WITH PROBLEMATIC ALCOHOL CONSUMPTION AND MAJOR DEPRESSION: A CONTROLLED CLINICAL TRIAL Dr. Carlos Hernández Ávila. Psychiatry and Mental Health Department. Faculty of Medicine of the Universidad Nacional Autónoma de México. Mexico. COGNITIVE BEHAVIORAL THERAPY COMBINED WITH BUPROPION EXTENDED RELEASE FOR RELAPSE PREVENTION IN THE PROCESS OF QUITTING Dr. Jorge Ocampo. Academia Mexicana de Patología Dual, AMEPAD. Mexico City, Mexico. Room 8 09:30 11:00 WORKSHOP W4-27 Track 10 CHILD AND ADOLESCENT PSYCHIATRY ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL PATHOLOGY: A COMPARATIVE DIAGNOSTIC STUDY Chairs/Presenters: Dr. Jordi Royo Isach. Clinical Psychologist. Clinical Director of Amalgama-7, Biopsychosocial Care Center. Barcelona, Spain. Dr. Ramon Martí Montraveta. Psychiatrist. Medical Director of Amalgama-7, Biopsychosocial Care Center. Barcelona, Spain. 136

135 SATURDAY 08th OCTOBER 08 Room 10 09:30 11:00 WORKSHOP W4-17 Track 23 MULTIDISCIPLINARY APPROACHES DUAL DIAGNOSIS: DIAGNOSIS FOR DIFFERENT OR THE SAME ISSUES Dr. Luciano Cobos Luna. Doctor Coordinator. Drug and Addictions Instituto Provincial de Bienestar Social. Córdoba, Spain. DUAL DIAGNOSIS AND EXPERIMENTAL COMMON ELEMENTS Dr. Bartolomé Marín Romero. Psychologist. Los Pedroches. Villanueva de Córdoba Drugs and Addiction Clinic. Córdoba, Spain. PHARMACOLOGY AND DUAL DIAGNOSIS Dr. Francisco Ignacio Mata Cala. Doctor. Psychiatrist. Vega del Guadalquivir Drugs and Addiction Clinic. Córdoba, Spain COGNITIVE THERAPY IN DUAL PATHOLOGY. FUTURE PERSPECTIVES Dr. Magdalena de Miguel Fernández. Psychologist. Córdoba Centro Drugs and Addiction Clinic. Córdoba, Spain. Room 11 09:30 11:00 WORKSHOP W4-18 Track 10 CHILD AND ADOLESCENT PSYCHIATRY DUAL JOY: MULTIMODAL INTERVENTION PROGRAM FOR CHILDREN AND ADOLESCENTS IN STATE STREET IN THE CITY OF MEDELLIN, COLOMBIA Dr. Jorge Mario Rubio Sánchez. Drug Psychologist Specialist. DX-Service Coordinator Mental Hospital of Antioquia. Colombia. Dr. Hernán Darío Giraldo. Psychiatrist. Specialist in Children and Adolescents. Mental Hospital of Antioquia. Colombia. Elsa Nidia Toro Balcázar. Psychologist specialist in Human Resource Management. Municipality of Medellín. Colombia. 137

136 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 12 09:30 11:00 WORKSHOP W4-19 Track 23 HOSPITAL ADDICTIONS. DUAL DIAGNOSIS MULTIDISCIPLINARY APPROACHES Chair/Presenter: Dr. Victor Puente Pazos. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria-Gasteiz. País Vasco, Spain. RELAPSE PREVENTION GROUP DAY HOSPITAL IN DUAL DIAGNOSIS Dr. Juan Miguel Llorente del Pozo. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria-Gasteiz. País Vasco, Spain. SOCIAL WORK IN THE DAY HOSPITAL OF ADDICTIONS. DUAL DIAGNOSIS Dr. Fernando Manzanos Ruiz de Eguino. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria-Gasteiz. País Vasco, Spain. DAY HOSPITAL IN ADDICTIONS. DUAL DIAGNOSIS Dr. Victor Puente Pazos. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria-Gasteiz. País Vasco, Spain. CLINICAL PRACTICE IN THE DAY HOSPITAL FOR DUAL DIAGNOSIS Dr. Ana Isabel Ramírez Gorostiza. Araba Addiction Service, Mental Health Network of Araba, Osakidetza, Vitoria- Gasteiz. País Vasco, Spain. 138

137 SATURDAY 08th OCTOBER 08 Room 1 11:00 12:30 SYMPOSIUM S4-66 Track 12 YOUNG WOMEN AND DUAL DIAGNOSIS GENDER AND DUAL DIAGNOSIS Prof. María Dolores Franco Fernández. Professor of Psychiatry. Universidad de Sevilla. Spain. THE COMPLEX REALTIONSHIP BETWEEN PERSONALITY AND DUAL DIAGNOSIS IN YOUNG WOMEN Prof. María José Moreno Díaz. Professor of Psychiatry. Universidad de Córdoba. Spain. Dr. María José Jaén. Mir3 Psychiatry. Hospital Reina Sofía de Córdoba. Spain. EATING AND SUBSTANCE USE/ABUSE Dr. Marina Díaz-Marsá. Hospital San Carlos. Associated Professor. Universidad Complutense. Madrid. Spain. VIOLENCE AND SUICIDE IN YOUNG WOMEN WITH DUAL DIAGNOSIS Prof. Pilar A. Sáiz Martínez. Professor of Psychiatry. Universidad Oviedo. Spain. 139

138 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 2 11:00 12:30 SYMPOSIUM S4-67 Track 05 PERSONALITY DUAL EFFECT OF PATHOLOGY AND SUBSTANCE ABUSE IN THE PATHOPYSHIOLOGY AND PROGNOSIS OF BORDERLINE PERSONALITY DISORDER Dr. Víctor Pérez Sola. Psychiatry Unit Director of H. Santa Creu i Sant Pau, Barcelona, Spain. COMMON NEUROBIOLOGICAL BASES BETWEEN BPD AND SUD Prof. José Luis Carrasco Perera. Head of the Unit Personality Disorders at the Hospital Clínico San Carlos, Madrid, Spain. NEURODEVELOPMENTAL INTERACTION: BPD, SUD AND ADHD Dr. Marc Ferrer Vinardell. Servei de Psiquiatria. Hospital Universitari Vall d Hebron. Universitat Autònoma de Barcelona. Spain. BPD RESISTANT. INFLUENCE OF THE TOXIC CONSUMPTION IN THE EVOLUTION AND PROGNOSIS OF PATIENTS WITH BPD Dr. Juan Carlos Pascual Mateos. TLP Program Coordinator of the Psychiatry Department of the Hospital de la Santa Creu i Sant Pau. Barcelona, Spain. Room 3 11:00 12:30 SYMPOSIUM S4-68 Track 28 RESOURCE MANAGEMENT INTERNATIONAL COOPERATION IN THE IMPROVEMENT OF CARE OF DUAL PATIENTS IN LATINAMERICA Dr. Luis Alfonzo, Specialist In Demand Reduction, CICAD - Organización de Estados Americanos. Washington, USA. Dr. Nestor Szerman. Psychiatrist. Hospital General Universitario Gregorio Marañón. Madrid, Spain. Dr. Edgard Belfort. Ex presidente de la APAL. University of Caracas. Venezuela. Prof. Elvia Velázquez. Department of Psychiatry. Universidad de Antioquía. Colombia. 140

139 SATURDAY 08th OCTOBER 08 Room 4 11:00 12:30 SYMPOSIUM S4-69 Track 28 RESOURCE MANAGEMENT DUAL PATHOLOGY BY DRUG CONSUMPTION AND IN AN OUT PATIENT IN DIFFERENTS RESOURCES OF TREATMENT IN CANARY ISLANDS Dr. Rafael Valenciano. Unidad Hospitalaria de Drogodependientes. Servicio de Psiquiatría. Hospital Universitario de Canarias. Spain. DUAL PATHOLOGY STUDIES ON DRUG CONSUMPTION IN A SAMPLE OF PATIENTS FROM THE UAD S / C DE TENERIFE Ms. María Natividad García Gómez. Clinical Psychologist UAD S / C de Tenerife of ACJ SAN MIGUEL. Tenerife. Canary Islands, Spain. DRUG CONSUMPTION AND ASSOCIATED PSYCHIATRIC PATHOLOGY Mr. Antonio M. Rodríguez Cerezo. Clinical Psychologist and Coordinator of the UAD S/C de La Palma. Canary Islands, Spain. PSYCHOPATHOLOGICAL PROFILE AND DUAL in PATIENT IN THIRD LEVEL S TREATMENT CENTER Dr. A. Rita Martín Caballero. Clinical Psychologist of the Day Centre Cercado del Marqués ACJ SAN MIGUEL and Collaborative Professor of ULL. Tenerife. Canary Islands, Spain. Room 5 11:00 12:30 WORKSHOP W4-20 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS DESIGNING AND IMPLEMENTING CONTINGENCY MANAGEMENT INTERVENTIONS FOR ADDICTIVE BEHAVIORS Chairs/Presenters: Carla J. Rash. University of Connecticut Health Center. Department of Medicine. Farmington, USA. Nancy M. Petry. University of Connecticut Health Center. Department of Medicine. Farmington, USA. 141

140 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 6 11:00 12:30 SYMPOSIUM S2-55 Track 02 DEPRESSION AND ADDICTIVE Prof. Marta Torrens. Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Spain. DEPRESSION ANIMAL MODELS IN DEPRESSION AND ADDICTIVE Prof. Olga Valverde. Universitat Pompeu Fabra, Barcelona, Spain. EPIDEMIOLOGICAL AND CLINICAL ASPECTS OF COMORBID DEPRESSION IN ADDICTIVE Prof. Marta Torrens,Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Universitat Autònoma Barcelona, Barcelona, Spain. PHARMACOLOGICAL TREATMENT OF COMORBID DEPRESSION AND ADDICTIVE Prof. Magi Farré. IMIM-Institut de Recerca Hospital del Mar, Universitat Autònoma Barcelona, Spain. 142

141 SATURDAY 08th OCTOBER 08 Room 9 11:00 12:30 SYMPOSIUM S4-70 Track 23 MULTIDISCIPLINARY APPROACHES ADDICTIVE BEHAVIORS AND OTHER MENTAL IN ILLEGAL-DRUG USERS IN DEPREVIED SOCIAL SITUATION Dr. Pere Antoni Soler Insa. Psychiatric Area Director of the Hospital Universitari Mutua Terrassa. Drug Addiction and AIDS Management Area. Cruz Roja Barcelona. Spain. PSYCHIATRIC IN LON-TERM HEROIN AND COCAINE USERS Dr. Jorge Fernández López. CEA- MARITIM (Comité Ciudadano Anti-SIDA de la Comunidad Valenciana). Valencia, Spain. PSYCHIATRIC MANIFESTATIONS IN THE ACUTE POST COCAINE USE SYNDROME Dr. Lorena Andreo Pagan. SAPS Creu Roja. Barcelona. Spain. In colaboration with the Injection Rooms from Barcelona, LLeida, Bilbao and Madrid, Spain. CONVULSIVE SYNDROME AND DRUG USE Dr. Anna Planas Ballvé. Hospital Universitari del Sagrat Cor. Barcelona, Spain. CARE OF DRUG USERS WITH PSYCHIATRIC SYMPTOMATOLOGY IN A NON-SPECIALIZED SERVICE Dr. Ana Altabas Reñé. AMBIT Prevenció. Barcelona. Spain. ALTER-PSICHIATRY: ANOTHER MODEL OF CARE FOR PATIENTS WITH DRUG PROBLEMS Mrs. Olga Díaz Grau. Centre Integral Lluis Companys. Creu Roja Barcelona. Spain. 143

142 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 10 11:00 12:30 WORKSHOP W4-21 Track 23 COMUNIDAD TERAPEUTICA Y PATOLOGIA DUAL MULTIDISCIPLINARY APPROACHES Lic. Daniel De Angelis, President of the Proyecto Uno, Comunidad Terapéutica en Adicciones y Salud Mental. Buenos Aires, Argentina. CONCEPTUALIZATION AND DEVELOPMENT OF AN INTEGRAL THERAPEUTIC COMMUNITY Lic. Daniel De Angelis. Proyecto Uno. Buenos Aires, Argentina. STRATEGIES OF INTERVENTION IN AN INTEGRAL THERAPEUTIC COMMUNITY FOR PATIENTS WITH DUAL DIAGNOSIS Lic. Sebastián Rodríguez. Proyecto Uno. Buenos Aires, Argentina. Room 11 11:00 12:30 SYMPOSIUM S4-71 Track 10 CHILD AND ADOLESCENT PSYCHIATRY EPIGENETICS AND DUAL DIAGNOSIS: ECOSYSTEMIC INFLUENCE IN CHILDREN AND ADOLESCENTS Dr. Emma Saad de Janon. Catholic University of Santiago de Guayaquil. Ecuador. TRANSIENT AND DEFINITIVE LOSSES IN CHILDHOOD AND ADOLESCENCE: GRIEF PROCESSES IN THE GENESIS OF DUAL PATHOLOGY Dr. Emma Saad de Janon. Catholic University of Santiago de Guayaquil. Ecuador. ABANDONMENT AND ABUSE DURING CHILDHOOD: ANOTHER PATHWAY TO DUAL DIAGNOSIS? Dr. Rodrigo Chamorro Oschilewsky. Universidad Central de Chile. Santiago de Chile, Chile. POST-TRAUMATIC STRESS DISORDER IN CHILDREN. BEHAVIORAL AND EMOTIONAL CONSEQUENCES AS DIVERSIONS IN THE DEVELOPMENT CYCLE Dr. Roberto Chaskel. Hospital Militar Central. Bogotá, Colombia. 144

143 SATURDAY 08th OCTOBER 08 Room 12 11:00 12:30 WORKSHOP W4-22 Track 23 DUAL DISORDER GROUP TREATMENT Challenging but worthy of further exploration MULTIDISCIPLINARY APPROACHES Chair/Presenter: Martje van Giffen. Project leader, Integrated Dual Disorder Treatment, Mentrum, Mental Health Care and Addiction Treatment, part of Arkin, Amsterdam, The Netherlands. Room 2 12:30 14:00 SYMPOSIUM S4-72 Track 05 PERSONALITY DRUG, PERSONALITY AND RELATIONSHIP WITH MENTAL HEALTH, CRITERIA FOR YOUNG PEOPLE Prof. Pablo García Medina. Professor of Department of Personality, Evaluation and Psychological Treatment of the ULL. Tenerife. Spain. PERSONALITY AND RELATIONSHIP WITH MENTAL HEALTH CRITERIA FOR YOUNG PEOPLE IN THE CANARY ISLANDS Prof. Pablo García Medina. Professor of Department of Personality, Evaluation and Psychological Treatment of the ULL. Tenerife. Spain. PERSONALITY & HEALTH: ADOLESCENTS WITH COURT DECISIONS D. Francisco David Lorenzo González. Psychologist Project Team of PROYECTA-ME, ACJ SAN MIGUEL. Tenerife. Canary Islands. Spain. PSYCHOPATHOLOGICAL PROFILE, SOCIAL COMPETENCE, HOSTILITY AND EMOTIONAL EXPRESSION IN YOUTH IN TREATMENT Dr. A. Rita Martín Caballero. Clinical Psychologist of the Day Centre Cercado del Marqués of the ACJ SAN MIGUEL and Teaching Assistant ULL. Tenerife. Canary Islands. Spain. 145

144 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 3 12:30 14:00 SYMPOSIUM S4-73 Track 28 RESOURCE MANAGEMENT UK PERSPECTIVES IN DUAL SERVICE DEVELOPMENT Dr. Elizabeth Hughes. Senior Lecturer. University of York, UK. TRAINING IN DUAL DIAGNOSIS INTERVENTIONS- EXPERIENCE FROM RCTS Dr. Elizabeth Hughes. Senior Lecturer. University of York, UK. DEVELOPING SERVICES AND SUPPORT FOR CARERS OF PEOPLE WITH DUAL DIAGNOSIS Dr. Tara O Neill. Consultant Clinical Psychologist. Psygroup Consulting/ C&IMHCT. Brighton, UK. DEVELOPING WORKFORCE COMPETEMCE USING INNOVATIVE LEARNING TECHNOLOGIES Mr. Justine Trippier. Consultant Nurse - Mental Health & Substance Use (Dual Diagnosis). Oxleas NHS Foundation Trust. London, UK. LOW THRESHOLD MENTAL HEALTH INTERVENTIONS FOR CANNABIS USERS- A PILOT GROUP PROGRAMME Mrs. Lois Dugmore. Consultant Nurse Dual Diagnosis. Leicestershire Partnership NHS Trust. Bradgate Unit. Glenfield Hospital. Leicester, UK. 146

145 SATURDAY 08th OCTOBER 08 Room 4 12:30 14:00 WORKSHOP W4-24 Track 22 FAMILY INTERVENTION IN DUAL DIAGNOSIS PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS Prof. Antonio Labad Alquézar. Professor of Psychiatry at the University Rovira i Virgili. Director of the teaching unit of the Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, Spain. DUAL DIAGNOSIS: FROM PATIENT TO FAMILY, A REVIEW FROM CLINICAL PRACTICE Dr. Blas Torrente Gutiérrez. Dual Diagnosis Unit. Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, Spain. EVALUATION OF FAMILY DYNAMICS IN PATIENTS ADMITTED TO A DUAL HOSPITALARY TREATMENT UNIT Dr. Samuel Pombo Chorto, Dual Diagnosis Unit. Hospital Psiquiátrico Universitario Institut Pere Mata. Reus. Tarragona, Spain. Room 5 12:30 14:00 WORKSHOP W4-25 Track 22 PSYCHOTHERAPEUTIC TREATMENT IN DUAL DIAGNOSIS EFFECTIVE TOOLS OF POSITIVE PSYCHOLOGY, RESILIENCE AND ETHICS FOR DUAL DIAGNOSIS PSYCHOEDUCATIONAL PROGRAM Dr. Guillermo Fernández Dadam. Director of Addictions and Positive Psychology, Neuropsychiatric Institute. Universidad Católica de Cuyo. Argentina. FROM HETERONOMY TO AUTONOMY LOOKING RESPONSIBILITY IN DUAL DIAGNOSIS Lic Hilda Tevez. Psychologist, Ethics and Drug Addiction. Association of Psychiatrists (APSA), Behavioral Addictions Institute of Neuropsychiatry and Positive Psychology. Buenos Aires, Argentina. 12 KEY STRATEGIES FOR THE PROMOTION OF SKILLS AND TECHNIQUES IN THE PATIENT AND FAMILY Dr. Guillermo Fernández Dadam. Addictions Institute of Neuropsychiatry and Positive Psychology. Buenos Aires, Argentina. 147

146 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL BARCELONA 5-8 OCTOBER Room 9 12:30 14:00 SYMPOSIUM S4-74 Track 23 TDAH MULTIDISCIPLINARY APPROACHES MULTIDISCIPLINARY MANAGEMENT OF DUAL PATHOLOGY COMMUNITY THERAPEUTIC FOR TREATMENT OF ADDICTION AND AMBULATORY NETWORK. EXPERIENCE OF TWO YEARS IN BOARDING PHARMACOLOGICAL AND PSYCHOTHERAPEUTIC AND SOCIAL Dr. Alicia Muñoz. Psychiatrist. Technical Director, Centro de Tratamiento de Adicciones El Jaguel de Maldonado (CETAM), Uruguay. PRESENTATION OF THE CENTER AND THE NETWORK Lic. Tatiana Scavone. Licenciada en Enfermería. Jefa de Personal del CETAM. Uruguay. EVALUATION STATISTICS Lic. Diana Mirabal. Licenciada en Servicio Social del CETAM y Equipo de Gestión. Uruguay. EXPERIENTIAL, THE UNDERSCORE AND CONCLUSIONS Lic. Adriana Ruiz. Psicóloga del CETAM y Equipo de Gestión, Uruguay. Room 10 12:30 14:00 WORKSHOP W4-26 Track 06 DUAL DIAGNOSIS IN DEVELOPMENTAL DISORDER (AUTISM SPECTRUM ADHD) Chairs/Presenters: Dr. Patricia J.M. Van Wijngaarden-Cremers MD. Psychiatrist, Head of Department of Addiction and Developmental Disorders, the Dimence GGz Zwolle. The Netherlands. Dr. Rutger Jan Van der Gaag MD PhD. Professor of Psychiatry (Child and Adolescent). University Medical Centre, St. Radboud Nijmegen. Department of Psychiatry and Karakter University Centre for Child and Adolescent Psychiatry. Zwolle, The Netherlands. 148

147 SATURDAY 08th OCTOBER 08 Room 11 12:30-14:00 SYMPOSIUM S4-88 Track 10 ADDICTED TEENS CHILD AND ADOLESCENT PSYCHIATRY Moderador: Dra. Fina Castro- Fornieles. Head of Child and Adolescent Psychiatry. Hospital Clínico Universitario de Barcelona. Spain. NEUROIMAGING IN DUAL ADOLESCENTS Dra. Mara Parellada. Servicio de Psiquiatría Hospital Gregorio Marañón. Madrid, Spain. ADHD AND DRUG ABUSE IN ADOLESCENTS Dra. Nuria Gómez. Psychiatry Service. Hospital Vall Hebron. Barcelona, Spain. ASSESSMENT OF PSYCHIATRIC COMORBIDITY IN ADDICTED ADOLESCENTS Rosa Díaz. Hospital Clínico Universitario (HCU). Barcelona, Spain. Room 12 12:30 14:00 WORKSHOP W4-28 Track 23 MULTIDISCIPLINARY APPROACHES IMPLEMENTING INTEGRATED TREATMENT FOR DUAL IN THE NETHERLANDS: LESSONS LEARNED Chairs/Presenters: Mrs. Anneke van Wamel. Research Associate. Programme Reintegration, Trimbos-institute. Utrecht, The Netherlands. Mrs. Christien Muusse. Research Associate. Programme Reintegration, Trimbos-institute. Utrecht, The Netherlands. POSTERS see pag 150 in the spanish version program CLINICAL CASES see pag 184 in the spanish version program INDEX AUTHORS see pag 200 in the spanish version program 149

148 II INTERNATIONAL CONGRESS DUAL ADDICTIVE BEHAVI ORS AND OTHER MENTAL EXHIBITION HALL: SALA GAUDI LABORATORIES SHIRE JUSTE LILLY FERRER PFIZER GEBRO SERVIER LUNDBECK BMS ADAMED ASTRAZENECA ALMIRALL RECKITT JANSSEN NEUROFARMAGEN ROVI SEPD SITUATION MAP The standing legal laws applicable to the promotion and publicity of medical drugs establishes that the promotion of prescription drugs can be addressed exclusively to those health professionals which are entitled to prescribe and facilitate them. 150

149 BARCELONA 5th-8th OCTOBER 2011 OFFICIAL SPONSORS ORGANIZED BY Sociedad Española de Patología Dual SECRETARIAT Londres, Madrid, Spain. Tel Fax